Annual Statements Open main menu

Trinity Capital Inc. - Quarter Report: 2022 June (Form 10-Q)

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended June 30, 2022

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 001-39958

TRINITY CAPITAL INC.

(Exact name of registrant as specified in its charter)

Maryland

35-2670395

(State or other jurisdiction of incorporation or
organization)

(IRS Employer Identification No.)

1 N. 1st Street
Suite 302
Phoenix, Arizona

85004

(Address of principal executive offices)

(Zip Code)

(480) 374-5350

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

   

Trading Symbol(s)

   

Name of each exchange on which registered

Common Stock, par value $0.001 per share

TRIN

Nasdaq Global Select Market

7.00% Notes Due 2025

TRINL

Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes      No   

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes      No   

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

 

 

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes      No   

As of August 3, 2022, the registrant had 31,405,672 shares of common stock ($0.001 par value per share) outstanding.

Table of Contents

TRINITY CAPITAL INC.

FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2022
TABLE OF CONTENTS

PAGE 
NO.

PART I

FINANCIAL INFORMATION

3

Item 1.

Consolidated Financial Statements

3

Consolidated Statements of Assets and Liabilities as of June 30, 2022 (unaudited) and December 31, 2021

3

Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2022 and 2021 (unaudited)

4

Consolidated Statements of Changes in Net Assets for the Three and Six Months Ended June 30, 2022 and 2021 (unaudited)

5

Consolidated Statement of Cash Flows for the Six Months Ended June 30, 2022 and 2021 (unaudited)

7

Consolidated Schedule of Investments as of June 30, 2022 (unaudited)

9

Consolidated Schedule of Investments as of December 31, 2021

29

Notes to Consolidated Financial Statements (unaudited)

46

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

80

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

97

Item 4.

Controls and Procedures

98

PART II

OTHER INFORMATION

99

Item 1.

Legal Proceedings

99

Item 1A.

Risk Factors

99

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

100

Item 3.

Defaults Upon Senior Securities

100

Item 4.

Mine Safety Disclosures

100

Item 5.

Other Information

100

Item 6.

Exhibits

101

SIGNATURES

102

2

Table of Contents

PART I: FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

TRINITY CAPITAL INC.

Consolidated Statements of Assets and Liabilities

(In thousands, except share and per share data)

    

June 30, 

    

December 31, 

2022

2021

 

(Unaudited)

ASSETS

 

  

 

  

Investments at fair value:

 

  

 

  

Control investments (cost of $36,704 and $38,994, respectively)

$

24,788

$

32,214

Affiliate investments (cost of $29,604 and $41,609, respectively)

 

23,837

 

32,192

Non-control / Non-affiliate investments (cost of $1,000,290 and $717,253, respectively)

 

1,002,449

 

809,064

Total investments (cost of $1,066,598 and $797,856, respectively)

 

1,051,074

 

873,470

Cash and cash equivalents

 

13,226

 

31,685

Restricted cash

 

 

15,057

Interest receivable

 

8,600

 

5,551

Deferred credit facility costs

2,848

2,308

Other assets

 

14,432

 

9,047

Total assets

$

1,090,180

$

937,118

 

  

 

  

LIABILITIES

 

  

 

  

KeyBank Credit Facility

$

220,000

$

81,000

August 2026 Notes, net of $2,391 and $2,679, respectively, of unamortized deferred financing costs

122,609

122,321

2025 Notes, net of $3,021 and $3,616, respectively, of unamortized deferred financing costs

 

121,979

 

121,384

December 2026 Notes, net of $1,661 and $1,842, respectively, of unamortized deferred financing costs

73,339

73,158

Convertible Notes, net of $2,201 and $2,515, respectively, of unamortized deferred financing costs and discount

47,799

47,485

Credit Suisse Credit Facility

10,000

Distribution payable

17,873

9,803

Security deposits

 

12,515

 

10,840

Accounts payable, accrued expenses and other liabilities

 

15,724

 

14,594

Total liabilities

 

631,838

 

490,585

 

  

 

  

Commitments and contingencies (Note 6)

 

  

 

  

 

  

 

  

NET ASSETS

 

  

 

  

Common stock, $0.001 par value per share (200,000,000 authorized, 31,355,832 and 27,229,541 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively)

 

31

 

27

Paid-in capital in excess of par

 

430,464

 

368,609

Distributable earnings/(accumulated loss)

 

27,847

 

77,897

Total net assets

 

458,342

 

446,533

Total liabilities and net assets

$

1,090,180

$

937,118

NET ASSET VALUE PER SHARE

$

14.62

$

16.40

See accompanying notes to consolidated financial statements.

3

Table of Contents

TRINITY CAPITAL INC.

Consolidated Statements of Operations

(In thousands, except share and per share data)

(Unaudited)

Three Months Ended

Six Months Ended

    

June 30, 2022

    

June 30, 2021

    

June 30, 2022

    

June 30, 2021

INVESTMENT INCOME:

 

  

  

 

  

  

Interest income:

 

  

  

 

  

  

Control investments

$

1,365

$

1,266

$

2,738

$

2,572

Affiliate investments

 

433

 

443

 

862

 

882

Non-Control / Non-Affiliate investments

 

30,713

 

16,405

 

57,317

 

31,004

Total interest income

32,511

18,114

60,917

34,458

Fee income:

Non-Control / Non-Affiliate investments

947

1,362

4,386

2,337

Total fee income

947

1,362

4,386

2,337

Total investment income

 

33,458

 

19,476

 

65,303

 

36,795

 

  

 

  

 

  

 

  

EXPENSES:

 

  

 

  

 

  

 

  

Interest expense and other debt financing costs

 

7,761

 

4,425

 

14,559

 

9,041

Compensation and benefits

 

6,877

 

3,370

 

13,331

 

7,366

Professional fees

891

570

 

1,723

 

1,216

General and administrative

 

1,558

 

1,031

3,035

1,780

Total expenses

 

17,087

 

9,396

 

32,648

 

19,403

NET INVESTMENT INCOME (LOSS) BEFORE TAXES

16,371

10,080

32,655

17,392

 

  

 

  

 

  

 

  

Excise tax expense

657

1,331

58

 

  

 

  

 

  

 

  

NET INVESTMENT INCOME

 

15,714

 

10,080

 

31,324

 

17,334

 

  

 

  

 

  

 

  

NET REALIZED GAIN/(LOSS) FROM INVESTMENTS:

 

  

 

  

 

  

 

  

Control investments

 

(228)

 

 

(228)

 

Affiliate investments

 

(9,633)

 

1,491

 

(9,633)

 

Non-Control / Non-Affiliate investments

 

244

 

504

 

52,888

 

4,590

Net realized gain/(loss) from investments

 

(9,617)

 

1,995

 

43,027

 

4,590

 

  

 

  

 

  

 

  

NET CHANGE IN UNREALIZED APPRECIATION/(DEPRECIATION) FROM INVESTMENTS:

 

  

 

  

 

  

 

  

Control investments

 

(804)

 

(4,530)

 

(5,136)

 

(12,084)

Affiliate investments

 

6,913

 

(1,892)

 

3,650

 

(8,204)

Non-Control / Non-Affiliate investments

 

(19,929)

 

19,052

 

(89,652)

 

48,394

Net change in unrealized appreciation/(depreciation) from investments

 

(13,820)

 

12,630

 

(91,138)

 

28,106

NET INCREASE/(DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS

$

(7,723)

$

24,705

$

(16,787)

$

50,030

 

  

 

  

 

  

 

  

NET INVESTMENT INCOME PER SHARE - BASIC

$

0.51

$

0.38

$

1.07

$

0.69

NET INVESTMENT INCOME PER SHARE - DILUTED(1)

$

0.48

0.38

$

1.02

$

0.69

 

  

 

  

 

  

 

  

NET CHANGE IN NET ASSETS RESULTING FROM OPERATIONS PER SHARE - BASIC & DILUTED

$

(0.25)

$

0.93

$

(0.58)

$

2.00

 

  

 

  

 

  

 

  

WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC & DILUTED

30,955,022

26,478,747

29,188,790

25,024,925

(1)Diluted net investment income per share for the three and six months ended June 30, 2022 has been calculated based on diluted weighted average shares of 34,331,597 and 32,565,365.

See accompanying notes to consolidated financial statements.

4

Table of Contents

TRINITY CAPITAL INC.

Consolidated Statements of Changes in Net Assets

(In thousands, except share and per share data)

(Unaudited)

Three Months Ended June 30, 2022:

    

    

    

    

Distributable

    

Earnings /

Common Stock

Paid In Capital

(Accumulated

Total

Shares

Par Value

in Excess of Par

Loss)

Net Assets

Balance as of March 31, 2022

 

27,982,842

$

28

$

370,570

$

53,443

$

424,041

Issuance of common stock pursuant to distribution reinvestment plan

30,800

588

588

Stock based compensation

1,767

1,767

Issuance of restricted stock awards

13,540

Issuance of common stock, net of issuance costs

3,344,214

3

57,911

57,914

Retired and forfeited shares of restricted stock

(15,564)

(372)

(372)

Distributions to stockholders

 

 

 

 

(17,873)

 

(17,873)

Net increase/(decrease) in net assets resulting from operations

 

 

 

 

(7,723)

 

(7,723)

Balance as of June 30, 2022

 

31,355,832

$

31

$

430,464

$

27,847

$

458,342

Three Months Ended June 30, 2021:

    

    

    

    

Distributable

    

Paid In Capital

Earnings /

Common Stock

in Excess of

(Accumulated

Total

Shares

Par Value

Par Value

Loss)

Net Assets

Balance as of March 31, 2021

 

26,415,275

$

26

$

368,245

$

(6,708)

$

361,563

Issuance of common stock pursuant to distribution reinvestment plan

75,999

1,134

1,134

Distributions to stockholders

 

 

 

 

(7,682)

 

(7,682)

Net increase/(decrease) in net assets resulting from operations

 

 

 

 

24,705

 

24,705

Balance as of June 30, 2021

 

26,491,274

$

26

$

369,379

$

10,315

$

379,720

5

Table of Contents

Six Months Ended June 30, 2022:

    

    

    

    

Distributable

    

Paid In Capital

Earnings /

Common Stock

in Excess of

(Accumulated

Total

Shares

Par Value

Par Value

Loss)

Net Assets

Balance as of December 31, 2021

 

27,229,541

$

27

$

368,609

$

77,897

$

446,533

Issuance of common stock pursuant to distribution reinvestment plan

 

90,334

 

 

1,642

 

 

1,642

Stock based compensation

2,677

2,677

Issuance of restricted stock

718,263

1

1

Issuance of common stock, net of issuance costs

3,344,214

3

57,911

57,914

Retired and forfeited shares of restricted stock

(26,520)

(375)

(375)

Distributions to stockholders

 

 

(33,263)

(33,263)

Net increase/(decrease) in net assets resulting from operations

 

 

 

 

(16,787)

 

(16,787)

Balance as of June 30, 2022

 

31,355,832

$

31

$

430,464

$

27,847

$

458,342

Six Months Ended June 30, 2021:

    

    

    

    

Distributable

    

Paid In Capital

Earnings /

Common Stock

in Excess of

(Accumulated

Total

Shares

Par Value

Par Value

Loss)

Net Assets

Balance as of December 31, 2020

 

18,321,274

$

18

$

263,366

$

(24,636)

$

238,748

Impact of adoption of ASU 2020-06

(462)

 

(462)

Issuance of common stock in initial public offering, net of issuance costs

8,006,291

8

104,200

 

104,208

Issuance of common stock pursuant to distribution reinvestment plan

 

163,709

 

 

2,275

 

2,275

Distributions to stockholders

 

 

(15,079)

(15,079)

Net increase/(decrease) in net assets resulting from operations

 

 

 

 

50,030

50,030

Balance as of June 30, 2021

 

26,491,274

$

26

$

369,379

$

10,315

$

379,720

See accompanying notes to consolidated financial statements.

6

Table of Contents

TRINITY CAPITAL INC.

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

Six Months Ended

Six Months Ended

 

June 30, 2022

 

June 30, 2021

Cash flows provided by/(used in) operating activities:

 

  

 

  

Net increase/(decrease) in net assets resulting from operations

$

(16,787)

$

50,030

Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash provided by/(used in) operating activities:

 

  

 

  

Purchase of investments, net of deferred fees

 

(413,615)

 

(208,232)

Proceeds from sales and paydowns of investments

 

203,416

 

146,879

Net change in unrealized appreciation/(depreciation) from investments, net of third party participation

 

91,138

 

(27,823)

Net realized gain/(loss) from investments

 

(43,027)

 

(4,590)

Accretion of original issue discounts and end of term payments on investments

 

(15,516)

 

(10,279)

Amortization of deferred financing costs

 

1,653

 

Stock-based compensation

2,677

1,837

Change in operating assets and liabilities

 

 

(Increase)/Decrease in interest receivable

 

(3,049)

 

(597)

(Increase)/Decrease in receivable from sale of investments

(3,086)

(554)

(Increase)/Decrease in other assets

 

(2,323)

 

(2,357)

Increase/(Decrease) in security deposits

 

1,675

 

938

Increase/(Decrease) in accounts payable, accrued expenses and other liabilities

 

1,130

 

(151)

Net cash provided by/(used in) operating activities

 

(195,714)

 

(54,899)

 

 

  

Cash flows provided by/(used in) investing activities:

 

 

Disposal/(Acquisition) of fixed assets

 

24

 

(822)

Net cash provided by/(used in) investing activities

 

24

 

(822)

 

  

 

  

Cash flows provided by/(used in) financing activities

 

  

 

  

Issuance of common stock

 

60,417

 

112,088

Common stock issuance costs

 

(2,503)

 

(7,880)

Retirement of employee shares

(375)

Cash distributions paid

(23,550)

(10,069)

Debt issuance costs

(815)

(54)

Borrowings under Credit Facilities

 

184,000

 

25,000

Repayments under Credit Facilities

(55,000)

(90,000)

Net cash provided by/(used in) financing activities

 

162,174

 

29,085

 

  

 

  

Net increase/(decrease) in cash, cash equivalents and restricted cash

 

(33,516)

 

(26,636)

Cash, cash equivalents and restricted cash at beginning of period

 

46,742

 

61,101

Cash, cash equivalents and restricted cash at end of period

$

13,226

$

34,465

Six Months Ended

Six Months Ended

 

June 30, 2022

 

June 30, 2021

Supplemental and non-cash investing and financing activities:

Cash paid for interest

$

12,279

$

6,829

Accrued but unpaid distributions

$

17,873

$

7,682

Distributions reinvested

$

1,642

$

2,275

Income tax, including excise tax, paid

$

310

$

79

Change to investments and net assets related to adoption of ASU 2020-06

$

$

(462)

7

Table of Contents

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the Consolidated Statements of Assets and Liabilities that sum to the total of the same such amounts on the Consolidated Statement of Cash Flows:

    

June 30, 2022

June 30, 2021

Cash and cash equivalents

$

13,226

$

19,124

Restricted cash

15,341

Total cash, cash equivalents and restricted cash shown in the Consolidated Statements of Cash Flows

$

13,226

$

34,465

See accompanying notes to consolidated financial statements.

8

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1)

  

Type of Investment (2)

  

Investment Date (3)

Maturity Date

  

Interest Rate (4)

  

Principal 
Amount (5)

  

Cost

Fair Value (6)

Debt Securities- United States

Accommodation and Food Services (7)

  

  

  

  

  

BlueGround US, Inc.

Equipment Financing

June 6, 2022

January 1, 2026

Fixed interest rate 9.6%; EOT 8.0%

$

3,905

$

3,915

$

3,915

Sub-total: Accommodation and Food Services (0.4%)*

  

$

3,905

$

3,915

$

3,915

Administrative and Support and Waste Management and Remediation (7)

  

  

  

  

  

Qwick, Inc.

Secured Loan

December 31, 2021

January 1, 2026

Variable interest rate Prime + 8.0% or Floor rate 11.0%; EOT 5.0% ⁽⁸⁾

$

5,000

$

4,966

$

5,169

RTS Holding, Inc.

Secured Loan

December 31, 2021

January 1, 2027

Fixed interest rate 10.5%; EOT 3.0%

$

23,000

$

22,834

$

22,626

SeaOn Environmental, LLC

Equipment Financing⁽¹⁴⁾

June 16, 2022

June 1, 2026

Fixed interest rate 9.3%; EOT 11.0%

$

6,750

$

6,731

$

6,731

Sub-total: Administrative and Support and Waste Management and Remediation (3.2%)*

  

$

34,750

$

34,531

$

34,526

Agriculture, Forestry, Fishing and Hunting (7)

  

  

  

 

  

 

  

 

  

Bowery Farming, Inc.

Secured Loan⁽¹⁴⁾

September 10, 2021

January 1, 2026

Variable interest rate LIBOR + 11.0% or Floor rate 10.1% ⁽⁸⁾

$

10,000

$

9,396

$

9,294

Robotany, Inc.

 

Equipment Financing⁽¹⁴⁾

January 16, 2020

January 1, 2024

Fixed interest rate 7.6%; EOT 17.3%

$

906

 

$

1,289

$

1,271

Sub-total: Agriculture, Forestry, Fishing and Hunting (1.0%)*

  

$

10,906

$

10,685

$

10,565

Arts, Entertainment, and Recreation (7)

SI Tickets, Inc.

Secured Loan

May 11, 2022

September 1, 2026

Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 3.0% ⁽⁸⁾

$

3,000

$

2,924

$

2,924

Sub-total: Arts, Entertainment, and Recreation (0.3%)*

  

$

3,000

$

2,924

$

2,924

Construction (7)

  

  

  

 

  

 

  

 

  

Dandelion Energy, Inc.

 

Equipment Financing

March 17, 2020

April 1, 2024

Fixed interest rate 9.0%; EOT 12.5%

$

264

$

312

$

308

Equipment Financing

October 27, 2020

November 1, 2024

Fixed interest rate 9.2%; EOT 12.5%

354

400

393

Equipment Financing

November 19, 2020

December 1, 2024

Fixed interest rate 9.1%; EOT 12.5%

444

498

488

Equipment Financing

December 29, 2020

January 1, 2025

Fixed interest rate 9.2%; EOT 12.5%

524

583

572

Equipment Financing

March 25, 2021

April 1, 2025

Fixed interest rate 9.1%; EOT 12.5%

1,070

1,166

1,146

Equipment Financing

December 1, 2021

January 1, 2026

Fixed interest rate 8.8%; EOT 12.5%

1,211

1,254

1,241

Equipment Financing

April 8, 2022

May 1, 2026

Fixed interest rate 8.9%; EOT 12.5%

2,159

2,178

2,178

Equipment Financing

May 27, 2022

June 1, 2026

Fixed interest rate 9.2%; EOT 12.5%

989

990

990

Equipment Financing

June 13, 2022

June 1, 2026

Fixed interest rate 9.5%; EOT 12.5%

1,500

1,497

1,497

Total Dandelion Energy, Inc.

8,515

8,878

8,813

Sub-total: Construction (0.8%)*

  

$

8,515

$

8,878

$

8,813

Educational Services (7)

Medical Sales Training Holding Company

Secured Loan⁽¹⁴⁾

March 18, 2021

April 1, 2025

Variable interest rate Prime + 8.8% or Floor rate 12.0%; EOT 5.0% ⁽⁸⁾

$

6,000

$

6,039

$

5,999

Secured Loan⁽¹⁴⁾

July 21, 2021

August 1, 2025

Variable interest rate Prime + 8.8% or Floor rate 12.0%; EOT 5.0% ⁽⁸⁾

2,000

1,998

1,987

Total Medical Sales Training Holding Company

8,000

8,037

7,986

Yellowbrick Learning, Inc.

Secured Loan⁽¹⁴⁾

February 1, 2021

September 1, 2025

Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 5.0% ⁽⁸⁾

$

7,500

$

7,640

$

6,822

Secured Loan⁽¹⁴⁾

August 10, 2021

March 1, 2026

Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 5.0% ⁽⁸⁾

2,500

2,524

2,194

Total Yellowbrick Learning, Inc.

10,000

10,164

9,016

Sub-total: Educational Services (1.6%)*

 

  

$

18,000

$

18,201

$

17,002

9

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1)

  

Type of Investment (2)

  

Investment Date (3)

Maturity Date

  

Interest Rate (4)

  

Principal 
Amount (5)

  

Cost

Fair Value (6)

Debt Securities- United States, Continued

Finance and Insurance (7)

  

  

 

  

 

  

 

  

 

  

BoardRE, Inc.

Secured Loan

October 15, 2021

June 1, 2026

Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.5% ⁽⁸⁾

$

5,000

$

5,225

$

4,945

DailyPay, Inc.

Secured Loan

September 30, 2020

November 1, 2024

Variable interest rate Prime + 7.0% or Floor rate 12.0%; EOT 6.0% ⁽⁸⁾

$

16,651

$

17,238

$

17,210

Secured Loan

December 30, 2020

January 1, 2025

Variable interest rate Prime + 7.0% or Floor rate 12.0%; EOT 6.0% ⁽⁸⁾

4,408

4,546

4,524

Total DailyPay, Inc.

21,059

21,784

21,734

Petal Card, Inc.

Secured Loan

January 16, 2020

October 1, 2024

Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾

$

10,000

$

10,183

$

10,208

Secured Loan

August 6, 2021

October 1, 2024

Variable interest rate Prime + 4.3% or Floor rate 11.5% ⁽⁸⁾

7,000

6,957

7,020

Secured Loan (12)(14)

January 28, 2021

January 1, 2024

Variable interest rate Prime + 7.3% or Floor rate 11.5%; EOT 0.0% ⁽⁸⁾

17,748

18,815

18,973

Total Petal Card, Inc.

34,748

35,955

36,201

Stilt, Inc.

Secured Loan (12)(14)

February 10, 2022

August 1, 2024

Variable interest rate SOFR 30 Day Forward + 1.0% or Floor rate 11.0% ⁽⁸⁾

$

3,824

$

4,022

$

3,823

Sub-total: Finance and Insurance (6.1%)*

 

  

$

64,631

$

66,986

$

66,703

Health Care and Social Assistance (7)

  

 

  

 

  

 

  

 

  

FemTec Health, Inc.

Secured Loan

December 1, 2021

February 1, 2026

Fixed interest rate 11.0%; EOT 7.5%

$

10,000

$

10,747

$

9,799

Secured Loan

July 23, 2021

September 1, 2022

Fixed interest rate 11.0%

2,151

2,150

2,162

Secured Loan

September 29, 2021

April 1, 2026

Fixed interest rate 11.0%; EOT 7.5%

3,000

3,053

2,921

Total FemTec Health, Inc. (20)

15,151

15,950

14,882

Lark Technologies, Inc.

Secured Loan

September 30, 2020

April 1, 2025

Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾

$

4,766

$

4,772

$

4,863

Secured Loan

June 30, 2021

January 1, 2026

Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾

5,000

4,888

4,992

Total Lark Technologies, Inc.

9,766

9,660

9,855

WorkWell Prevention & Care Inc.

Secured Loan(14)(18)

January 16, 2020

July 1, 2024

Fixed interest rate 8.0%; EOT 10.0%

$

3,370

$

3,659

$

834

Secured Loan(14)(18)

January 16, 2020

July 1, 2024

Fixed interest rate 8.0%

 

700

 

718

 

173

Total WorkWell Prevention & Care Inc. (20)

 

 

4,070

 

4,377

 

1,007

Sub-total: Health Care and Social Assistance (2.4%)*

 

$

28,987

$

29,987

$

25,744

Information (7)

  

 

 

  

 

  

 

  

Rigetti & Co, Inc.

Secured Loan

March 10, 2021

April 1, 2025

Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 2.8% ⁽⁸⁾

$

12,000

 

$

11,989

$

12,185

Secured Loan

May 18, 2021

June 1, 2025

Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 2.8% ⁽⁸⁾

8,000

7,962

8,101

Secured Loan

November 10, 2021

December 1, 2025

Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 2.8% ⁽⁸⁾

7,000

6,907

7,050

Secured Loan

January 27, 2022

February 1, 2026

Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 2.8% ⁽⁸⁾

5,000

4,996

5,106

Total Rigetti & Co, Inc.

32,000

31,854

32,442

Stratifyd, Inc.

Secured Loan

September 3, 2021

January 1, 2026

Variable interest rate Prime + 7.8% or Floor rate 11.0%; EOT 3.5% ⁽⁸⁾

$

6,000

$

5,994

$

6,137

Whip Networks, Inc.

 

Secured Loan

June 14, 2021

July 1, 2025

Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 3.5% ⁽⁸⁾

$

5,000

 

$

5,028

$

4,971

Secured Loan

September 10, 2021

July 1, 2025

Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 3.5% ⁽⁸⁾

1,000

1,003

991

Secured Loan

February 3, 2022

July 1, 2025

Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 3.5% ⁽⁸⁾

4,000

3,988

3,939

Total Whip Networks, Inc.

10,000

10,019

9,901

Zuum Transportation, Inc.

Secured Loan

December 17, 2021

January 1, 2027

Variable interest rate Prime + 6.0% or Floor rate 10.8%; EOT 2.5% ⁽⁸⁾

$

5,000

$

4,995

$

4,959

Sub-total: Information (4.9%)*

 

  

$

53,000

$

52,862

$

53,439

10

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1)

  

Type of Investment (2)

  

Investment Date (3)

Maturity Date

  

Interest Rate (4)

  

Principal 
Amount (5)

  

Cost

Fair Value (6)

Debt Securities- United States, Continued

Information, Continued (7)

  

 

 

  

 

  

 

  

Management of Companies and Enterprises (7)

Bestow, Inc.

Secured Loan

April 25, 2022

May 1, 2027

Variable interest rate Prime + 6.5% or Floor rate 10.0%; EOT 1.5% ⁽⁸⁾

$

25,000

$

24,900

$

24,900

Secured Loan

May 12, 2022

June 1, 2027

Variable interest rate Prime + 6.5% or Floor rate 10.0%; EOT 1.5% ⁽⁸⁾

15,000

14,933

14,933

Total Bestow, Inc.

40,000

39,833

39,833

Exer Holdings, LLC

Secured Loan

November 19, 2021

December 1, 2026

Variable interest rate Prime + 7.0% or Floor rate 11.5%; EOT 3.0% ⁽⁸⁾

$

22,500

$

22,361

$

21,859

Secured Loan

February 18, 2022

December 1, 2026

Variable interest rate Prime + 7.0% or Floor rate 11.5%; EOT 3.0% ⁽⁸⁾

7,500

7,436

7,282

Total Exer Holdings, LLC

30,000

29,797

29,141

Sub-total: Management of Companies and Enterprises (6.3%)*

 

  

$

70,000

$

69,630

$

68,974

Manufacturing (7)

  

  

 

  

  

 

  

  

3DEO, Inc.

Equipment Financing

February 23, 2022

March 1, 2025

Fixed interest rate 9.6%; EOT 9.0%

$

3,172

$

3,208

$

3,001

Equipment Financing

April 12, 2022

May 1, 2025

Fixed interest rate 9.4%; EOT 9.0%

1,493

1,497

1,497

Total 3DEO, Inc.

4,665

4,705

4,498

Athletic Brewing Company, LLC

Equipment Financing

December 7, 2021

January 1, 2026

Fixed interest rate 11.0%; EOT 7.0%

$

19,944

$

20,111

$

19,978

Equipment Financing

March 16, 2022

April 1, 2026

Fixed interest rate 11.1%; EOT 7.0%

4,976

4,987

4,969

Total Athletic Brewing Company, LLC

24,920

25,098

24,947

Bolb, Inc.

Equipment Financing

October 12, 2021

November 1, 2024

Fixed interest rate 10.3%; EOT 6.0%

$

1,370

$

1,403

$

1,401

Cepton Technologies, Inc.

Secured Loan

January 4, 2022

February 1, 2026

Variable interest rate Prime + 7.0% or Floor rate 10.8%; EOT 2.5% ⁽⁸⁾

$

10,000

$

9,855

$

10,026

Daring Foods, Inc.

Equipment Financing

April 8, 2021

May 1, 2024

Fixed interest rate 9.6%; EOT 7.5%

$

322

$

342

$

342

Equipment Financing

July 7, 2021

August 1, 2024

Fixed interest rate 9.5%; EOT 7.5%

1,582

1,651

1,641

Equipment Financing

August 17, 2021

September 1, 2024

Fixed interest rate 9.7%; EOT 7.5%

783

812

811

Equipment Financing

August 31, 2021

September 1, 2024

Fixed interest rate 10.0%; EOT 7.5%

455

471

470

Equipment Financing

November 1, 2021

December 1, 2024

Fixed interest rate 9.4%; EOT 7.5%

877

896

894

Equipment Financing

March 8, 2022

April 1, 2025

Fixed interest rate 9.5%; EOT 7.5%

2,107

2,111

2,111

Equipment Financing

April 29, 2022

May 1, 2025

Fixed interest rate 10.2%; EOT 7.5%

948

942

942

Equipment Financing

June 1, 2022

July 1, 2025

Fixed interest rate 10.1%; EOT 7.5%

3,808

3,791

3,791

Total Daring Foods, Inc.

10,882

11,016

11,002

Deerfield Imaging Holdings, Inc.

Secured Loan⁽¹⁴⁾

April 14, 2022

May 1, 2027

Variable interest rate Prime + 6.0% or Floor rate 10.0%; EOT 5.0% ⁽⁸⁾

$

18,250

$

18,213

$

18,213

Eterneva, Inc.

Equipment Financing⁽¹⁴⁾

November 24, 2021

December 1, 2025

Fixed interest rate 10.6%; EOT 11.5%

$

486

$

502

$

493

Equipment Financing⁽¹⁴⁾

March 16, 2022

April 1, 2026

Fixed interest rate 10.4%; EOT 11.5%

715

725

715

Equipment Financing⁽¹⁴⁾

June 17, 2022

July 1, 2026

Fixed interest rate 16.2%; EOT 11.0%

1,898

1,897

1,897

Total Eterneva, Inc.

3,099

3,124

3,105

Footprint International Holding, Inc.

 

Secured Loan

February 18, 2022

March 1, 2027

Variable interest rate Prime + 7.3% or Floor rate 10.5%; EOT 3.0% ⁽⁸⁾

$

20,000

 

$

17,738

$

18,581

Secured Loan

April 20, 2022

March 1, 2027

Variable interest rate Prime + 7.3% or Floor rate 10.5%; EOT 3.0% ⁽⁸⁾

20,000

 

17,612

17,612

Total Footprint International Holding, Inc.

40,000

35,350

36,193

11

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1)

  

Type of Investment (2)

  

Investment Date (3)

Maturity Date

  

Interest Rate (4)

  

Principal 
Amount (5)

  

Cost

Fair Value (6)

Debt Securities- United States, Continued

Manufacturing, Continued (7)

  

  

 

  

  

 

  

  

Hadrian, Inc.

Equipment Financing

March 2, 2022

October 1, 2025

Fixed interest rate 12.6%; EOT 0.0%

$

471

 

$

469

$

472

Equipment Financing

May 6, 2022

December 1, 2025

Fixed interest rate 12.9%; EOT 0.0%

4,787

 

4,763

4,763

Total Hadrian, Inc.

5,258

5,232

5,235

Happiest Baby, Inc.

Equipment Financing

January 16, 2020

September 1, 2022

Fixed interest rate 8.4%; EOT 9.5%

$

98

$

259

$

255

Equipment Financing

January 16, 2020

November 1, 2022

Fixed interest rate 8.6%; EOT 9.5%

 

145

 

263

 

261

Equipment Financing

January 16, 2020

January 1, 2023

Fixed interest rate 8.6%; EOT 9.5%

 

191

 

295

 

293

Equipment Financing

February 7, 2020

June 1, 2023

Fixed interest rate 8.2%; EOT 9.5%

 

363

 

466

 

462

Equipment Financing

September 16, 2020

January 1, 2024

Fixed interest rate 8.4%; EOT 9.5%

663

764

759

Equipment Financing

January 22, 2021

May 1, 2024

Fixed interest rate 8.4%; EOT 9.5%

597

662

657

Total Happiest Baby, Inc.

 

  

 

2,057

 

2,709

 

2,687

Hi-Power, LLC

Equipment Financing

September 30, 2021

April 1, 2025

Fixed interest rate 12.4%; EOT 1.0%

$

5,687

$

5,700

$

5,743

Mainspring Energy, Inc.

Secured Loan

March 18, 2022

October 1, 2026

Fixed interest rate 11.0%; EOT 3.8%

$

30,000

$

29,785

$

29,562

Miyoko's Kitchen

 

Equipment Financing

February 19, 2020

September 1, 2022

Fixed interest rate 8.8%; EOT 9.0%

$

62

$

138

$

136

Equipment Financing

August 27, 2020

March 1, 2023

Fixed interest rate 8.9%; EOT 9.0%

285

368

365

Equipment Financing

February 5, 2021

September 1, 2023

Fixed interest rate 8.5%; EOT 9.0%

321

368

365

Equipment Financing

June 25, 2021

January 1, 2024

Fixed interest rate 8.9%; EOT 9.0%

372

407

403

Total Miyoko's Kitchen

1,040

1,281

1,269

Molekule, Inc.

Equipment Financing

June 19, 2020

January 1, 2024

Fixed interest rate 8.8%; EOT 10.0%

$

1,346

$

1,570

$

1,559

Equipment Financing

September 29, 2020

April 1, 2025

Fixed interest rate 12.3%; EOT 15.7%

323

377

386

Equipment Financing

December 18, 2020

July 1, 2025

Fixed interest rate 11.9%; EOT 16.3%

550

629

640

Equipment Financing

August 25, 2021

March 1, 2026

Fixed interest rate 11.3%; EOT 17.8%

434

481

478

Total Molekule, Inc.

2,653

3,057

3,063

Quip NYC, Inc.

Secured Loan

March 9, 2021

April 1, 2026

Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.0% ⁽⁸⁾

$

17,500

$

17,425

$

17,879

Secured Loan

February 10, 2022

April 1, 2026

Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.0% ⁽⁸⁾

2,500

2,510

2,517

Total Quip NYC, Inc.

20,000

19,935

20,396

Space Perspective, Inc.

Secured Loan

March 3, 2022

July 1, 2026

Variable interest rate Prime + 7.8% or Floor rate 11.0%; EOT 5.0% ⁽⁸⁾

$

5,000

$

4,881

$

5,057

The Fynder Group, Inc.

Equipment Financing

October 14, 2020

May 1, 2024

Fixed interest rate 9.1%; EOT 10.0%

$

393

$

433

$

428

Equipment Financing

March 31, 2022

October 1, 2025

Fixed interest rate 9.3%; EOT 10.0%

2,594

2,569

2,562

Total The Fynder Group, Inc.

2,987

3,002

2,990

Vertical Communications, Inc.

Secured Loan⁽¹⁴⁾

August 23, 2021

March 1, 2026

Fixed interest rate 11.0%; EOT 23.8%

$

13,300

$

15,268

$

13,837

viaPhoton, Inc.

Secured Loan⁽¹⁴⁾

March 31, 2022

April 1, 2027

Variable interest rate Prime + 6.6% or Floor rate 9.9%; EOT 5.0% ⁽⁸⁾

$

15,000

$

14,941

$

15,362

VitaCup, Inc.

Secured Loan

June 23, 2021

July 1, 2025

Variable interest rate Prime + 7.5% or Floor rate 11.5%; EOT 2.5% ⁽⁸⁾

$

5,500

$

5,500

$

5,563

Sub-total:  Manufacturing (20.2%)*

 

  

  

 

  

$

221,668

$

220,055

$

220,149

12

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1)

  

Type of Investment (2)

  

Investment Date (3)

Maturity Date

  

Interest Rate (4)

  

Principal 
Amount (5)

  

Cost

Fair Value (6)

Debt Securities- United States, Continued

Other Services (except Public Administration) (7)

Rinse, Inc.

Secured Loan

May 10, 2022

June 1, 2027

Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.8% ⁽⁸⁾

$

5,000

$

4,895

$

4,895

Sub-total:  Other Services (except Public Administration)(0.4%)*

$

5,000

$

4,895

$

4,895

Professional, Scientific, and Technical Services (7)

 

  

  

 

  

 

  

 

  

 

  

AllSeated, Inc.

Secured Loan

February 28, 2022

March 1, 2027

Variable interest rate Prime + 7.0% or Floor rate 10.8%; EOT 3.5% ⁽⁸⁾

$

6,000

$

5,983

$

6,101

BackBlaze, Inc.

 

Equipment Financing

January 16, 2020

January 1, 2023

Fixed interest rate 7.2%; EOT 11.5%

$

239

$

430

$

425

 

Equipment Financing

January 16, 2020

April 1, 2023

Fixed interest rate 7.4%; EOT 11.5%

 

41

 

63

 

62

 

Equipment Financing

January 16, 2020

June 1, 2023

Fixed interest rate 7.4%; EOT 11.5%

 

362

 

516

 

509

 

Equipment Financing

January 16, 2020

August 1, 2023

Fixed interest rate 7.5%; EOT 11.5%

 

80

 

108

 

106

 

Equipment Financing

January 16, 2020

September 1, 2023

Fixed interest rate 7.7%; EOT 11.5%

 

85

 

113

 

112

 

Equipment Financing

January 16, 2020

October 1, 2023

Fixed interest rate 7.5%; EOT 11.5%

 

89

 

116

 

114

 

Equipment Financing

January 16, 2020

November 1, 2023

Fixed interest rate 7.2%; EOT 11.5%

 

308

 

394

 

389

 

Equipment Financing

January 16, 2020

December 1, 2023

Fixed interest rate 7.5%; EOT 11.5%

422

 

531

523

 

Equipment Financing

January 16, 2020

January 1, 2024

Fixed interest rate 7.4%; EOT 11.5%

378

 

469

462

 

Equipment Financing

January 20, 2020

February 1, 2024

Fixed interest rate 7.4%; EOT 11.5%

396

 

486

478

 

Equipment Financing

February 1, 2020

March 1, 2024

Fixed interest rate 7.2%; EOT 11.5%

353

 

428

421

 

Equipment Financing

March 26, 2020

April 1, 2024

Fixed interest rate 7.4%; EOT 11.5%

109

 

131

130

Equipment Financing

April 17, 2020

May 1, 2024

Fixed interest rate 7.3%; EOT 11.5%

723

857

847

Equipment Financing

July 27, 2020

August 1, 2024

Fixed interest rate 7.4%; EOT 11.5%

820

944

930

Equipment Financing

September 4, 2020

October 1, 2024

Fixed interest rate 7.2%; EOT 11.5%

151

171

169

Equipment Financing

March 29, 2021

April 1, 2025

Fixed interest rate 7.5%; EOT 11.5%

1,990

2,162

2,133

Total BackBlaze, Inc.

 

  

  

  

 

6,546

 

7,919

7,810

Cleanspark, Inc.

Equipment Financing

April 22, 2022

May 1, 2025

Fixed interest rate 10.3%; EOT 5.0%

18,929

18,960

18,792

Commonwealth Fusion Systems, LLC

Equipment Financing

September 10, 2021

October 1, 2024

Fixed interest rate 9.5%; EOT 8.5%

$

1,815

 

$

1,897

$

1,887

Equipment Financing

October 20, 2021

November 1, 2024

Fixed interest rate 9.7%; EOT 8.5%

543

 

564

561

Total Commonwealth Fusion Systems, LLC

2,358

2,461

2,448

Core Scientific, Inc.

Equipment Financing

August 31, 2021

October 1, 2024

Fixed interest rate 10.3%; EOT 5.0%

$

778

$

801

$

801

Equipment Financing

November 19, 2021

December 1, 2024

Fixed interest rate 10.7%; EOT 5.0%

11,555

11,799

11,802

Equipment Financing

December 13, 2021

January 1, 2025

Fixed interest rate 10.5%; EOT 5.0%

4,258

4,336

4,338

Equipment Financing

February 9, 2022

March 1, 2025

Fixed interest rate 10.5%; EOT 5.0%

9,012

9,127

9,130

Total Core Scientific, Inc.

25,603

26,063

26,071

Edeniq, Inc.

 

Secured Loan⁽¹⁴⁾

November 30, 2021

June 1, 2025

Fixed interest rate 18.0%

$

5,267

 

$

1,707

$

5,331

Emerald Cloud Lab, Inc.

Equipment Financing

July 13, 2021

August 1, 2024

Fixed interest rate 9.7%; EOT 7.0%

$

7,658

 

$

8,046

$

8,016

Emergy, Inc.

Equipment Financing

January 8, 2021

May 1, 2024

Fixed interest rate 9.1%; EOT 8.5%

$

348

 

$

381

$

378

Equipment Financing

December 15, 2021

July 1, 2025

Fixed interest rate 9.3%; EOT 11.5%

9,684

 

9,967

9,840

Total Emergy, Inc.

10,032

10,348

10,218

13

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1)

  

Type of Investment (2)

  

Investment Date (3)

Maturity Date

  

Interest Rate (4)

  

Principal 
Amount (5)

  

Cost

Fair Value (6)

Debt Securities- United States, Continued

Professional, Scientific, and Technical Services, Continued

  

 

  

 

  

 

  

 

  

Eqis Capital Management, Inc.

Secured Loan

June 15, 2022

July 1, 2026

Variable interest rate Prime + 7.5% or Floor rate 10.8%; EOT 3.0% ⁽⁸⁾

$

7,000

 

$

6,942

$

6,942

Grabit Interactive Media, Inc.

Secured Loan

April 8, 2022

November 1, 2026

Variable interest rate Prime + 7.5% or Floor rate 10.8%; EOT 2.5% ⁽⁸⁾

$

4,500

 

$

4,450

$

4,450

Greenlight Biosciences Inc.

Equipment Financing⁽¹⁴⁾

March 29, 2021

April 1, 2024

Fixed interest rate 9.7%; EOT 8.0%

$

2,050

 

$

2,203

$

2,184

Equipment Financing⁽¹⁴⁾

June 17, 2021

July 1, 2024

Fixed interest rate 9.5%; EOT 8.0%

3,042

3,202

3,180

Equipment Financing⁽¹⁴⁾

August 31, 2021

September 1, 2024

Fixed interest rate 9.7%; EOT 8.0%

1,665

1,728

1,705

Equipment Financing⁽¹⁴⁾

August 31, 2021

September 1, 2024

Fixed interest rate 9.7%; EOT 8.0%

965

1,001

982

Total Greenlight Biosciences Inc.

7,722

8,134

8,051

Incontext Solutions, Inc.

 

Secured Loan⁽¹⁴⁾

January 16, 2020

October 1, 2024

Fixed interest rate 11.8%; EOT 16.4%

$

6,149

 

$

6,958

$

5,853

Nomad Health, Inc.

Secured Loan

March 29, 2022

October 1, 2026

Variable interest rate Prime + 5.5% or Floor rate 9.3%; EOT 4.0% ⁽⁸⁾

$

30,000

 

$

29,812

$

30,433

PebblePost, Inc.

Secured Loan

May 7, 2021

June 1, 2025

Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 3.8% ⁽⁸⁾

$

12,500

 

$

12,558

$

12,824

Pendulum Therapeutics, Inc.

 

Equipment Financing

January 16, 2020

May 1, 2023

Fixed interest rate 7.7%; EOT 5.0%

$

131

 

$

152

$

152

 

Equipment Financing

January 17, 2020

August 1, 2023

Fixed interest rate 7.8%; EOT 5.0%

925

 

1,049

1,052

 

Equipment Financing

March 6, 2020

October 1, 2023

Fixed interest rate 7.7%; EOT 5.0%

296

 

327

328

Equipment Financing

July 15, 2020

February 1, 2024

Fixed interest rate 9.8%; EOT 6.0%

492

536

538

Secured Loan

December 31, 2021

January 1, 2026

Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 3.0% ⁽⁸⁾

5,000

4,984

5,132

Secured Loan

February 28, 2022

March 1, 2026

Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 3.0% ⁽⁸⁾

5,000

4,975

5,119

Secured Loan

March 30, 2022

April 1, 2026

Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 3.0% ⁽⁸⁾

5,000

4,970

5,096

Secured Loan

May 6, 2022

June 1, 2026

Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 3.0% ⁽⁸⁾

5,000

4,961

4,961

Secured Loan

June 17, 2022

July 1, 2026

Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 3.0% ⁽⁸⁾

5,000

4,954

4,954

Total Pendulum Therapeutics, Inc.

 

  

  

 

  

26,844

26,908

27,332

Reciprocity, Inc.

 

Secured Loan

September 25, 2020

October 1, 2024

Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 2.0% ⁽⁸⁾

$

9,420

 

$

9,466

$

9,439

Secured Loan

April 29, 2021

May 1, 2025

Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 2.0% ⁽⁸⁾

5,000

5,008

4,954

Total Reciprocity, Inc.

14,420

14,474

14,393

Smartly, Inc.

Secured Loan

May 16, 2022

December 1, 2026

Variable interest rate Prime + 7.0% or Floor rate 10.5%; EOT 2.5% ⁽⁸⁾

$

10,000

 

$

9,854

$

9,854

Sun Basket, Inc.

Secured Loan

December 31, 2020

April 1, 2023

Variable interest rate Prime + 8.5% or Floor rate 11.8%; EOT 5.8% ⁽⁸⁾

$

16,905

 

$

17,961

$

17,388

TMRW Life Sciences, Inc.

Secured Loan

April 29, 2022

May 1, 2027

Variable interest rate Prime + 5.0% or Floor rate 8.8%; EOT 4.0% ⁽⁸⁾

$

5,000

 

$

4,966

$

4,967

Utility Associates, Inc.

 

Secured Loan (18)

January 16, 2020

September 30, 2023

PIK Fixed interest rate 11.0% (15)

$

750

 

$

830

$

729

ZenDrive, Inc.

Secured Loan

July 16, 2021

August 1, 2026

Variable interest rate Prime + 7.0% or Floor rate 10.3%; EOT 3.0% ⁽⁸⁾

$

15,000

 

$

14,977

$

15,395

Sub-total:  Professional, Scientific, and Technical Services (22.3%)*

 

  

$

239,183

$

240,311

$

243,398

14

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1)

  

Type of Investment (2)

  

Investment Date (3)

Maturity Date

  

Interest Rate (4)

  

Principal 
Amount (5)

  

Cost

Fair Value (6)

Debt Securities- United States, Continued

Real Estate (7)

 

  

 

  

 

  

  

 

  

  

Knockaway, Inc.

 

Secured Loan

November 10, 2021

June 1, 2026

Variable interest rate Prime + 6.3% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾

$

14,734

 

$

14,694

$

14,337

 

Secured Loan

November 30, 2021

June 1, 2026

Variable interest rate Prime + 6.3% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾

 

2,000

 

1,993

 

1,947

 

Secured Loan

December 28, 2021

July 1, 2026

Variable interest rate Prime + 6.3% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾

 

4,275

 

4,257

 

4,152

Total Knockaway, Inc.

 

  

  

 

  

 

21,009

 

20,944

 

20,436

Orchard Technologies, Inc.

Secured Loan

March 11, 2021

April 1, 2026

Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 4.0% ⁽⁸⁾

$

5,000

 

$

5,060

$

5,140

Secured Loan

July 23, 2021

April 1, 2026

Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 4.0% ⁽⁸⁾

12,500

12,601

12,814

Total Orchard Technologies, Inc.

17,500

17,661

17,954

Wanderjaunt, Inc.

 

Equipment Financing(18)

January 16, 2020

June 1, 2023

Fixed interest rate 10.2%; EOT 12.0%

$

155

 

$

201

$

20

 

Equipment Financing(18)

January 16, 2020

August 1, 2023

Fixed interest rate 10.2%; EOT 12.0%

 

545

 

699

 

61

Equipment Financing(18)

January 7, 2022

August 1, 2025

Fixed interest rate 10.3%; EOT 11.0%

2,649

2,658

114

Equipment Financing(18)

March 4, 2022

October 1, 2025

Fixed interest rate 10.2%; EOT 11.0%

2,133

2,121

88

Total Wanderjaunt, Inc.

 

  

  

 

  

 

5,482

 

5,679

 

283

Sub-total: Real Estate (3.5%)*

 

  

$

43,991

$

44,284

$

38,673

 

  

  

 

  

 

  

 

  

 

  

Rental and Leasing Services(7)

 

  

 

  

 

  

  

 

  

  

EquipmentShare, Inc.

Equipment Financing

June 24, 2020

July 1, 2023

Fixed interest rate 11.0%; EOT 5.0%

$

2,238

 

$

2,510

$

2,525

Equipment Financing

August 7, 2020

September 1, 2023

Fixed interest rate 10.2%; EOT 5.0%

899

989

993

Equipment Financing

October 2, 2020

November 1, 2023

Fixed interest rate 10.4%; EOT 5.0%

411

446

448

Equipment Financing

October 9, 2020

November 1, 2023

Fixed interest rate 10.5%; EOT 5.0%

1,299

1,408

1,417

Total EquipmentShare, Inc.

4,847

5,353

5,383

Maxwell Financial Labs, Inc.

Secured Loan

September 30, 2021

April 1, 2026

Variable interest rate Prime + 6.0% or Floor rate 10.0%; EOT 5.0% ⁽⁸⁾

$

18,000

 

$

17,998

$

18,156

NextCar Holding Company, Inc.

Secured Loan

December 14, 2021

January 1, 2026

Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% ⁽⁸⁾

$

5,000

 

$

5,065

$

5,100

Secured Loan

December 15, 2021

January 1, 2026

Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% ⁽⁸⁾

2,000

2,028

2,040

Secured Loan

February 23, 2022

January 1, 2026

Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% ⁽⁸⁾

2,500

2,515

2,577

Secured Loan

March 16, 2022

January 1, 2026

Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% ⁽⁸⁾

3,000

3,012

3,098

Secured Loan

April 18, 2022

January 1, 2026

Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% ⁽⁸⁾

2,500

2,490

2,550

Secured Loan

April 18, 2022

January 1, 2026

Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% ⁽⁸⁾

2,500

2,490

2,550

Secured Loan

May 17, 2022

January 1, 2026

Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% ⁽⁸⁾

5,000

4,965

5,100

Secured Loan

June 22, 2022

January 1, 2026

Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 2.0% ⁽⁸⁾

2,500

2,470

2,550

Total NextCar Holding Company, Inc.

25,000

25,035

25,565

Sub-total:  Rental and Leasing Services (4.5%)*

 

  

$

47,847

$

48,386

$

49,104

15

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1)

  

Type of Investment (2)

  

Investment Date (3)

Maturity Date

  

Interest Rate (4)

  

Principal 
Amount (5)

  

Cost

Fair Value (6)

Debt Securities- United States, Continued

Retail Trade (7)

 

  

  

 

  

 

  

 

  

 

  

Fernished, Inc.

Equipment Financing⁽¹⁴⁾

October 29, 2021

November 1, 2024

Fixed interest rate 13.4%; EOT 3.0%

$

401

 

$

404

$

407

Equipment Financing⁽¹⁴⁾

March 21, 2022

April 1, 2025

Fixed interest rate 13.2%; EOT 3.0%

1,387

1,382

1,345

Equipment Financing⁽¹⁴⁾

May 10, 2022

June 1, 2025

Fixed interest rate 13.2%; EOT 3.0%

975

969

969

Total Fernished, Inc.

2,763

2,755

2,721

Gobble, Inc.

 

Secured Loan

January 16, 2020

July 1, 2023

Fixed interest rate 11.3%; EOT 6.0%

$

1,566

 

$

1,780

$

1,762

 

Secured Loan

January 16, 2020

July 1, 2023

Fixed interest rate 11.5%; EOT 6.0%

 

788

 

895

 

886

Total Gobble Inc.

 

  

  

 

  

 

2,354

 

2,675

 

2,648

Portofino Labs, Inc.

Secured Loan

April 1, 2021

November 1, 2025

Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾

$

2,000

 

$

1,904

$

1,941

Super73, Inc.

Secured Loan

December 31, 2020

January 1, 2025

Variable interest rate Prime + 7.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾

$

4,844

 

$

4,925

$

4,945

Secured Loan

October 25, 2021

January 1, 2025

Variable interest rate Prime + 7.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾

3,963

3,982

4,000

Total Super73, Inc.

8,807

8,907

8,945

UnTuckIt, Inc.

 

Secured Loan⁽¹⁴⁾

January 16, 2020

June 1, 2025

Fixed interest rate 12.0%; EOT 3.8%

$

15,000

 

$

15,778

$

15,202

Sub-total:  Retail Trade (2.9%)*

 

  

  

 

  

$

30,924

$

32,019

$

31,457

 

  

  

 

  

 

  

 

  

 

  

Space Research and Technology (7)

Axiom Space, Inc.

Secured Loan

May 28, 2021

June 1, 2026

Variable interest rate Prime + 6.0% or Floor rate 9.3%; EOT 2.5% ⁽⁸⁾

$

30,000

 

$

29,975

$

30,755

Sub-total: Space Research and Technology (2.8%)*

$

30,000

$

29,975

$

30,755

Wholesale Trade (7)

 

  

  

 

  

 

  

 

  

 

  

BaubleBar, Inc.

 

Secured Loan⁽¹⁴⁾

January 16, 2020

March 1, 2023

Fixed interest rate 11.5%; EOT 7.3%

$

2,084

 

$

3,014

$

2,904

Grandpad, Inc.

Equipment Financing

November 16, 2020

June 1, 2023

Fixed interest rate 10.6%; EOT 5.0%

$

1,188

$

1,317

$

1,312

Equipment Financing

December 23, 2020

July 1, 2023

Fixed interest rate 10.8%; EOT 5.0%

1,578

1,730

1,724

Total Grandpad, Inc.

2,766

3,047

3,036

Sub-total:  Wholesale Trade (0.5%)*

 

  

  

 

  

$

4,850

$

6,061

$

5,940

Total:  Debt Securities- United States (84.1%)*

$

919,157

$

924,585

$

916,976

Debt Securities- Canada

Information (7)

  

 

 

  

 

  

 

  

Hut 8 Holdings, Inc. (10)

Equipment Financing

December 30, 2021

January 1, 2025

Fixed interest rate 9.5%; EOT 3.5%

$

25,383

$

25,477

$

25,320

Sub-total:  Information (2.3%)*

$

25,383

$

25,477

$

25,320

16

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1)

  

Type of Investment (2)

  

Investment Date (3)

Maturity Date

  

Interest Rate (4)

  

Principal 
Amount (5)

  

Cost

Fair Value (6)

Debt Securities- Canada, Continued

Manufacturing (7)

  

  

 

  

  

 

  

  

Nexii Building Solutions, Inc. (10)

Secured Loan

August 27, 2021

September 1, 2025

Variable interest rate Prime + 7.0% or Floor rate 10.3%; EOT 2.5% ⁽⁸⁾

$

10,000

$

9,698

$

9,938

Secured Loan

June 8, 2022

July 1, 2026

Variable interest rate Prime + 7.0% or Floor rate 10.3%; EOT 2.5% ⁽⁸⁾

5,000

4,750

4,750

Total Nexii Building Solutions, Inc.

15,000

14,448

14,688

Sub-total:  Manufacturing (1.3%)*

$

15,000

$

14,448

$

14,688

Transportation and Warehousing (7)

GoFor Industries, Inc. (10)

Secured Loan(18)

January 21, 2022

February 1, 2026

Variable interest rate Prime + 8.8% or Floor rate 12.0%; EOT 2.5% ⁽⁸⁾

$

9,792

 

$

9,660

$

3,838

Sub-total: Transportation and Warehousing (0.4%)*

$

9,792

$

9,660

$

3,838

Utilities (7)

 

  

  

 

  

 

  

 

  

 

  

Invenia, Inc.

 

Secured Loan

January 16, 2020

January 1, 2023

Fixed interest rate 11.5%; EOT 5.0%

$

2,000

 

$

2,451

$

2,427

 

Secured Loan

January 16, 2020

May 1, 2023

Fixed interest rate 11.5%; EOT 5.0%

 

1,371

 

1,572

 

1,556

 

Secured Loan

January 16, 2020

January 1, 2024

Fixed interest rate 11.5%; EOT 5.0%

 

1,711

 

1,835

 

1,831

 

Secured Loan

January 17, 2020

February 1, 2024

Fixed interest rate 11.5%; EOT 5.0%

 

2,390

 

2,565

 

2,547

Secured Loan

June 8, 2020

July 1, 2024

Fixed interest rate 11.5%; EOT 5.0%

2,920

3,063

3,063

Secured Loan

October 29, 2020

November 1, 2024

Fixed interest rate 11.5%; EOT 5.0%

4,157

4,309

4,301

Total Invenia, Inc. (10)

 

  

  

 

  

14,549

15,795

15,725

Sub-total:  Utilities (1.4%)*

 

  

  

 

  

$

14,549

$

15,795

$

15,725

Total:  Debt Securities- Canada (5.5%)*

$

64,724

$

65,380

$

59,571

Debt Securities- Europe

Manufacturing (7)

  

  

 

  

  

 

  

  

Aledia, Inc. (10)

Equipment Financing⁽¹⁴⁾

March 31, 2022

April 1, 2025

Fixed interest rate 9.0%; EOT 7.0%

$

16,774

$

16,868

$

16,880

Equipment Financing⁽¹⁴⁾

June 30, 2022

July 1, 2025

Fixed interest rate 9.7%; EOT 7.0%

1,174

1,166

1,166

Total Aledia, Inc.

17,948

18,034

18,046

Sub-total:  Manufacturing (1.7%)*

$

17,948

$

18,034

$

18,046

Total:  Debt Securities- Europe (1.7%)*

$

17,948

$

18,034

$

18,046

Total:  Debt Securities (91.2%)(19)*

 

  

  

 

  

$

1,001,829

$

1,007,999

$

994,593

17

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1)

  

Type of
Investment (2)

  

Investment Date (3)

  

Expiration Date

  

Series

  

Shares

  

Strike Price

  

Cost

  

Fair Value (6)

Warrant Investments- United States

  

  

  

  

  

  

 

Administrative and Support and Waste Management and Remediation (7)

Qwick, Inc.

Warrant¹⁴

December 31, 2021

December 31, 2031

Common Stock

16,956

$

2.79

$

96

$

64

BetterLeap, Inc.

Warrant¹⁴

April 20, 2022

April 20, 2032

Common Stock

88,435

$

2.26

$

38

$

38

RTS Holding, Inc.

Warrant¹⁴

December 10, 2021

December 10, 2031

Preferred Series C

3,857

$

205.28

$

153

$

184

Sub-Total: Administrative and Support and Waste Management and Remediation (0.0%)*

 

$

287

$

286

Agriculture, Forestry, Fishing and Hunting (7)

  

  

  

  

Bowery Farming, Inc.

Warrant¹⁴

January 16, 2020

June 10, 2029

Common Stock

68,863

$

5.08

$

410

$

1,372

Warrant¹⁴

December 22, 2020

December 22, 2030

Common Stock

29,925

$

6.24

160

569

Warrant¹⁴

September 10, 2021

September 10, 2028

Common Stock

21,577

$

0.01

616

518

Total Bowery Farming, Inc.

1,186

2,459

Robotany, Inc.

Warrant

January 16, 2020

July 19, 2029

Common Stock

262,870

$

0.26

$

129

$

37

Sub-Total: Agriculture, Forestry, Fishing and Hunting (0.2%)*

 

$

1,315

$

2,496

Arts, Entertainment, and Recreation (7)

SI Tickets, Inc.

Warrant¹⁴

May 11, 2022

May 11, 2032

Common Stock

53,029

$

2.52

$

162

$

199

Sub-total: Arts, Entertainment, and Recreation (0.0%)*

$

162

$

199

Construction (7)

  

 

 

  

 

  

Project Frog, Inc. (20)

Warrant¹⁴

January 16, 2020

July 26, 2026

Preferred Series AA

211,633

$

0.19

$

9

$

Warrant¹⁴

January 16, 2020

July 26, 2026

Common Stock

180,356

$

0.19

9

Warrant¹⁴

August 3, 2021

December 31, 2031

Preferred Series CC

250,000

$

0.01

20

22

Total Project Frog, Inc.

38

22

Sub-Total: Construction (0.0%)*

  

 

$

38

$

22

Educational Services (7)

  

 

 

  

 

  

Medical Sales Training Holding Company

Warrant¹⁴

March 18, 2021

March 18, 2031

Common Stock

28,732

$

7.74

$

108

$

62

Yellowbrick Learning, Inc.

Warrant¹⁴

January 16, 2020

September 28, 2028

Common Stock

222,222

$

0.90

$

120

$

7

Sub-Total: Educational Services (0.0%)*

  

$

228

$

69

18

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1)

  

Type of
Investment (2)

  

Investment Date (3)

  

Expiration Date

  

Series

  

Shares

  

Strike Price

  

Cost

  

Fair Value (6)

Warrant Investments- United States

  

  

  

  

  

 

Finance and Insurance (7)

DailyPay, Inc.

Warrant¹⁴

September 30, 2020

September 30, 2030

Common Stock

89,264

$

3.00

$

151

$

720

Petal Card, Inc.

Warrant¹⁴

January 16, 2020

November 27, 2029

Preferred Series B

250,268

$

1.32

$

147

$

1,233

Warrant¹⁴

January 11, 2021

January 11, 2031

Common Stock

135,835

$

0.01

312

797

Warrant¹⁴

August 6, 2021

August 6, 2031

Common Stock

111,555

$

1.60

197

528

Total Petal Card, Inc.

656

2,558

RealtyMogul, Co.

Warrant¹⁴

January 16, 2020

December 18, 2027

Preferred Series B

234,421

$

3.88

$

285

$

23

Stilt, Inc.

Warrant¹⁴

February 10, 2022

February 10, 2032

Common Stock

67,465

$

0.01

$

106

$

117

Sub-Total: Finance and Insurance (0.3%)*

  

 

$

1,198

$

3,418

Health Care and Social Assistance (7)

  

 

 

  

 

  

Lark Technologies, Inc.

Warrant¹⁴

September 30, 2020

September 30, 2030

Common Stock

76,231

$

1.76

$

177

$

461

Warrant¹⁴

June 30, 2021

June 30, 2031

Common Stock

79,325

$

1.76

258

479

Total Lark Technologies, Inc.

435

940

Sub-Total: Health Care and Social Assistance (0.1%)*

 

$

435

$

940

Information (7)

  

 

 

  

 

  

Everalbum, Inc.

Warrant¹⁴

January 16, 2020

July 29, 2026

Preferred Series A

851,063

$

0.10

$

25

$

1

Figg, Inc.

Warrant¹¹⁾⁽¹⁴

January 16, 2020

March 31, 2028

Common Stock

935,198

$

0.10

$

$

Firefly Systems, Inc.

Warrant¹⁴

January 31, 2020

January 29, 2030

Common Stock

133,147

$

1.14

$

282

$

465

Gtxcel, Inc.

Warrant¹⁴

January 16, 2020

September 24, 2025

Preferred Series C

1,000,000

$

0.21

$

83

$

8

Warrant¹⁴

January 16, 2020

September 24, 2025

Preferred Series D

1,000,000

$

0.21

 

83

 

8

Total Gtxcel, Inc.

  

 

 

166

 

16

Lucidworks, Inc.

Warrant¹⁴

January 16, 2020

June 27, 2026

Preferred Series D

619,435

$

0.77

$

806

$

1,615

RapidMiner, Inc.

Warrant¹⁴

January 16, 2020

March 25, 2029

Preferred Series C-1

11,624

$

60.22

$

528

$

Stratifyd, Inc.

Warrant¹⁴

September 3, 2021

September 3, 2031

Preferred Series B-2

106,719

$

2.53

$

83

$

27

Sub-Total: Information (0.2%)*

 

  

$

1,890

$

2,124

Management of Companies and Enterprises (7)

Exer Holdings, LLC

Warrant¹⁴

November 19, 2021

November 19, 2031

Common Stock

281

$

479.25

$

93

$

59

Sub-Total: Management of Companies and Enterprises (0.0%)*

  

$

93

$

59

 

19

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1)

  

Type of
Investment (2)

  

Investment Date (3)

  

Expiration Date

  

Series

  

Shares

  

Strike Price

  

Cost

  

Fair Value (6)

Warrant Investments- United States, Continued

  

  

  

  

Manufacturing (7)

  

 

  

 

  

3DEO, Inc.

Warrant¹⁴

February 23, 2022

February 23, 2032

Common Stock

37,218

$

1.81

$

93

$

37

Bolb, Inc.

Warrant¹⁴

October 12, 2021

October 12, 2031

Common Stock

181,784

$

0.07

$

36

$

10

Daring Foods, Inc.

Warrant¹⁴

April 8, 2021

April 8, 2031

Common Stock

68,100

$

0.27

$

106

$

666

Footprint International Holding, Inc.

Warrant¹⁴

February 14, 2020

February 14, 2030

Common Stock

38,171

$

0.31

$

9

$

926

Warrant¹⁴

February 18, 2022

February 18, 2032

Common Stock

77,524

$

0.01

4,246

1,903

Warrant¹⁴

June 23, 2022

June 23, 2032

Common Stock

14,624

$

0.01

359

359

Total Footprint International Holding, Inc.

$

4,614

3,188

Happiest Baby, Inc.

Warrant¹⁴

January 16, 2020

May 16, 2029

Common Stock

182,554

$

0.33

$

193

$

262

Mainspring Energy, Inc.

Warrant¹⁴

January 16, 2020

July 9, 2029

Common Stock

140,186

$

1.15

$

283

$

462

Warrant¹⁴

November 20, 2020

November 20, 2030

Common Stock

81,294

$

1.15

226

$

268

Warrant¹⁴

March 18, 2022

March 18, 2032

Common Stock

137,692

$

1.66

344

430

Total Mainspring Energy, Inc.

$

853

1,160

Molekule, Inc.

Warrant¹⁴

June 19, 2020

June 19, 2030

Common Stock

3,205

$

3.12

$

8

$

11

Warrant¹⁴

June 1, 2022

June 1, 2032

Preferred Series 1

257,135

$

0.39

22

22

Warrant¹⁴

June 19, 2020

June 19, 2030

Preferred Series 2

100,000

$

1.00

8

11

Total Molekule, Inc.

$

38

44

Quip NYC, Inc.

Warrant¹⁴

March 9, 2021

March 9, 2031

Preferred Series A-1

10,833

$

48.46

$

203

$

458

SBG Labs, Inc.

Warrant¹⁴

January 16, 2020

July 29, 2023

Preferred Series A-1

42,857

$

0.70

$

13

$

Warrant¹⁴

January 16, 2020

September 18, 2024

Preferred Series A-1

25,714

$

0.70

 

8

 

Warrant¹⁴

January 16, 2020

January 14, 2024

Preferred Series A-1

21,492

$

0.70

 

7

 

Warrant¹⁴

January 16, 2020

March 24, 2025

Preferred Series A-1

12,155

$

0.70

 

4

 

Warrant¹⁴

January 16, 2020

October 10, 2023

Preferred Series A-1

11,150

$

0.70

 

4

 

Warrant¹⁴

January 16, 2020

May 6, 2024

Preferred Series A-1

11,145

$

0.70

 

4

 

Warrant¹⁴

January 16, 2020

June 9, 2024

Preferred Series A-1

7,085

$

0.70

 

2

 

Warrant¹⁴

January 16, 2020

May 20, 2024

Preferred Series A-1

342,857

$

0.70

 

110

 

Warrant¹⁴

January 16, 2020

March 26, 2025

Preferred Series A-1

200,000

$

0.70

 

65

 

Total SBG Labs, Inc.

  

217

 

Space Perspective, Inc.

Warrant¹⁴

March 3, 2022

March 3, 2032

Preferred Series A

221,280

$

2.75

$

256

$

252

Tarana Wireless, Inc.

Warrant¹⁴

June 30, 2021

June 30, 2031

Common Stock

5,027,629

$

0.19

$

967

$

2,058

The Fynder Group, Inc.

Warrant¹⁴

October 14, 2020

October 14, 2030

Common Stock

36,445

$

0.49

$

68

$

322

Vertical Communications, Inc. (20)

Warrant¹¹⁾⁽¹⁴

January 16, 2020

July 11, 2026

Preferred Series A

828,479

$

1.00

$

$

viaPhoton, Inc.

Warrant¹⁴

March 31, 2022

March 31, 2032

Common Stock

15,839

$

0.60

$

22

$

29

VitaCup, Inc.

Warrant¹⁴

June 23, 2021

June 23, 2031

Preferred Series C

68,996

$

2.79

$

9

$

6

Sub-Total: Manufacturing (0.8%)*

  

$

7,675

$

8,492

20

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1)

  

Type of
Investment (2)

  

Investment Date (3)

  

Expiration Date

  

Series

  

Shares

  

Strike Price

  

Cost

Fair Value (6)

Warrant Investments- United States, Continued

  

  

  

  

Other Services (except Public Administration) (7)

Rinse, Inc.

Warrant¹⁴

May 10, 2022

May 10, 2032

Preferred Series C

278,761

$

1.13

$

118

$

120

Sub-total:  Other Services (except Public Administration)(0.0%)*

$

118

$

120

Pharmaceutical (7)

  

 

  

 

  

 

  

Zosano Pharma Corporation

Warrant (9)

January 16, 2020

September 25, 2025

Common Stock

75,000

$

3.59

$

69

$

Sub-Total: Pharmaceutical (0.0%)*

  

$

69

$

 

Professional, Scientific, and Technical Services (7)

  

 

  

 

  

All Seated, Inc.

Warrant¹⁴

February 28, 2022

February 28, 2032

Common Stock

5,101

$

15.72

$

20

$

29

Crowdtap, Inc.

Warrant¹⁴

January 16, 2020

December 16, 2025

Preferred Series B

442,233

$

1.09

$

42

$

172

Warrant¹⁴

January 16, 2020

December 11, 2027

Preferred Series B

100,000

$

1.09

 

9

 

39

Total Crowdtap, Inc.

  

 

 

51

 

211

Dynamics, Inc.

Warrant¹⁴

January 16, 2020

March 10, 2024

Common Stock

17,000

$

10.59

$

85

$

E La Carte, Inc.

Warrant¹⁴

January 16, 2020

April 28, 2027

Preferred Series A

497,183

$

0.30

$

185

$

2,159

Warrant¹⁴

January 16, 2020

July 28, 2027

Common Stock

104,284

$

7.49

 

14

 

259

Warrant¹⁴

January 16, 2020

April 28, 2027

Preferred Series AA-1

106,841

$

7.49

 

14

 

122

Total E La Carte, Inc.

  

 

 

213

 

2,540

Edeniq, Inc.

Warrant(11)(14)

January 16, 2020

December 23, 2026

Preferred Series B

2,685,501

$

0.22

$

$

8

Warrant(11)(14)

January 16, 2020

December 23, 2026

Preferred Series B

2,184,672

$

0.01

 

 

18

Warrant(11)(14)

January 16, 2020

June 29, 2027

Preferred Series C

5,106,972

$

0.44

 

 

Warrant(11)(14)

January 16, 2020

November 2, 2028

Preferred Series C

3,850,294

$

0.01

 

 

99

Warrant(14)

November 29, 2021

November 29, 2031

Preferred Series D

154,906,320

$

0.01

 

7

 

36

Total Edeniq, Inc.(20)

  

 

 

7

 

161

Eqis Capital Management, Inc.

Warrant¹⁴

June 15, 2022

June 15, 2032

Preferred Class B

904,000

$

0.99

$

10

$

10

Grabit Interactive Media, Inc.

Warrant¹⁴

April 8, 2022

April 8, 2034

Preferred Series A

142,828

$

1.00

$

39

$

25

Hologram, Inc.

Warrant¹⁴

January 31, 2020

January 27, 2030

Common Stock

193,054

$

0.26

$

49

$

658

Hospitalists Now, Inc.

Warrant¹⁴

January 16, 2020

March 30, 2026

Preferred Series D-2

135,807

$

5.89

$

71

$

887

Warrant¹⁴

January 16, 2020

December 6, 2026

Preferred Series D-2

750,000

$

5.89

 

391

 

4,898

Total Hospitalists Now, Inc.

  

 

 

462

 

5,785

Incontext Solutions, Inc.

Warrant¹⁴

January 16, 2020

September 28, 2028

Common Stock

2,219

$

220.82

$

34

$

PebblePost, Inc.

Warrant¹⁴

May 7, 2021

May 7, 2031

Common Stock

657,343

$

0.75

$

68

$

248

Pendulum Therapeutics, Inc.

Warrant¹⁴

January 16, 2020

October 9, 2029

Preferred Series B

55,263

$

1.90

$

44

$

14

Warrant¹⁴

June 1, 2020

July 15, 2030

Preferred Series B

36,842

$

1.90

36

9

Warrant¹⁴

December 31, 2021

December 31, 2031

Preferred Series C

322,251

$

3.24

118

16

Total Pendulum Therapeutics, Inc.

 

198

 

39

21

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1)

  

Type of
Investment (2)

  

Investment Date (3)

  

Expiration Date

  

Series

  

Shares

  

Strike Price

  

Cost

  

Fair Value (6)

Warrant Investments- United States, Continued

  

  

  

  

 

Professional, Scientific, and Technical Services, Continued (7)

 

  

 

  

 

  

Reciprocity, Inc.

Warrant¹⁴

September 25, 2020

September 25, 2030

Common Stock

114,678

$

4.17

$

99

$

77

Warrant¹⁴

April 29, 2021

April 29, 2031

Common Stock

57,195

$

4.17

54

38

Total Reciprocity, Inc.

 

153

 

115

Resilinc, Inc.

Warrant¹⁴

January 16, 2020

December 15, 2025

Preferred Series A

589,275

$

0.51

$

40

$

Smartly, Inc.

Warrant¹⁴

May 16, 2022

May 16, 2034

Common Stock

68,939

$

1.10

$

84

$

89

Sun Basket, Inc.

Warrant¹⁴

January 16, 2020

October 5, 2027

Common Stock

103,636

$

14.47

$

111

$

8

Warrant¹⁴

December 31, 2020

December 29, 2032

Common Stock

33,348

$

3.17

546

191

Total Sun Basket, Inc.

657

199

TMRW Life Sciences, Inc.

Warrant¹⁴

April 29, 2022

April 29, 2032

Preferred Class A

537,966

$

2.09

$

160

$

78

Utility Associates, Inc.

Warrant¹⁴

January 16, 2020

June 30, 2025

Preferred Series A

92,511

$

4.54

$

55

$

Warrant¹⁴

January 16, 2020

May 1, 2026

Preferred Series A

60,000

$

4.54

 

36

 

Warrant¹⁴

January 16, 2020

May 22, 2027

Preferred Series A

200,000

$

4.54

 

120

 

Total Utility Associates, Inc.

  

  

 

 

211

 

ZenDrive, Inc.

Warrant¹⁴

July 16, 2021

July 16, 2031

Common Stock

30,466

$

2.46

$

29

$

20

Sub-Total: Professional, Scientific, and Technical Services (0.9%)*

$

2,570

$

10,207

Real Estate (7)

  

 

  

 

  

Egomotion Corporation

Warrant¹¹⁾⁽¹⁴

January 16, 2020

December 10, 2028

Preferred Series A

60,786

$

1.32

$

$

46

Warrant¹⁴

January 16, 2020

June 29, 2028

Preferred Series A

121,571

$

1.32

219

93

Total Egomotion Corporation

219

139

Knockaway, Inc.

Warrant¹⁴

January 16, 2020

May 24, 2029

Preferred Series B

87,955

$

8.53

$

209

$

Warrant¹⁴

November 10, 2021

November 10, 2031

Common Stock

148,730

$

7.74

265

4

Total Knockaway, Inc.

474

4

Sub-Total: Real Estate (0.0%)*

$

693

$

143

Rental and Leasing Services (7)

  

 

  

 

  

Maxwell Financial Labs, Inc.

Warrant¹⁴

October 7, 2020

October 7, 2030

Common Stock

106,735

$

0.29

$

20

$

318

Warrant¹⁴

December 22, 2020

December 22, 2030

Common Stock

110,860

$

0.29

34

330

Warrant¹⁴

September 30, 2021

September 30, 2031

Common Stock

79,135

$

1.04

148

210

Total Maxwell Financial Labs, Inc.

202

858

NextCar Holding Company, Inc.

Warrant¹⁴

December 14, 2021

December 14, 2026

Preferred Series A

169,898

(13)

$

2.81

(13)

$

35

$

26

Warrant¹⁴

February 23, 2022

February 23, 2032

Preferred Series A

13,273

(13)

$

2.81

(13)

3

5

Warrant¹⁴

March 16, 2022

March 16, 2032

Preferred Series A

15,928

(13)

$

2.81

(13)

3

6

Warrant¹⁴

April 18, 2022

April 18, 2032

Preferred Series A

146,006

(13)

$

2.81

(13)

6

52

Total NextCar Holding Company, Inc.

47

89

Sub-Total: Rental and Leasing Services (0.1%)*

$

249

$

947

22

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1)

  

Type of
Investment (2)

  

Investment Date (3)

  

Expiration Date

  

Series

  

Shares

  

Strike Price

  

Cost

  

Fair Value (6)

Warrant Investments- United States, Continued

  

  

  

  

 

Retail Trade (7)

  

 

  

 

  

Boosted eCommerce, Inc.

Warrant¹⁴

December 18, 2020

December 14, 2030

Preferred Series A-1

759,263

$

0.84

$

259

$

79

Fernished, Inc.

Warrant¹⁴

May 5, 2021

May 5, 2031

Common Stock

54,427

$

0.15

$

39

$

30

Gobble, Inc.

Warrant¹⁴

January 16, 2020

May 9, 2028

Common Stock

74,635

$

1.20

$

73

$

48

Warrant¹⁴

January 16, 2020

December 27, 2029

Common Stock

10,000

$

1.22

 

617

 

358

Total Gobble, Inc.

 

 

690

 

406

Madison Reed, Inc.

Warrant¹⁴

January 16, 2020

March 23, 2027

Preferred Series C

194,553

$

2.57

$

185

$

300

Warrant¹⁴

January 16, 2020

July 18, 2028

Common Stock

43,158

$

0.99

 

71

 

118

Warrant¹⁴

January 16, 2020

June 30, 2029

Common Stock

36,585

$

1.23

 

56

 

93

Total Madison Reed, Inc.

 

 

312

 

511

Portofino Labs, Inc.

Warrant¹⁴

December 31, 2020

December 31, 2030

Common Stock

39,659

$

1.53

$

160

$

109

Warrant¹⁴

April 1, 2021

April 1, 2031

Common Stock

39,912

$

1.46

 

100

 

45

Total Portofino Labs, Inc.

 

260

 

154

Super73, Inc.

Warrant¹⁴

December 31, 2020

December 31, 2030

Common Stock

177,305

$

3.16

$

105

$

136

Trendly, Inc.

Warrant¹⁴

January 16, 2020

August 10, 2026

Preferred Series A

245,506

$

1.14

$

221

$

37

Sub-Total: Retail Trade (0.1%)*

 

$

1,886

$

1,353

Space Research and Technology (7)

  

 

  

 

  

 

  

Axiom Space, Inc.

Warrant¹⁴

May 28, 2021

May 28, 2031

Common Stock

1,773

$

169.24

$

121

$

62

Warrant¹⁴

May 28, 2021

May 28, 2031

Common Stock

882

$

340.11

39

10

Total Axiom Space, Inc.

160

72

Sub-Total: Space Research and Technology (0.0%)*

$

160

$

72

Wholesale Trade (7)

BaubleBar, Inc.

Warrant¹⁴

January 16, 2020

March 29, 2027

Preferred Series C

531,806

$

1.96

$

639

$

483

Warrant¹⁴

January 16, 2020

April 20, 2028

Preferred Series C

60,000

$

1.96

 

72

 

54

Total BaubleBar, Inc.

  

 

 

711

 

537

GrubMarket, Inc.

Warrant¹⁴

June 15, 2020

June 15, 2030

Common Stock

405,000

$

1.10

$

115

$

703

Sub-Total: Wholesale Trade (0.1%)*

$

826

$

1,240

Total: Warrant Investments- United States (3.0%)*

$

19,892

$

32,187

23

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1)

  

Type of
Investment (2)

  

Investment Date (3)

  

Expiration Date

  

Series

  

Shares

  

Strike Price

  

Cost

  

Fair Value (6)

Warrant Investments- Canada

Manufacturing (7)

  

 

  

 

  

Nexii Building Solutions, Inc. (10)

Warrant¹⁴

August 27, 2021

August 27, 2026

Common Stock

63,071

(13)

$

15.86

(13)

$

410

$

386

Warrant¹⁴

June 8, 2022

June 8, 2027

Common Stock

24,196

(13)

$

15.96

(13)

204

204

Total Nexii Building Solutions, Inc.

  

 

 

614

 

590

Sub-Total: Manufacturing (0.1%)*

$

614

$

590

Transportation and Warehousing (7)

GoFor Industries, Inc. (10)

Warrant¹⁴

January 21, 2022

February 21, 2022

Common Stock

171,954

$

0.45

$

105

$

Sub-Total: Transportation and Warehousing (0.0%)*

$

105

$

Total: Warrant Investments- Canada (0.1%)*

$

719

$

590

Warrant Investments- Europe

Manufacturing (7)

  

 

  

 

  

Aledia, Inc. (10)

Warrant¹⁴

March 31, 2022

March 31, 2032

Preferred Series D-3

33,552

(13)

$

148.92

(13)

$

130

$

415

Sub-Total: Manufacturing (0.0%)*

$

130

$

415

Total: Warrant Investments- Europe (0.0%)*

$

130

$

415

Total: Warrant Investments- (3.0%)(19)*

$

20,741

$

33,192

24

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1)

  

Type of
Investment (2)

  

Investment Date (3)

  

Shares / Principal

  

Series

  

Cost

  

Fair Value (6)

Equity Investments- United States

  

  

  

  

  

Construction (7)

  

  

  

  

  

Project Frog, Inc.

 

Equity¹⁴

 

January 16, 2020

 

4,383,173

 

Preferred Series AA-1¹⁷

$

351

$

17

 

Equity¹⁴

 

January 16, 2020

 

3,401,427

 

Preferred Series BB¹⁷

 

1,333

 

40

Equity¹⁴

August 3, 2021

6,634,061

Common Stock

1,684

10

Equity¹⁴

August 3, 2021

3,129,887

Preferred Series CC¹⁷

1,254

 

296

Total Project Frog, Inc. (20)

 

  

 

 

 

  

 

4,622

 

363

 

  

 

 

 

  

 

  

 

  

Sub-Total:  Construction (0.0%)*

 

  

 

 

 

  

$

4,622

$

363

Health Care and Social Assistance (7)

 

  

 

 

 

  

 

  

 

  

FemTec, Inc. (20)

Equity¹⁴

July 22, 2021

1,098,093

Common Stock

$

13,046

$

8,956

 

  

 

 

 

  

 

  

 

  

Lark Technologies, Inc.

Equity¹⁴

August 19, 2021

32,416

Preferred Series D¹⁷

$

500

$

457

 

  

 

 

 

  

 

  

 

  

WorkWell Prevention & Care Inc.

 

Equity¹⁴

 

January 16, 2020

 

7,000,000

 

Common Stock

$

51

$

 

Equity¹⁴

 

January 16, 2020

 

3,450

 

Preferred Series P¹⁷

 

3,450

 

 

Equity¹⁴

 

January 16, 2020

 

$

3,170

 

Convertible Note¹⁶⁾

 

3,219

 

Total WorkWell Prevention & Care Inc. (20)

 

  

 

 

 

  

 

6,720

 

 

  

 

 

 

  

 

  

 

  

Sub-Total:  Health Care and Social Assistance (0.9%)*

 

  

 

 

 

  

$

20,266

$

9,413

Information (7)

Rigetti & Co, Inc.

Equity(9)(14)

February 25, 2022

50,000

Common Stock

$

500

$

184

Equity(9)(14)

May 18, 2021

757,297

Common Stock

506

2,670

Total Rigetti & Co, Inc.

1,006

2,854

Sub-Total:  Information (0.3%)*

 

  

 

 

 

  

$

1,006

$

2,854

 

  

 

 

 

  

 

  

 

  

Manufacturing (7)

 

  

 

 

 

  

 

  

 

  

Hadrian, Inc.

Equity¹⁴

March 29, 2022

53,154

Preferred A-4¹⁷

$

500

$

500

Mainspring Energy, Inc.

Equity¹⁴

March 30, 2022

$

500

Convertible Note¹⁶⁾

$

500

$

500

Quip NYC, Inc.

Equity¹⁴

August 17, 2021

3,320

Preferred Series B-1¹⁷

$

500

$

445

Store Intelligence, Inc. (20)

Equity¹⁴

May 2, 2020

1,430,000

Preferred Series A¹⁷

$

608

$

Tarana Wireless, Inc.

Equity¹⁴

March 16, 2022

611,246

Preferred Series 6¹⁷

$

500

$

487

 

  

 

 

 

  

 

  

 

  

Vertical Communications, Inc.

 

Equity¹¹⁾⁽¹⁴

 

January 16, 2020

 

3,892,485

 

Preferred Series 1¹⁷

$

$

 

Equity¹⁴

 

January 16, 2020

 

$

5,500

 

Convertible Note¹⁶⁾

 

3,966

 

3,550

Total Vertical Communications, Inc. (20)

 

 

 

 

  

 

3,966

 

3,550

 

 

 

 

  

 

  

 

  

Sub-Total:  Manufacturing (0.5%)*

 

 

 

 

  

$

6,574

$

5,482

 

 

 

 

  

 

  

 

  

Professional, Scientific, and Technical Services (7)

 

 

 

 

  

 

  

 

  

Dynamics, Inc.

 

Equity¹⁴

 

January 16, 2020

 

17,726

 

Preferred Series A¹⁷

$

390

$

 

  

 

 

 

  

 

  

 

  

 

  

 

 

 

  

 

  

 

  

Edeniq, Inc.

 

Equity¹¹⁾⁽¹⁴

 

January 16, 2020

 

2,527,449

 

Preferred Series B¹⁷

$

$

66

 

Equity¹¹⁾⁽¹⁴

 

January 16, 2020

 

3,657,487

 

Preferred Series C¹⁷

 

 

98

 

Equity¹¹⁾⁽¹⁴

 

November 29, 2021

 

133,766,138

 

Preferred Series D¹⁷

 

 

354

Total Edeniq, Inc. (20)

 

  

 

 

 

  

 

 

518

Emerald Cloud Lab, Inc.

Equity¹¹⁾⁽¹⁴

June 3, 2022

Preferred Series C¹⁷

$

500

$

500

Emergy, Inc.

Equity¹⁴

June 28, 2021

75,958

Preferred Series B¹⁷

$

500

$

509

Nomad Health, Inc.

Equity¹¹⁾⁽¹⁴

May 27, 2022

37,920

Preferred Series D-1¹⁷

$

500

$

500

Sub-Total: Professional, Scientific, and Technical Services (0.2%)*

 

$

1,890

$

2,027

25

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2022

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1)

  

Type of
Investment (2)

  

Investment Date (3)

  

Shares / Principal

  

Series

  

Cost

  

Fair Value (6)

Equity Investments- United States, Continued

  

  

  

  

  

Real Estate (7)

Knockaway, Inc.

Equity¹⁴

March 30, 2022

$

500

Convertible Note¹⁶⁾

$

500

$

500

Orchard Technologies, Inc.

Equity¹⁴

August 6, 2021

74,406

Preferred Series D¹⁷

$

500

$

281

Sub-Total:  Real Estate (0.1%)*

$

1,000

$

781

Rental and Leasing Services (7)

 

  

 

 

 

  

 

  

 

  

Maxwell Financial Labs, Inc

 

Equity¹⁴

 

January 22, 2021

 

135,641

 

Preferred Series B¹⁷

$

500

$

508

Sub-Total:  Rental and Leasing Services (0.0%)*

 

  

 

 

 

  

$

500

$

508

Retail Trade (7)

Fernished, Inc.

 

Equity¹⁴

 

October 6, 2021

 

454,905

 

Preferred Series B-1¹⁷

$

500

$

389

Portofino Labs, Inc.

 

Equity¹⁴

 

November 1, 2021

 

256,291

 

Preferred Series B-1¹⁷

$

500

$

496

Sub-Total:  Retail Trade (0.1%)*

 

  

 

 

 

  

$

1,000

$

885

 

  

 

 

 

  

 

  

 

  

Space Research and Technology (7)

Axiom Space, Inc.

Equity¹⁴

August 11, 2021

$

500

Convertible Note¹⁶⁾

$

500

$

500

Sub-Total:  Rental and Leasing Services (0.0%)*

$

500

$

500

Total:  Equity Investments- United States (2.1%)*

 

  

 

 

  

 

  

$

37,358

$

22,813

Equity Investments- Canada

Manufacturing (7)

 

  

 

 

 

  

 

  

 

  

Nexii Building Solutions, Inc. (10)

Equity¹⁴

February 28, 2022

24,418

Common Stock

$

500

$

476

Sub-Total:  Manufacturing (0.0%)*

$

500

$

476

Total:  Equity Investments- Canada (0.0%)*

$

500

$

476

Total:  Equity Investments (2.1%)(19)*

$

37,858

$

23,289

 

  

 

 

  

 

  

 

  

 

  

Total Investment in Securities (96.4%)*

 

  

 

 

  

 

  

$

1,066,598

$

1,051,074

 

  

 

 

  

 

  

 

  

 

  

Cash, Cash Equivalents, and Restricted Cash

 

  

 

 

  

 

  

 

  

 

  

Goldman Sachs Financial Square Government Institutional Fund

  

 

  

$

12,474

$

12,474

Other cash accounts

 

  

 

 

  

 

  

 

752

 

752

Cash, Cash Equivalents, and Restricted Cash (1.2%)*

 

  

 

 

  

 

  

 

13,226

 

13,226

 

  

 

 

  

 

  

 

  

 

  

Total Portfolio Investments and Cash and Cash Equivalents (97.6% of net assets)

 

  

 

 

  

 

  

$

1,079,824

$

1,064,300

(1)All portfolio companies are located in North America and Europe. As of June 30, 2022 the Company had five foreign domiciled portfolio companies, four of which are based in Canada and one of which is based in Europe. In total, these foreign domiciled portfolio investments represent 17.3% of total net asset value based on fair value. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale and may be deemed to be “restricted securities” under the Securities Act.
(2)All debt investments are income producing unless otherwise noted. All equity and warrant investments are non-income producing unless otherwise noted. Equipment financed under our equipment financing investments relates to operational equipment essential to revenue production for the portfolio company in the industry noted. 
(3)Investment date represents the date of initial investment date, either purchases or funding, not adjusted for modifications. For assets purchased from the Legacy Funds (as defined below) as part of the Formation Transactions (as defined below), investment date is January 16, 2020, the date of the Formation Transactions.

26

Table of Contents

(4)Interest rate is the fixed or variable rate of the debt investments and does not include any original issue discount, end-of-term (“EOT”) payment, or additional fees related to such investments, such as deferred interest, commitment fees, prepayment fees or exit fees. EOT payments are contractual payments due in cash at the maturity date of the loan, including upon prepayment, and are a fixed rate determined at the inception of the loan. At the end of the term of certain equipment financings, the borrower has the option to purchase the underlying assets at fair value, generally subject to a cap, or return the equipment and pay a restocking fee. The fair values of the financed assets have been estimated as a percentage of original cost for purpose of the EOT payment value. The EOT payment is amortized and recognized as non-cash income over the loan or equipment financing prior to its payment and is included as a component of the cost basis of the Company’s current debt securities.
(5)Principal is net of repayments, if any, as per the terms of the debt instrument’s contract.
(6)Except as noted, all investments were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s board of directors.
(7)The Company uses the North American Industry Classification System (“NAICS”) code for classifying the industry grouping of its portfolio companies.
(8)The interest rate on variable interest rate investments represents a benchmark rate plus spread. The benchmark interest rate is subject to an interest rate floor. The benchmark rate Prime was 4.75% and 1-month U.S. Dollar London Interbank Offered Rate (“LIBOR”) was 1.79% as of June 30, 2022.
(9)Asset is valued using Level 2 inputs.
(10)Indicates a “non-qualifying asset” under section 55(a) by the Investment Company Act of 1940, as amended (the “1940 Act”). The Company’s percentage of non-qualifying assets at fair value represents 7.3% of the Company’s total assets as of June 30, 2022. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets. Asset is not a U.S. entity.
(11)Investment has zero cost basis as it was purchased at a fair value of zero as part of the Formation Transactions (as defined below).
(12)Investment is a secured loan warehouse facility collateralized by interest in specific assets that meet the eligibility requirements under the facility during the warehouse period. Repayment of the facility will occur over the amortizing period unless otherwise prepaid.
(13)Company has been issued warrants with pricing and number of shares dependent upon a future round of equity issuance by the portfolio company.
(14)Investment is not pledged as collateral supporting amounts outstanding under the credit facility with KeyBank.
(15)Interest on this loan includes a payment-in-kind (“PIK”) provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected.
(16)Convertible notes represent investments through which the Company will participate in future equity rounds at preferential rates. There are no principal or interest payments made against the note unless conversion does not occur.
(17)Preferred stock represents investments through which the Company will have preference in liquidation rights and do not contain any cumulative preferred dividends.
(18)Investment is on non-accrual status as of June 30, 2022 and is therefore considered non-income producing.

27

Table of Contents

(19)All of the Company’s debt securities are pledged as collateral supporting the amounts outstanding under the credit facility with KeyBank (see “Note 5 – Borrowings”), except as noted.
(20)This investment is deemed to be a “Control Investment” or an “Affiliate Investment.” The Company classifies its investment portfolio in accordance with the requirements of the 1940 Act. Control Investments are defined by the Investment Company Act of 1940, as amended, as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. Affiliate Investments are defined by the 1940 Act, as amended, as investments in companies in which the Company owns between 5% and 25% (inclusive) of the voting securities and does not have rights to maintain greater than 50% of the board representation. As defined in the 1940 Act, the Company is deemed to be an “Affiliated Person” of this portfolio company. Fair value as of June 30, 2022, along with transactions during the six months ended June 30, 2022 in these control or affiliated investments are as follows:

Net change in

 Unrealized 

Fair Value at

Gross

Gross

Realized

(Depreciation)/

Fair Value at

Interest

  

December 31, 2021

  

Additions (1)

  

Reductions (2)

  

Gain/(Loss)

  

 Appreciation

 

June 30, 2022

 

 Income

  

For the Six Months Ended June 30, 2022

Control Investments

 

  

    

  

    

  

  

    

Edeniq, Inc.

$

5,522

$

1,237

$

$

$

(751)

$

6,008

$

1,527

Project Frog, Inc.

4,209

27

(3,878)

(228)

256

386

228

Vertical Communications, Inc.

17,382

252

(247)

17,387

983

WorkWell Prevention and Care Inc.

5,101

300

(4,394)

1,007

Total Control Investments

$

32,214

 

$

1,816

 

$

(3,878)

$

(228)

$

(5,136)

$

24,788

$

2,738

 

  

 

 

  

 

 

  

 

  

 

  

 

  

 

  

Affiliate Investments

 

  

 

 

  

 

 

  

 

  

 

  

 

  

 

  

FemTec Health, Inc.

$

27,748

$

28

$

$

$

(3,939)

$

23,837

$

862

Store Intelligence, Inc.

4,444

(2,400)

(9,633)

7,589

Total Affiliate Investments

$

32,192

 

$

28

 

$

(2,400)

$

(9,633)

$

3,650

$

23,837

$

862

 

  

 

 

  

 

 

  

 

  

 

  

 

  

 

  

Total Control and Affiliate Investments

$

64,406

 

$

1,844

 

$

(6,278)

$

(9,861)

$

(1,486)

$

48,625

$

3,600

(1)Gross additions may include increases in the cost basis of investments resulting from new portfolio investments, PIK interest, the accretion of discounts, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category.
(2)Gross reductions may include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.

28

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2021

(In thousands, except share and per share data)

Portfolio Company (1)

  

Type of Investment (2)

  

Investment Date (3)

Maturity Date

  

Interest Rate (4)

  

Principal 
Amount (5)

  

Cost

  

Fair Value (6)

Debt Securities

Administrative and Support and Waste Management and Remediation (7)

  

  

  

  

  

Qwick, Inc.

Secured Loan⁽¹⁹⁾

December 31, 2021

January 1, 2026

Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 5.0% ⁽⁸⁾

$

5,000

$

4,903

$

4,903

RTS Holding, Inc.

Secured Loan⁽¹⁹⁾

December 31, 2021

January 1, 2027

Fixed interest rate 10.5%; EOT 3.0%

$

23,000

$

22,711

$

22,711

SeaOn Environmental, LLC

Equipment Financing

January 16, 2020

January 1, 2023

Fixed interest rate 9.0%; EOT 12.0%

$

1,115

$

1,490

$

1,474

Sub-total: Administrative and Support and Waste Management and Remediation (3.1%)*

  

$

29,115

$

29,104

$

29,088

Agriculture, Forestry, Fishing and Hunting (7)

  

  

  

 

  

 

  

 

  

Bowery Farming, Inc.

Secured Loan⁽¹⁴⁾

September 10, 2021

January 1, 2026

Variable interest rate LIBOR + 11.0% or Floor rate 10.1% ⁽⁸⁾

$

10,000

$

9,253

$

9,300

Robotany, Inc.

 

Equipment Financing

January 16, 2020

January 1, 2024

Fixed interest rate 7.6%; EOT 22.0%

$

1,186

 

$

1,458

 

$

1,492

Sub-total: Agriculture, Forestry, Fishing and Hunting (1.2%)*

  

$

11,186

$

10,711

$

10,792

Construction (7)

  

  

  

 

  

 

  

 

  

Dandelion Energy, Inc.

 

Equipment Financing

March 17, 2020

April 1, 2024

Fixed interest rate 9.0%; EOT 12.5%

$

332

$

367

$

368

Equipment Financing

October 27, 2020

November 1, 2024

Fixed interest rate 9.2%; EOT 12.5%

421

456

453

Equipment Financing

November 19, 2020

December 1, 2024

Fixed interest rate 9.1%; EOT 12.5%

524

564

561

Equipment Financing

December 29, 2020

January 1, 2025

Fixed interest rate 9.2%; EOT 12.5%

615

657

653

Equipment Financing

March 25, 2021

April 1, 2025

Fixed interest rate 9.1%; EOT 12.5%

1,238

1,300

1,295

Equipment Financing

December 1, 2021

January 1, 2026

Fixed interest rate 8.8%; EOT 12.5%

1,356

1,362

1,362

Total Dandelion Energy, Inc.

4,486

4,706

4,692

Project Frog, Inc. (22)

Secured Loan

April 30, 2020

May 1, 2023

Fixed interest rate 12.0%

$

4,128

$

4,080

$

3,754

Sub-total: Construction (0.9%)*

  

$

8,614

$

8,786

$

8,446

Educational Services (7)

Medical Sales Training Holding Company

Secured Loan

March 18, 2021

April 1, 2025

Variable interest rate Prime + 8.8% or Floor rate 12.0%; EOT 5.0% ⁽⁸⁾

$

6,000

$

5,962

$

6,052

Secured Loan

July 21, 2021

August 1, 2025

Variable interest rate Prime + 8.8% or Floor rate 12.0%; EOT 5.0% ⁽⁸⁾

2,000

1,973

2,013

Total Medical Sales Training Holding Company

8,000

7,935

8,065

Yellowbrick Learning, Inc.

Secured Loan

February 1, 2021

September 1, 2025

Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 5.0% ⁽⁸⁾

$

7,500

$

7,579

$

7,630

Secured Loan

August 10, 2021

March 1, 2026

Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 5.0% ⁽⁸⁾

2,500

2,504

2,525

Total Yellowbrick Learning, Inc.

10,000

10,083

10,155

Sub-total: Educational Services (2.0%)*

 

  

$

18,000

$

18,018

$

18,220

29

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2021

(In thousands, except share and per share data)

Portfolio Company (1)

  

Type of Investment (2)

  

Investment Date (3)

Maturity Date

  

Interest Rate (4)

  

Principal 
Amount (5)

  

Cost

  

Fair Value (6)

Debt Securities, Continued

Finance and Insurance (7)

  

  

 

  

 

  

 

  

 

  

BoardRE, Inc.

Secured Loan⁽¹⁹⁾

October 15, 2021

May 1, 2025

Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.5% ⁽⁸⁾

$

5,000

$

4,973

$

4,973

DailyPay, Inc.

Secured Loan

September 30, 2020

November 1, 2024

Variable interest rate Prime + 5.0% or Floor rate 12.0%; EOT 6.0% ⁽⁸⁾

$

19,536

$

19,869

$

20,040

Secured Loan

December 30, 2020

January 1, 2025

Variable interest rate Prime + 5.0% or Floor rate 12.0%; EOT 6.0% ⁽⁸⁾

5,000

5,076

5,101

Total DailyPay, Inc.

24,536

24,945

25,141

Petal Card, Inc.

Secured Loan

January 16, 2020

October 1, 2024

Variable interest rate Prime + 3.5% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾

$

10,000

$

10,140

$

10,078

Secured Loan (12)(14)

January 28, 2021

January 1, 2024

Variable interest rate Prime + 4.3% or Floor rate 11.5% ⁽⁸⁾

14,234

13,986

14,236

Secured Loan

August 6, 2021

October 1, 2024

Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾

7,000

6,855

6,908

Total Petal Card, Inc.

31,234

30,981

31,222

Sub-total: Finance and Insurance (6.6%)*

 

  

$

60,770

$

60,899

$

61,336

Health Care and Social Assistance (7)

  

 

  

 

  

 

  

 

  

FemTec Health, Inc.

Secured Loan

December 1, 2021

July 1, 2026

Fixed interest rate 11.0%; EOT 7.5%

$

10,000

$

10,752

$

10,168

Secured Loan

July 23, 2021

September 1, 2022

Fixed interest rate 11.0%

2,151

2,152

2,171

Secured Loan

September 29, 2021

April 1, 2026

Fixed interest rate 11.0%; EOT 7.5%

3,000

3,019

3,040

Total FemTec Health, Inc. (22)

15,151

15,923

15,379

Lark Technologies, Inc.

Secured Loan

September 30, 2020

April 1, 2025

Variable interest rate Prime + 3.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾

$

5,000

$

4,939

$

4,986

Secured Loan

June 30, 2021

January 1, 2026

Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾

5,000

4,818

4,847

Total Lark Technologies, Inc.

10,000

9,757

9,833

WorkWell Prevention & Care Inc.

Secured Loan

January 16, 2020

March 1, 2024

Fixed interest rate 8.0%; EOT 10.0%

$

3,370

$

3,659

$

3,522

Secured Loan

January 16, 2020

March 1, 2024

Fixed interest rate 8.0%

 

700

 

718

 

676

Total WorkWell Prevention & Care Inc. (22)

 

 

4,070

 

4,377

 

4,198

Sub-total: Health Care and Social Assistance (3.1%)*

 

$

29,221

$

30,057

$

29,410

Information (7)

  

 

 

  

 

  

 

  

Firefly Systems, Inc.

Equipment Financing

January 29, 2020

February 1, 2023

Fixed interest rate 9.0%; EOT 10.0%

$

2,144

$

2,579

$

2,549

Equipment Financing

August 28, 2020

September 1, 2023

Fixed interest rate 8.9%; EOT 10.0%

2,094

2,356

2,338

Equipment Financing

September 18, 2020

October 1, 2023

Fixed interest rate 8.8%; EOT 10.0%

256

286

284

Total Firefly Systems, Inc.

4,494

5,221

5,171

Gobiquity, Inc.

Equipment Financing

January 16, 2020

April 1, 2022

Fixed interest rate 7.5%; EOT 20.0%

$

61

$

193

$

189

Group Nine Media, Inc.

Secured Loan⁽¹⁹⁾

September 17, 2021

October 1, 2026

Variable interest rate Prime + 7.3% or Floor rate 10.5%; EOT 3.5% ⁽⁸⁾

$

20,000

$

19,962

$

20,108

Hut 8 Holdings, Inc. (10)

Equipment Financing⁽¹⁹⁾

December 30, 2021

January 1, 2025

Fixed interest rate 9.5%; EOT 3.5%

$

30,000

$

29,705

$

29,705

Rigetti & Co, Inc.

Secured Loan

March 10, 2021

April 1, 2025

Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 2.8% ⁽⁸⁾

$

12,000

 

$

11,891

 

$

11,977

Secured Loan

May 18, 2021

June 1, 2025

Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 2.8% ⁽⁸⁾

8,000

7,895

7,954

Secured Loan

November 10, 2021

December 1, 2025

Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 2.8% ⁽⁸⁾

7,000

6,848

6,848

Total Rigetti & Co, Inc.

27,000

26,634

26,779

Smule, Inc.

Secured Loan (15)

July 1, 2020

January 1, 2022

Fixed interest rate 0.0%

$

10

$

10

$

10

Stratifyd, Inc.

Secured Loan⁽¹⁹⁾

September 3, 2021

December 1, 2025

Variable interest rate Prime + 7.8% or Floor rate 11.0%; EOT 3.5% ⁽⁸⁾

$

6,000

$

5,947

$

5,993

30

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2021

(In thousands, except share and per share data)

Portfolio Company (1)

  

Type of Investment (2)

  

Investment Date (3)

Maturity Date

  

Interest Rate (4)

  

Principal 
Amount (5)

  

Cost

  

Fair Value (6)

Debt Securities, Continued

Information, Continued (7)

  

 

 

  

 

  

 

  

Whip Networks, Inc.

 

Secured Loan⁽¹⁹⁾

June 14, 2021

July 1, 2025

Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 3.5% ⁽⁸⁾

$

5,000

 

$

4,992

 

$

5,029

Secured Loan⁽¹⁹⁾

September 10, 2021

July 1, 2025

Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 3.5% ⁽⁸⁾

1,000

995

1,003

Total Whip Networks, Inc.

6,000

5,987

6,032

Zuum Transportation, Inc.

Secured Loan⁽¹⁹⁾

December 17, 2021

January 1, 2027

Variable interest rate Prime + 6.0% or Floor rate 10.8%; EOT 2.5% ⁽⁸⁾

$

5,000

$

4,976

$

4,976

Sub-total: Information (10.6%)*

 

  

$

98,565

$

98,635

$

98,963

Management of Companies and Enterprises (7)

Exer Holdings, LLC

Secured Loan⁽¹⁹⁾

November 19, 2021

December 1, 2026

Variable interest rate Prime + 7.0% or Floor rate 11.5%; EOT 3.0% ⁽⁸⁾

$

22,500

$

22,240

$

22,240

Sub-total: Management of Companies and Enterprises (2.4%)*

 

  

$

22,500

$

22,240

$

22,240

Manufacturing (7)

  

  

 

  

  

 

  

 

  

Athletic Brewing Company, LLC

Equipment Financing⁽¹⁹⁾

December 7, 2021

December 1, 2025

Fixed interest rate 11.0%; EOT 7.0%

$

20,000

$

19,932

$

19,932

Bolb, Inc.

Equipment Financing⁽¹⁹⁾

October 12, 2021

November 1, 2024

Fixed interest rate 10.3%; EOT 6.0%

$

1,624

$

1,625

$

1,625

Daring Foods, Inc.

Equipment Financing⁽¹⁹⁾

April 8, 2021

May 1, 2024

Fixed interest rate 9.6%; EOT 7.5%

$

400

$

411

$

413

Equipment Financing⁽¹⁹⁾

July 7, 2021

July 1, 2024

Fixed interest rate 9.5%; EOT 7.5%

1,917

1,938

1,937

Equipment Financing⁽¹⁹⁾

August 17, 2021

September 1, 2024

Fixed interest rate 9.7%; EOT 7.5%

942

947

952

Equipment Financing⁽¹⁹⁾

August 31, 2021

September 1, 2024

Fixed interest rate 10.0%; EOT 7.5%

546

548

552

Equipment Financing⁽¹⁹⁾

November 1, 2021

December 1, 2024

Fixed interest rate 9.4%; EOT 7.5%

1,034

1,028

1,028

Total Daring Foods, Inc.

4,839

4,872

4,882

Eterneva, Inc.

Equipment Financing⁽¹⁴⁾

November 24, 2021

December 1, 2025

Fixed interest rate 10.6%; EOT 11.5%

$

544

$

546

$

546

Footprint International Holding, Inc.

 

Equipment Financing

February 14, 2020

March 1, 2024

Fixed interest rate 10.3%; EOT 8.0%

$

10,611

 

$

11,576

 

$

12,405

Secured Loan

June 22, 2020

November 1, 2024

Fixed interest rate 12.0%; EOT 9.0%

6,837

7,162

6,837

Total Footprint International Holding, Inc.

17,448

18,738

19,242

Happiest Baby, Inc.

Equipment Financing

January 16, 2020

September 1, 2022

Fixed interest rate 8.4%; EOT 9.5%

$

385

$

538

$

527

Equipment Financing

January 16, 2020

November 1, 2022

Fixed interest rate 8.6%; EOT 9.5%

 

355

 

469

 

464

Equipment Financing

January 16, 2020

January 1, 2023

Fixed interest rate 8.6%; EOT 9.5%

 

375

 

469

 

469

Equipment Financing

February 7, 2020

June 1, 2023

Fixed interest rate 8.2%; EOT 9.5%

 

550

 

640

 

640

Equipment Financing

September 16, 2020

January 1, 2024

Fixed interest rate 8.4%; EOT 9.5%

866

945

947

Equipment Financing

January 22, 2021

May 1, 2025

Fixed interest rate 8.4%; EOT 9.5%

745

790

792

Total Happiest Baby, Inc.

 

  

 

3,276

 

3,851

 

3,839

Health-Ade, LLC

Equipment Financing

January 16, 2020

February 1, 2022

Fixed interest rate 9.4%; EOT 15.0%

$

110

$

709

$

703

Equipment Financing

January 16, 2020

April 1, 2022

Fixed interest rate 8.6%; EOT 15.0%

 

163

 

462

 

454

Equipment Financing

January 16, 2020

July 1, 2022

Fixed interest rate 9.1%; EOT 15.0%

 

682

 

1,295

 

1,270

Total Health-Ade, LLC

 

  

 

  

 

  

 

955

 

2,466

 

2,427

Hi-Power, LLC

Equipment Financing⁽¹⁹⁾

September 30, 2021

April 1, 2025

Fixed interest rate 12.4%; EOT 1.0%

$

6,529

$

6,524

$

6,598

31

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2021

(In thousands, except share and per share data)

Portfolio Company (1)

  

Type of Investment (2)

  

Investment Date (3)

Maturity Date

  

Interest Rate (4)

  

Principal 
Amount (5)

  

Cost

  

Fair Value (6)

Debt Securities, Continued

Manufacturing, Continued (7)

  

  

 

  

  

 

  

 

  

Mainspring Energy, Inc.

Secured Loan

January 16, 2020

August 1, 2023

Fixed interest rate 11.0%; EOT 3.8%

$

5,660

$

5,942

$

5,956

Secured Loan

November 20, 2020

December 1, 2024

Fixed interest rate 11.0%; EOT 3.8%

5,500

5,436

5,539

Total Mainspring Energy, Inc.

11,160

11,378

11,495

Miyoko's Kitchen

 

Equipment Financing

February 19, 2020

September 1, 2022

Fixed interest rate 8.8%; EOT 9.0%

$

242

$

311

$

310

Equipment Financing

August 27, 2020

March 1, 2023

Fixed interest rate 8.9%; EOT 9.0%

488

558

556

Equipment Financing

February 5, 2021

September 1, 2023

Fixed interest rate 8.5%; EOT 9.0%

450

484

483

Equipment Financing

June 25, 2021

December 1, 2023

Fixed interest rate 8.9%; EOT 9.0%

486

506

505

Total Miyoko's Kitchen

1,666

1,859

1,854

Molekule, Inc.

Equipment Financing

June 19, 2020

January 1, 2024

Fixed interest rate 8.8%; EOT 10.0%

$

1,756

$

1,931

$

1,918

Equipment Financing

September 29, 2020

April 1, 2024

Fixed interest rate 9.0%; EOT 10.0%

391

425

421

Equipment Financing

December 18, 2020

July 1, 2024

Fixed interest rate 8.8%; EOT 10.0%

652

695

688

Equipment Financing

August 25, 2021

March 1, 2025

Fixed interest rate 8.9%; EOT 10.0%

494

504

500

Total Molekule, Inc.

3,293

3,555

3,527

Nexii Building Solutions, Inc. (10)

Secured Loan⁽¹⁹⁾

August 27, 2021

September 1, 2025

Variable interest rate Prime + 7.0% or Floor rate 10.3%; EOT 2.5% ⁽⁸⁾

$

10,000

$

9,575

$

9,648

Quip NYC, Inc.

Secured Loan

March 9, 2021

April 1, 2026

Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 3.0% ⁽⁸⁾

$

17,500

$

17,319

$

17,448

Store Intelligence, Inc. (22)

Secured Loan (18)

May 2, 2020

August 1, 2024

Fixed interest rate 12.0%; EOT 7.7%

$

11,641

$

12,033

$

4,444

Tarana Wireless, Inc.

Secured Loan⁽¹⁹⁾

June 30, 2021

July 1, 2025

Variable interest rate Prime + 8.0% or Floor rate 11.5%; EOT 4.5% ⁽⁸⁾

$

18,500

$

17,728

$

17,551

The Fynder Group, Inc.

Equipment Financing

October 14, 2020

May 1, 2024

Fixed interest rate 9.1%; EOT 10.0%

$

489

$

516

$

515

Vertical Communications, Inc.

Secured Loan

August 23, 2021

March 1, 2026

Fixed interest rate 11.0%; EOT 23.8%

$

13,300

$

15,016

$

13,656

VitaCup, Inc.

Secured Loan⁽¹⁹⁾

June 23, 2021

July 1, 2025

Variable interest rate Prime + 7.5% or Floor rate 11.5%; EOT 2.5% ⁽⁸⁾

$

5,500

 

$

5,471

 

$

5,519

Sub-total:  Manufacturing (15.5%)*

 

  

  

 

  

$

148,264

$

153,004

$

144,748

32

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2021

(In thousands, except share and per share data)

Portfolio Company (1)

  

Type of Investment (2)

  

Investment Date (3)

Maturity Date

  

Interest Rate (4)

  

Principal 
Amount (5)

  

Cost

  

Fair Value (6)

Debt Securities, Continued

Pharmaceutical (7)

 

  

  

 

  

 

  

 

  

 

  

Zosano Pharma Corporation

 

Equipment Financing

January 16, 2020

April 1, 2022

Fixed interest rate 9.4%; EOT 12.0%

$

473

 

$

1,070

 

$

1,038

 

Equipment Financing

January 16, 2020

July 1, 2022

Fixed interest rate 9.7%; EOT 12.0%

525

 

853

 

822

 

Equipment Financing

January 16, 2020

January 1, 2023

Fixed interest rate 9.9%; EOT 12.0%

844

 

1,091

 

1,059

 

Equipment Financing

January 16, 2020

April 1, 2023

Fixed interest rate 9.9%; EOT 12.0%

1,042

 

1,273

 

1,245

 

Equipment Financing

January 16, 2020

May 1, 2023

Fixed interest rate 10.5%; EOT 12.0%

811

 

973

 

949

Total Zosano Pharma Corporation

 

  

  

 

  

3,695

 

5,260

 

5,113

Sub-total:  Pharmaceutical (0.5%)*

 

  

  

 

  

$

3,695

$

5,260

$

5,113

Professional, Scientific, and Technical Services (7)

 

  

  

 

  

 

  

 

  

 

  

BackBlaze, Inc.

 

Equipment Financing

January 16, 2020

January 1, 2023

Fixed interest rate 7.2%; EOT 11.5%

$

470

$

650

$

645

 

Equipment Financing

January 16, 2020

April 1, 2023

Fixed interest rate 7.4%; EOT 11.5%

 

67

 

87

 

87

 

Equipment Financing

January 16, 2020

June 1, 2023

Fixed interest rate 7.4%; EOT 11.5%

 

550

 

690

 

686

 

Equipment Financing

January 16, 2020

August 1, 2023

Fixed interest rate 7.5%; EOT 11.5%

 

114

 

140

 

139

 

Equipment Financing

January 16, 2020

September 1, 2023

Fixed interest rate 7.7%; EOT 11.5%

 

120

 

145

 

144

 

Equipment Financing

January 16, 2020

October 1, 2023

Fixed interest rate 7.5%; EOT 11.5%

 

123

 

146

 

145

 

Equipment Financing

January 16, 2020

November 1, 2023

Fixed interest rate 7.2%; EOT 11.5%

 

416

 

493

 

489

 

Equipment Financing

January 16, 2020

December 1, 2023

Fixed interest rate 7.5%; EOT 11.5%

560

 

657

 

651

 

Equipment Financing

January 16, 2020

January 1, 2024

Fixed interest rate 7.4%; EOT 11.5%

495

 

575

 

570

 

Equipment Financing

January 20, 2020

February 1, 2024

Fixed interest rate 7.4%; EOT 11.5%

512

 

590

 

585

 

Equipment Financing

February 1, 2020

March 1, 2024

Fixed interest rate 7.2%; EOT 11.5%

451

 

515

 

512

 

Equipment Financing

March 26, 2020

April 1, 2024

Fixed interest rate 7.4%; EOT 11.5%

138

 

156

 

157

Equipment Financing

April 17, 2020

May 1, 2024

Fixed interest rate 7.3%; EOT 11.5%

903

1,018

1,014

Equipment Financing

July 27, 2020

August 1, 2024

Fixed interest rate 7.4%; EOT 11.5%

998

1,100

1,093

Equipment Financing

September 4, 2020

October 1, 2024

Fixed interest rate 7.2%; EOT 11.5%

181

197

197

Equipment Financing

March 29, 2021

April 1, 2025

Fixed interest rate 7.5%; EOT 11.5%

2,310

2,426

2,421

Total BackBlaze, Inc.

 

  

  

  

 

8,408

 

9,585

 

9,535

Commonwealth Fusion Systems, LLC

Equipment Financing⁽¹⁹⁾

September 10, 2021

October 1, 2024

Fixed interest rate 9.5%; EOT 8.5%

$

2,169

 

$

2,196

 

$

2,207

Equipment Financing⁽¹⁹⁾

October 20, 2021

November 1, 2024

Fixed interest rate 9.7%; EOT 8.5%

$

644

 

$

648

 

$

648

Total Commonwealth Fusion Systems, LLC

2,813

2,844

2,855

Core Scientific, Inc.

Equipment Financing⁽¹⁹⁾

August 31, 2021

October 1, 2024

Fixed interest rate 10.3%; EOT 5.0%

$

928

$

938

$

964

Equipment Financing⁽¹⁹⁾

August 31, 2021

December 1, 2024

Fixed interest rate 10.7%; EOT 5.0%

$

13,596

$

13,649

$

13,649

Equipment Financing⁽¹⁹⁾

August 31, 2021

January 1, 2025

Fixed interest rate 10.5%; EOT 5.0%

$

5,000

$

5,008

$

5,008

Total Core Scientific, Inc.

19,524

19,595

19,621

Edeniq, Inc.

 

Secured Loan

November 30, 2021

June 1, 2025

Fixed interest rate 18.0%

$

5,267

 

$

469

 

$

5,074

Emerald Cloud Lab, Inc.

Equipment Financing⁽¹⁹⁾

July 13, 2021

August 1, 2024

Fixed interest rate 9.7%; EOT 7.0%

$

9,278

 

$

9,486

 

$

9,528

Emergy, Inc.

Equipment Financing⁽¹⁹⁾

January 8, 2021

May 1, 2024

Fixed interest rate 9.1%; EOT 8.5%

$

434

 

$

456

 

$

456

Equipment Financing⁽¹⁹⁾

December 15, 2021

July 1, 2025

Fixed interest rate 9.3%; EOT 11.5%

$

10,419

 

$

10,396

 

$

10,396

Total Emergy, Inc.

10,853

10,852

10,852

33

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2021

(In thousands, except share and per share data)

Portfolio Company (1)

  

Type of Investment (2)

  

Investment Date (3)

Maturity Date

  

Interest Rate (4)

  

Principal 
Amount (5)

  

Cost

  

Fair Value (6)

Debt Securities, Continued

Professional, Scientific, and Technical Services, Continued

  

 

  

 

  

 

  

 

  

Greenlight Biosciences Inc.

Equipment Financing

March 29, 2021

April 1, 2024

Fixed interest rate 9.7%; EOT 8.0%

$

2,575

 

$

2,656

 

$

2,667

Equipment Financing

June 17, 2021

July 1, 2024

Fixed interest rate 9.5%; EOT 8.0%

3,716

3,774

3,808

Equipment Financing

August 31, 2021

September 1, 2024

Fixed interest rate 9.7%; EOT 8.0%

2,003

2,008

2,011

Equipment Financing

August 31, 2021

September 1, 2024

Fixed interest rate 9.7%; EOT 8.0%

1,160

1,163

1,157

Total Greenlight Biosciences Inc.

9,454

9,601

9,643

Incontext Solutions, Inc.

 

Secured Loan

January 16, 2020

October 1, 2024

Fixed interest rate 11.8%; EOT 16.4%

$

6,149

 

$

6,818

 

$

5,476

PebblePost, Inc.

Secured Loan⁽¹⁹⁾

May 7, 2021

June 1, 2025

Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 3.8% ⁽⁸⁾

$

12,500

 

$

12,450

 

$

12,547

Pendulum Therapeutics, Inc.

 

Equipment Financing

January 16, 2020

May 1, 2023

Fixed interest rate 7.7%; EOT 5.0%

$

206

 

$

220

 

$

220

 

Equipment Financing

January 17, 2020

August 1, 2023

Fixed interest rate 7.8%; EOT 5.0%

1,326

 

1,436

 

1,445

 

Equipment Financing

March 6, 2020

October 1, 2023

Fixed interest rate 7.7%; EOT 5.0%

407

 

431

 

433

Equipment Financing

July 15, 2020

February 1, 2024

Fixed interest rate 9.8%; EOT 6.0%

633

665

671

Secured Loan

December 31, 2021

January 1, 2026

Variable interest rate Prime + 6.8% or Floor rate 10.0%; EOT 3.0% ⁽⁸⁾

5,000

4,972

4,972

Total Pendulum Therapeutics, Inc.

 

  

  

 

  

7,572

7,724

7,741

Reciprocity, Inc.

 

Secured Loan

September 25, 2020

October 1, 2024

Variable interest rate Prime + 3.3% or Floor rate 11.3%; EOT 2.0% ⁽⁸⁾

$

10,000

 

$

9,984

 

$

10,200

Secured Loan

April 29, 2021

May 1, 2025

Variable interest rate Prime + 8.0% or Floor rate 11.3%; EOT 2.0% ⁽⁸⁾

5,000

4,984

5,100

Total Reciprocity, Inc.

15,000

14,968

15,300

Sun Basket, Inc.

Secured Loan

December 31, 2020

December 1, 2024

Variable interest rate Prime + 3.3% or Floor rate 11.8%; EOT 5.8% ⁽⁸⁾

$

16,905

$

16,984

$

16,882

Utility Associates, Inc.

 

Secured Loan (18)

January 16, 2020

September 30, 2023

PIK Fixed interest rate 11.0% (20)

$

750

 

$

830

 

$

697

ZenDrive, Inc.

Secured Loan⁽¹⁹⁾

July 16, 2021

August 1, 2026

Variable interest rate Prime + 7.0% or Floor rate 10.3%; EOT 3.0% ⁽⁸⁾

$

15,000

$

14,899

$

15,006

Sub-total:  Professional, Scientific, and Technical Services (15.1%)*

 

  

$

139,473

$

137,105

$

140,757

34

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2021

(In thousands, except share and per share data)

Portfolio Company (1)

  

Type of Investment (2)

  

Investment Date (3)

Maturity Date

  

Interest Rate (4)

  

Principal 
Amount (5)

  

Cost

  

Fair Value (6)

Debt Securities, Continued

Real Estate (7)

 

  

 

  

 

  

  

 

  

 

  

Knockaway, Inc.

 

Secured Loan

November 10, 2021

June 1, 2026

Variable interest rate Prime + 6.3% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾

$

14,734

$

14,608

$

14,608

 

Secured Loan

November 30, 2021

June 1, 2026

Variable interest rate Prime + 6.3% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾

 

2,000

 

1,982

 

1,982

 

Secured Loan

December 28, 2021

July 1, 2026

Variable interest rate Prime + 6.3% or Floor rate 11.0%; EOT 3.0% ⁽⁸⁾

 

4,275

 

4,231

 

4,231

Total Knockaway, Inc.

 

  

  

 

  

 

21,009

 

20,821

 

20,821

Orchard Technologies, Inc.

Secured Loan

March 11, 2021

April 1, 2026

Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 4.0% ⁽⁸⁾

$

5,000

 

$

5,030

 

$

5,064

Secured Loan

July 23, 2021

April 1, 2026

Variable interest rate Prime + 7.5% or Floor rate 11.0%; EOT 4.0% ⁽⁸⁾

12,500

12,520

12,612

Total Orchard Technologies, Inc.

17,500

17,550

17,676

Wanderjaunt, Inc.

 

Equipment Financing

January 16, 2020

June 1, 2023

Fixed interest rate 10.2%; EOT 12.0%

$

238

$

277

$

271

 

Equipment Financing

January 16, 2020

August 1, 2023

Fixed interest rate 10.2%; EOT 12.0%

 

792

 

935

 

928

Total Wanderjaunt, Inc.

 

  

  

 

  

 

1,030

 

1,212

 

1,199

Sub-total:  Real Estate (4.3%)*

 

  

$

39,539

$

39,583

$

39,696

 

  

  

 

  

 

  

 

  

 

  

Rental and Leasing Services(7)

 

  

 

  

 

  

  

 

  

 

  

EquipmentShare, Inc.

Equipment Financing

June 24, 2020

July 1, 2023

Fixed interest rate 11.0%; EOT 5.0%

$

3,269

$

3,501

$

3,532

Equipment Financing

August 7, 2020

September 1, 2023

Fixed interest rate 10.2%; EOT 5.0%

1,252

1,328

1,335

Equipment Financing

October 2, 2020

November 1, 2023

Fixed interest rate 10.4%; EOT 5.0%

551

579

585

Equipment Financing

October 9, 2020

November 1, 2023

Fixed interest rate 10.5%; EOT 5.0%

1,741

1,829

1,846

Total EquipmentShare, Inc.

6,813

7,237

7,298

Maxwell Financial Labs, Inc.

Secured Loan

September 30, 2021

April 1, 2026

Variable interest rate Prime + 6.0% or Floor rate 10.0%; EOT 5.0% ⁽⁸⁾

$

18,000

$

17,828

$

17,949

NextCar Holding Company, Inc.

Secured Loan⁽¹⁹⁾

December 14, 2021

January 1, 2026

Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 12.0% ⁽⁸⁾

$

5,000

 

$

4,961

 

$

4,961

Secured Loan⁽¹⁹⁾

December 15, 2021

January 1, 2026

Variable interest rate Prime + 5.8% or Floor rate 9.0%; EOT 12.0% ⁽⁸⁾

2,000

1,986

1,986

Total NextCar Holding Company, Inc.

7,000

6,947

6,947

Sub-total:  Rental and Leasing Services (3.4%)*

 

  

$

31,813

$

32,012

$

32,194

Retail Trade (7)

 

  

  

 

  

 

  

 

  

 

  

Fernished, Inc.

Equipment Financing⁽¹⁴⁾

October 29, 2021

November 1, 2024

Fixed interest rate 13.4%; EOT 3.0%

$

472

$

470

$

470

Gobble, Inc.

 

Secured Loan

January 16, 2020

July 1, 2023

Fixed interest rate 11.3%; EOT 6.0%

$

2,227

$

2,414

$

2,398

 

Secured Loan

January 16, 2020

July 1, 2023

Fixed interest rate 11.5%; EOT 6.0%

 

1,120

 

1,214

 

1,206

Total Gobble Inc.

 

  

  

 

  

 

3,347

 

3,628

 

3,604

Portofino Labs, Inc.

Secured Loan⁽¹⁹⁾

December 31, 2020

July 1, 2025

Variable interest rate Prime + 3.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾

$

2,000

$

2,014

$

2,023

Secured Loan⁽¹⁹⁾

March 12, 2021

October 1, 2025

Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾

3,000

 

2,904

 

2,918

Secured Loan⁽¹⁹⁾

April 1, 2021

November 1, 2025

Variable interest rate Prime + 8.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾

2,000

 

1,860

 

1,873

Total Portofino Labs, Inc.

7,000

 

6,778

 

6,814

Super73, Inc.

Secured Loan

December 31, 2020

January 1, 2025

Variable interest rate Prime + 4.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾

$

5,500

$

5,528

$

5,567

Secured Loan

October 25, 2021

January 1, 2025

Variable interest rate Prime + 7.3% or Floor rate 11.5%; EOT 4.0% ⁽⁸⁾

$

4,500

$

4,456

$

4,456

Total Super73, Inc.

10,000

9,984

10,023

UnTuckIt, Inc.

 

Secured Loan

January 16, 2020

June 1, 2025

Fixed interest rate 12.0%; EOT 3.8%

$

15,000

$

15,796

$

15,200

Sub-total:  Retail Trade (3.9%)*

 

  

  

 

  

$

35,819

$

36,656

$

36,111

35

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2021

(In thousands, except share and per share data)

Portfolio Company (1)

  

Type of Investment (2)

  

Investment Date (3)

Maturity Date

  

Interest Rate (4)

  

Principal 
Amount (5)

  

Cost

  

Fair Value (6)

Debt Securities, Continued

Space Research and Technology (7)

Axiom Space, Inc.

Secured Loan⁽¹⁹⁾

May 28, 2021

June 1, 2026

Variable interest rate Prime + 6.0% or Floor rate 9.3%; EOT 2.5% ⁽⁸⁾

$

30,000

$

29,819

$

30,015

Sub-total: Space Research and Technology (3.2%)*

$

30,000

$

29,819

$

30,015

Utilities (7)

 

  

  

 

  

 

  

 

  

 

  

Invenia, Inc.

 

Secured Loan

January 16, 2020

January 1, 2023

Fixed interest rate 11.5%; EOT 5.0%

$

3,611

$

4,068

$

4,012

 

Secured Loan

January 16, 2020

May 1, 2023

Fixed interest rate 11.5%; EOT 5.0%

 

2,060

 

2,264

 

2,240

 

Secured Loan

January 16, 2020

January 1, 2024

Fixed interest rate 11.5%; EOT 5.0%

 

2,190

 

2,297

 

2,308

 

Secured Loan

January 17, 2020

February 1, 2024

Fixed interest rate 11.5%; EOT 5.0%

 

3,023

 

3,183

 

3,177

Secured Loan

June 8, 2020

July 1, 2024

Fixed interest rate 11.5%; EOT 5.0%

3,523

3,638

3,669

Secured Loan

October 29, 2020

November 1, 2024

Fixed interest rate 11.5%; EOT 5.0%

4,883

4,995

5,030

Total Invenia, Inc. (10)

 

  

  

 

  

19,290

20,445

20,436

Sub-total:  Utilities (2.2%)*

 

  

  

 

  

$

19,290

$

20,445

$

20,436

 

  

  

 

  

 

  

 

  

 

  

Wholesale Trade (7)

 

  

  

 

  

 

  

 

  

 

  

BaubleBar, Inc.

 

Secured Loan

January 16, 2020

March 1, 2023

Fixed interest rate 11.5%; EOT 7.3%

$

3,377

$

4,285

$

4,085

Grandpad, Inc.

Equipment Financing⁽¹⁹⁾

November 16, 2020

June 1, 2023

Fixed interest rate 10.6%; EOT 5.0%

$

1,789

$

1,887

$

1,893

Equipment Financing⁽¹⁹⁾

December 23, 2020

July 1, 2023

Fixed interest rate 10.8%; EOT 5.0%

2,306

2,419

2,425

Total Grandpad, Inc.

4,095

4,306

4,318

Sub-total:  Wholesale Trade (0.9%)*

 

  

  

 

  

$

7,472

$

8,591

$

8,403

Total:  Debt Securities (78.8%)* (13)

 

  

  

 

  

$

733,336

$

740,925

$

735,968

36

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2021

(In thousands, except share and per share data)

Portfolio Company (1)

  

Type of
Investment (2)

  

Investment Date (3)

  

Expiration Date

  

Series

  

Shares

  

Strike Price

  

Cost

  

Fair Value (6)

Warrant Investments

  

  

  

  

  

  

 

Administrative and Support and Waste Management and Remediation (7)

Qwick, Inc.

Warrant¹⁴

December 31, 2021

December 31, 2031

Common Stock

16,956

$

2.79

$

96

$

96

RTS Holding, Inc.

Warrant¹⁴

December 10, 2021

December 10, 2031

Preferred Series C

3,857

$

205.28

$

153

$

153

Sub-Total: Administrative and Support and Waste Management and Remediation (0.0%)*

 

$

249

$

249

Agriculture, Forestry, Fishing and Hunting (7)

  

  

  

  

  

Bowery Farming, Inc.

Warrant

January 16, 2020

June 10, 2029

Common Stock

68,863

$

5.08

$

410

$

1,419

Warrant

December 22, 2020

December 22, 2030

Common Stock

29,925

$

6.24

160

594

Warrant

September 10, 2021

September 10, 2028

Common Stock

21,577

$

0.01

617

518

Total Bowery Farming, Inc.

1,187

2,531

Robotany, Inc.

Warrant

January 16, 2020

July 19, 2029

Common Stock

262,870

$

0.26

$

127

$

73

Sub-Total: Agriculture, Forestry, Fishing and Hunting (0.3%)*

 

$

1,314

$

2,604

Construction (7)

  

 

 

  

 

  

Project Frog, Inc. (22)

Warrant

January 16, 2020

July 26, 2026

Preferred Series AA

211,633

$

0.19

$

9

$

Warrant

January 16, 2020

July 26, 2026

Common Stock

180,356

$

0.19

9

Warrant

August 3, 2021

December 31, 2031

Preferred Series CC

250,000

$

0.01

20

31

Total Project Frog, Inc.

38

31

Sub-Total: Construction (0.0%)*

  

 

$

38

$

31

Educational Services (7)

  

 

 

  

 

  

Medical Sales Training Holding Company

Warrant¹⁴

March 18, 2021

March 18, 2031

Common Stock

28,732

$

7.74

$

108

$

108

Yellowbrick Learning, Inc.

Warrant

January 16, 2020

September 28, 2028

Common Stock

222,222

$

0.90

$

120

$

485

Sub-Total: Educational Services (0.1%)*

  

  

 

$

228

$

593

Finance and Insurance (7)

  

  

 

 

  

 

  

BoardRE, Inc.

Warrant¹⁴

October 15, 2021

October 15, 2031

Common Stock

105,347

$

1.94

$

9

$

8

DailyPay, Inc.

Warrant

September 30, 2020

September 30, 2030

Common Stock

89,264

$

3.00

$

151

$

839

Petal Card, Inc.

Warrant

January 16, 2020

November 27, 2029

Preferred Series B

250,268

$

1.32

$

147

$

1,412

Warrant¹⁴

January 11, 2021

January 11, 2031

Common Stock

135,835

$

0.01

312

908

Warrant

August 6, 2021

August 6, 2031

Common Stock

111,555

$

1.60

197

605

Total Petal Card, Inc.

656

2,925

RealtyMogul, Co.

Warrant

January 16, 2020

December 18, 2027

Preferred Series B

234,421

$

3.88

$

285

$

1

Sub-Total: Finance and Insurance (0.4%)*

  

 

$

1,101

$

3,773

Health Care and Social Assistance (7)

  

 

 

  

 

  

Lark Technologies, Inc.

Warrant

September 30, 2020

September 30, 2030

Common Stock

76,231

$

1.76

$

177

$

674

Warrant

June 30, 2021

June 30, 2031

Common Stock

79,325

$

1.76

258

701

Total Lark Technologies, Inc.

435

1,375

Sub-Total: Health Care and Social Assistance (0.1%)*

 

$

435

$

1,375

Information (7)

  

 

 

  

 

  

Everalbum, Inc.

Warrant

January 16, 2020

July 29, 2026

Preferred Series A

851,063

$

0.10

$

25

$

Figg, Inc.

Warrant¹¹

January 16, 2020

March 31, 2028

Common Stock

935,198

$

0.10

$

$

Firefly Systems, Inc.

Warrant

January 31, 2020

January 29, 2030

Common Stock

133,147

$

1.14

$

282

$

477

Gtxcel, Inc.

Warrant

January 16, 2020

September 24, 2025

Preferred Series C

1,000,000

$

0.21

$

83

$

21

Warrant

January 16, 2020

September 24, 2025

Preferred Series D

1,000,000

$

0.21

 

83

 

14

Total Gtxcel, Inc.

  

 

 

166

 

35

Lucidworks, Inc.

Warrant

January 16, 2020

June 27, 2026

Preferred Series D

619,435

$

0.77

$

805

$

2,302

RapidMiner, Inc.

Warrant

January 16, 2020

March 25, 2029

Preferred Series C-1

11,624

$

60.22

$

528

$

18

Rigetti & Co, Inc.

Warrant

May 18, 2021

May 18, 2031

Common Stock

995,099

$

0.21

$

506

$

5,830

Stratifyd, Inc.

Warrant

September 3, 2021

September 3, 2031

Preferred Series B-2

106,719

$

2.53

$

84

$

71

Sub-Total: Information (0.6%)*

 

  

 

 

  

 

$

2,396

$

8,733

37

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2021

(In thousands, except share and per share data)

Portfolio Company (1)

  

Type of
Investment (2)

  

Investment Date (3)

  

Expiration Date

  

Series

  

Shares

  

Strike Price

  

Cost

  

Fair Value (6)

Warrant Investments, Continued

  

  

  

  

  

Management of Companies and Enterprises (7)

Exer Holdings, LLC

Warrant⁽¹⁴⁾

November 19, 2021

November 19, 2031

Common Stock

281

$

479.25

(21)

$

93

$

92

Sub-Total: Management of Companies and Enterprises (0.0%)*

  

  

 

  

$

93

$

92

 

Manufacturing (7)

  

  

 

 

  

 

  

Bolb, Inc.

Warrant⁽¹⁴⁾

October 12, 2021

October 12, 2031

Common Stock

181,784

$

0.07

$

35

$

34

Daring Foods, Inc.

Warrant

April 8, 2021

April 8, 2031

Common Stock

68,100

$

0.27

$

106

$

431

Footprint International Holding, Inc.

Warrant

February 14, 2020

February 14, 2030

Common Stock

38,171

$

0.31

$

9

$

2,137

Happiest Baby, Inc.

Warrant

January 16, 2020

May 16, 2029

Common Stock

182,554

$

0.33

$

193

$

241

Mainspring Energy, Inc.

Warrant

January 16, 2020

July 9, 2029

Common Stock

140,186

$

1.15

$

284

$

534

Warrant

November 20, 2020

November 20, 2030

Common Stock

81,294

$

1.15

226

310

Total Mainspring Energy, Inc.

510

844

Molekule, Inc.

Warrant

June 19, 2020

June 19, 2030

Preferred Series C-1

32,051

$

3.12

$

16

$

23

Nexii Building Solutions, Inc. (10)

Warrant⁽¹⁴⁾

August 27, 2021

August 27, 2026

Common Stock

63,071

(21)

$

15.86

(21)

$

410

$

421

Quip NYC, Inc.

Warrant

March 9, 2021

March 9, 2031

Preferred Series A-1

10,833

$

48.46

$

203

$

311

SBG Labs, Inc.

Warrant

January 16, 2020

July 29, 2023

Preferred Series A-1

42,857

$

0.70

$

13

$

Warrant

January 16, 2020

September 18, 2024

Preferred Series A-1

25,714

$

0.70

 

8

 

Warrant

January 16, 2020

January 14, 2024

Preferred Series A-1

21,492

$

0.70

 

7

 

Warrant

January 16, 2020

March 24, 2025

Preferred Series A-1

12,155

$

0.70

 

4

 

Warrant

January 16, 2020

October 10, 2023

Preferred Series A-1

11,150

$

0.70

 

4

 

Warrant

January 16, 2020

May 6, 2024

Preferred Series A-1

11,145

$

0.70

 

4

 

Warrant

January 16, 2020

June 9, 2024

Preferred Series A-1

7,085

$

0.70

 

2

 

Warrant

January 16, 2020

May 20, 2024

Preferred Series A-1

342,857

$

0.70

 

110

 

Warrant

January 16, 2020

March 26, 2025

Preferred Series A-1

200,000

$

0.70

 

65

 

Total SBG Labs, Inc.

  

  

 

  

 

217

 

Tarana Wireless, Inc.

Warrant⁽¹⁴⁾

June 30, 2021

June 30, 2031

Common Stock

5,027,629

$

0.19

$

967

$

641

The Fynder Group, Inc.

Warrant

October 14, 2020

October 14, 2030

Common Stock

36,445

$

0.49

$

68

$

337

Vertical Communications, Inc. (22)

Warrant⁽¹¹⁾

January 16, 2020

July 11, 2026

Preferred Series A

828,479

$

1.00

$

$

VitaCup, Inc.

Warrant⁽¹⁴⁾

June 23, 2021

June 23, 2031

Preferred Series C

68,996

$

2.79

$

9

$

5

Sub-Total: Manufacturing (0.6%)*

  

  

 

  

$

2,743

$

5,425

38

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2021

(In thousands, except share and per share data)

Portfolio Company (1)

  

Type of
Investment (2)

  

Investment Date (3)

  

Expiration Date

  

Series

  

Shares

  

Strike Price

  

Cost

Fair Value (6)

Warrant Investments, Continued

  

  

  

  

  

Pharmaceutical (7)

  

  

 

  

 

  

 

  

Zosano Pharma Corporation

Warrant (9)

January 16, 2020

September 25, 2025

Common Stock

75,000

$

3.59

$

69

$

17

Sub-Total: Pharmaceutical (0.0%)*

  

  

 

  

$

69

$

17

 

Professional, Scientific, and Technical Services (7)

  

  

 

  

 

  

 

  

Continuity, Inc.

Warrant

January 16, 2020

March 29, 2026

Preferred Series C

1,588,806

$

0.25

$

21

$

17

Crowdtap, Inc.

Warrant

January 16, 2020

December 16, 2025

Preferred Series B

442,233

$

1.09

$

41

$

240

Warrant

January 16, 2020

December 11, 2027

Preferred Series B

100,000

$

1.09

 

9

 

54

Total Crowdtap, Inc.

  

 

 

50

 

294

Dynamics, Inc.

Warrant

January 16, 2020

March 10, 2024

Common Stock

17,000

$

10.59

$

86

$

E La Carte, Inc.

Warrant

January 16, 2020

April 27, 2027

Preferred Series A

497,183

$

0.30

$

185

$

861

Warrant

January 16, 2020

July 28, 2027

Common Stock

104,284

$

7.49

 

14

 

156

Warrant

January 16, 2020

April 28, 2027

Preferred Series AA-1

106,841

$

7.49

 

14

 

43

Total E La Carte, Inc.

  

 

 

213

 

1,060

Edeniq, Inc.

Warrant⁽¹¹⁾

January 16, 2020

December 23, 2026

Preferred Series B

2,685,501

$

0.22

$

$

2

Warrant⁽¹¹⁾

January 16, 2020

December 23, 2026

Preferred Series B

2,184,672

$

0.01

 

 

5

Warrant⁽¹¹⁾

January 16, 2020

June 29, 2027

Preferred Series C

5,106,972

$

0.44

 

 

Warrant⁽¹¹⁾

January 16, 2020

November 2, 2028

Preferred Series C

3,850,294

$

0.01

 

 

12

Warrant

November 29, 2021

November 29, 2031

Preferred Series D

154,906,320

$

0.01

 

7

 

34

Total Edeniq, Inc. (22)

  

 

 

7

 

53

Greenlight Biosciences Inc.

Warrant⁽¹⁴⁾

March 29, 2021

March 29, 2031

Common Stock

219,839

$

0.82

$

139

$

857

Hologram, Inc.

Warrant

January 31, 2020

January 27, 2030

Common Stock

193,054

$

0.26

$

49

$

914

Hospitalists Now, Inc.

Warrant

January 16, 2020

March 30, 2026

Preferred Series D-2

135,807

$

5.89

$

71

$

1,840

Warrant

January 16, 2020

December 6, 2026

Preferred Series D-2

750,000

$

5.89

 

391

 

333

Total Hospitalists Now, Inc.

  

 

 

462

 

2,173

Incontext Solutions, Inc.

Warrant

January 16, 2020

September 28, 2028

Common Stock

2,219

$

220.82

$

34

$

PebblePost, Inc.

Warrant⁽¹⁴⁾

May 7, 2021

May 7, 2031

Common Stock

657,343

$

0.75

$

68

$

379

Pendulum Therapeutics, Inc.

Warrant

January 16, 2020

October 9, 2029

Preferred Series B

55,263

$

1.90

$

44

$

46

Warrant

June 1, 2020

July 15, 2030

Preferred Series B

36,842

$

1.90

36

31

Warrant⁽¹⁴⁾

December 31, 2021

December 31, 2021

Preferred Series C

322,251

$

3.24

118

118

Total Pendulum Therapeutics, Inc.

 

198

 

195

Reciprocity, Inc.

Warrant

September 25, 2020

September 25, 2030

Common Stock

114,678

$

4.17

$

99

$

656

Warrant

April 29, 2021

April 29, 2031

Common Stock

57,195

$

4.17

54

327

Total Reciprocity, Inc.

 

153

 

983

Resilinc, Inc.

Warrant

January 16, 2020

December 15, 2025

Preferred Series A

589,275

$

0.51

$

40

$

Sun Basket, Inc.

Warrant

January 16, 2020

October 5, 2027

Common Stock

103,636

$

14.47

$

111

$

1,172

Warrant

December 31, 2020

December 29, 2032

Common Stock

33,348

$

3.17

546

81

Total Sun Basket, Inc.

657

1,253

39

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2021

(In thousands, except share and per share data)

Portfolio Company (1)

  

Type of
Investment (2)

  

Investment Date (3)

  

Expiration Date

  

Series

  

Shares

  

Strike Price

  

Cost

  

Fair Value (6)

Warrant Investments, Continued

  

  

  

  

  

 

Professional, Scientific, and Technical Services, Continued (7)

  

  

 

  

 

  

 

  

Utility Associates, Inc.

Warrant

January 16, 2020

June 30, 2025

Preferred Series A

92,511

$

4.54

$

55

$

Warrant

January 16, 2020

May 1, 2026

Preferred Series A

60,000

$

4.54

 

36

 

Warrant

January 16, 2020

May 22, 2027

Preferred Series A

200,000

$

4.54

 

120

 

Total Utility Associates, Inc.

  

  

 

 

211

 

ZenDrive, Inc.

Warrant⁽¹⁴⁾

July 16, 2021

July 16, 2031

Common Stock

30,466

$

2.46

$

29

$

55

Sub-Total: Professional, Scientific, and Technical Services (0.9%)*

$

2,417

$

8,233

Real Estate (7)

  

  

 

  

 

  

 

  

Egomotion Corporation

Warrant⁽¹¹⁾

January 16, 2020

December 10, 2028

Preferred Series A

60,786

$

1.32

$

$

47

Warrant

January 16, 2020

June 29, 2028

Preferred Series A

121,571

$

1.32

219

94

Total Egomotion Corporation

219

141

Knockaway, Inc.

Warrant

January 16, 2020

May 24, 2029

Preferred Series B

87,955

$

8.53

$

209

$

458

Warrant

November 10, 2021

November 10, 2031

Common Stock

148,730

(21)

$

7.74

(21)

$

265

$

557

Total Knockaway, Inc.

474

1,015

Sub-Total: Real Estate (0.1%)*

  

  

$

693

$

1,156

Rental and Leasing Services (7)

  

  

  

 

  

 

  

Maxwell Financial Labs, Inc.

Warrant

October 7, 2020

October 7, 2030

Common Stock

106,735

$

0.29

$

20

$

283

Warrant

December 22, 2020

December 22, 2030

Common Stock

110,860

$

0.29

34

273

Warrant

September 30, 2021

September 30, 2031

Common Stock

79,135

$

1.04

148

174

Total Maxwell Financial Labs, Inc.

202

730

NextCar Holding Company, Inc.

Warrant

December 14, 2021

December 14, 2026

Preferred Series A

167,543

(21)

$

2.62

(21)

$

35

$

80

Sub-Total: Rental and Leasing Services (0.1%)*

  

  

$

237

$

810

Retail Trade (7)

  

  

  

 

  

 

  

Boosted eCommerce, Inc.

Warrant

December 18, 2020

December 14, 2030

Preferred Series A-1

759,263

$

0.84

$

259

$

154

Fernished, Inc.

Warrant⁽¹⁴⁾

May 5, 2021

May 5, 2031

Common Stock

54,427

$

0.15

$

39

$

39

Gobble, Inc.

Warrant

January 16, 2020

May 9, 2028

Common Stock

74,635

$

1.20

$

73

$

101

Warrant

January 16, 2020

December 27, 2029

Common Stock

10,000

$

1.22

 

617

 

754

Total Gobble, Inc.

 

 

690

 

855

Madison Reed, Inc.

Warrant

January 16, 2020

March 23, 2027

Preferred Series C

194,553

$

2.57

$

185

$

398

Warrant

January 16, 2020

July 18, 2028

Common Stock

43,158

$

0.99

 

71

 

131

Warrant

January 16, 2020

June 30, 2029

Common Stock

36,585

$

1.23

 

56

 

105

Total Madison Reed, Inc.

 

 

312

 

634

Portofino Labs, Inc.

Warrant⁽¹⁴⁾

December 31, 2020

December 31, 2030

Common Stock

39,659

$

1.53

$

160

$

107

Warrant⁽¹⁴⁾

April 1, 2021

April 1, 2031

Common Stock

39,912

$

1.46

 

99

 

44

Total Portofino Labs, Inc.

 

259

 

151

Super73, Inc.

Warrant⁽¹⁴⁾

December 31, 2020

December 31, 2030

Common Stock

177,305

$

3.16

$

105

$

132

Trendly, Inc.

Warrant

January 16, 2020

August 10, 2026

Preferred Series A

245,506

$

1.14

$

222

$

86

Sub-Total: Retail Trade (0.2%)*

 

$

1,886

$

2,051

40

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2021

(In thousands, except share and per share data)

Portfolio Company (1)

  

Type of
Investment (2)

  

Investment Date (3)

  

Expiration Date

  

Series

  

Shares

  

Strike Price

  

Cost

  

Fair Value (6)

Warrant Investments, Continued

  

  

  

  

  

 

Space Research and Technology (7)

  

  

 

  

 

  

 

  

Axiom Space, Inc.

Warrant

May 28, 2021

May 28, 2031

Common Stock

1,773

$

169.24

$

121

$

146

Warrant

May 28, 2021

May 28, 2031

Common Stock

882

$

340.11

39

37

Total Axiom Space, Inc.

160

183

Sub-Total: Space Research and Technology (0.0%)*

  

  

$

160

$

183

 

Wholesale Trade (7)

  

 

 

  

 

  

BaubleBar, Inc.

Warrant

January 16, 2020

March 29, 2027

Preferred Series C

531,806

$

1.96

$

639

$

788

Warrant

January 16, 2020

April 20, 2028

Preferred Series C

60,000

$

1.96

 

72

 

89

Total BaubleBar, Inc.

  

 

 

711

 

877

GrubMarket, Inc.

Warrant

June 15, 2020

June 15, 2030

Common Stock

405,000

$

1.10

$

115

$

568

Sub-Total: Wholesale Trade (0.2%)*

$

826

$

1,445

Total: Warrant Investments (3.6%)* (13)

$

14,885

$

36,770

41

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2021

(In thousands, except share and per share data)

Portfolio Company (1)

  

Type of
Investment (2)

  

Investment Date (3)

  

Shares / Principal

  

Series

  

Cost

  

Fair Value (6)

Equity Investments

  

  

  

  

  

Construction (7)

  

  

  

  

  

Project Frog, Inc.

 

Equity

 

January 16, 2020

 

4,383,173

 

Preferred Series AA-1¹⁷

$

351

$

 

Equity

 

January 16, 2020

 

3,401,427

 

Preferred Series BB¹⁷

 

1,333

 

Equity

August 3, 2021

6,634,061

Common Stock

1,684

Equity

August 3, 2021

3,129,887

Preferred Series CC¹⁷

1,253

 

426

Total Project Frog, Inc. (22)

 

  

 

 

 

  

 

4,621

 

426

 

  

 

 

 

  

 

  

 

  

Sub-Total:  Construction (0.0%)*

 

  

 

 

 

  

$

4,621

$

426

 

  

 

 

 

  

 

  

 

  

Health Care and Social Assistance (7)

 

  

 

 

 

  

 

  

 

  

FemTec, Inc. (22)

Equity

July 22, 2021

1,098,093

Common Stock

$

13,046

$

12,369

 

  

 

 

 

  

 

  

 

  

Lark Technologies, Inc.

Equity¹⁴

August 19, 2021

32,416

Preferred Series D¹⁷

$

500

$

461

 

  

 

 

 

  

 

  

 

  

WorkWell Prevention & Care Inc.

 

Equity

 

January 16, 2020

 

7,000,000

 

Common Stock

$

51

$

 

Equity

 

January 16, 2020

 

3,450

 

Preferred Series P¹⁷

 

3,450

 

 

Equity

 

January 16, 2020

 

$

2,870

 

Convertible Note¹⁶⁾

 

2,919

 

903

Total WorkWell Prevention & Care Inc. (22)

 

  

 

 

 

  

 

6,420

 

903

 

  

 

 

 

  

 

  

 

  

Sub-Total:  Health Care and Social Assistance (1.5%)*

 

  

 

 

 

  

$

19,966

$

13,733

 

  

 

 

 

  

 

  

 

  

Manufacturing (7)

 

  

 

 

 

  

 

  

 

  

Lucid Motors, Inc.

Equity (9)

July 26, 2021

1,867,973

Common Stock

$

8,560

$

67,620

Quip NYC, Inc.

Equity¹⁴

August 17, 2021

3,321

Preferred Series B-1¹⁷

$

500

$

493

Store Intelligence, Inc. (22)

Equity

May 2, 2020

1,430,000

Preferred Series A¹⁷

$

608

$

 

  

 

 

 

  

 

  

 

  

Vertical Communications, Inc.

 

Equity¹¹

 

January 16, 2020

 

3,892,485

 

Preferred Series 1¹⁷

$

$

 

Equity

 

January 16, 2020

 

$

5,500

 

Convertible Note¹⁶⁾

 

3,966

 

3,725

Total Vertical Communications, Inc. (22)

 

 

 

 

  

 

3,966

 

3,725

 

 

 

 

  

 

  

 

  

Sub-Total:  Manufacturing (7.7%)*

 

 

 

 

  

$

13,634

$

71,838

 

 

 

 

  

 

  

 

  

Professional, Scientific, and Technical Services (7)

 

 

 

 

  

 

  

 

  

Dynamics, Inc.

 

Equity

 

January 16, 2020

 

17,726

 

Preferred Series A¹⁷

$

391

$

 

  

 

 

 

  

 

  

 

  

Matterport, Inc.

 

Equity (9)

 

July 23, 2021

 

571,941

 

Common Stock

$

434

$

11,324

 

  

 

 

 

  

 

  

 

  

Edeniq, Inc.

 

Equity¹¹

 

January 16, 2020

 

7,807,499

 

Preferred Series B¹⁷

$

$

19

 

Equity¹¹

 

January 16, 2020

 

3,657,487

 

Preferred Series C¹⁷

 

 

34

 

Equity¹¹

 

November 29, 2021

 

133,766,138

 

Preferred Series D¹⁷

 

 

343

Total Edeniq, Inc. (22)

 

  

 

 

 

  

 

 

396

Emergy, Inc.

Equity

June 28, 2021

75,958

Preferred Series B¹⁷

$

500

$

507

Sub-Total: Professional, Scientific, and Technical Services (1.3%)*

 

$

1,325

$

12,227

42

Table of Contents

TRINITY CAPITAL INC.
Consolidated Schedule of Investments
December 31, 2021
(In thousands, except share and per share data)

Portfolio Company (1)

  

Type of
Investment (2)

  

Investment Date (3)

  

Shares / Principal

  

Series

  

Cost

  

Fair Value (6)

Equity Investments, Continued

  

  

  

  

  

Real Estate (7)

Orchard Technologies, Inc.

Equity¹⁴

August 6, 2021

74,406

Preferred Series D¹⁷

$

500

$

499

Sub-Total:  Real Estate (0.1%)*

$

500

$

499

Rental and Leasing Services (7)

 

  

 

 

 

  

 

  

 

  

Maxwell Financial Labs, Inc

 

Equity¹⁴

 

January 22, 2021

 

135,641

 

Preferred Series B¹⁷

$

500

$

509

Sub-Total:  Rental and Leasing Services (0.1%)*

 

  

 

 

 

  

$

500

$

509

Retail Trade (7)

Fernished, Inc.

 

Equity¹¹⁾⁽¹⁴

 

October 6, 2021

 

454,905

 

Preferred Series B-1¹⁷

$

500

$

500

Portofino Labs, Inc.

 

Equity¹¹⁾⁽¹⁴

 

November 1, 2021

 

256,291

 

Preferred Series B-1¹⁷

$

500

$

500

Sub-Total:  Retail Trade (0.1%)*

 

  

 

 

 

  

$

1,000

$

1,000

 

  

 

 

 

  

 

  

 

  

Space Research and Technology (7)

Axiom Space, Inc.

Equity¹⁴

August 11, 2021

$

500

Convertible Note¹⁶⁾

$

500

$

500

Sub-Total:  Rental and Leasing Services (0.1%)*

$

500

$

500

Total:  Equity Investments (10.8%)* (13)

 

  

 

 

  

 

  

$

42,046

$

100,732

 

  

 

 

  

 

  

 

  

 

  

Total Investment in Securities (93.2%)*

 

  

 

 

  

 

  

$

797,856

$

873,470

 

  

 

 

  

 

  

 

  

 

  

Cash, Cash Equivalents, and Restricted Cash

 

  

 

 

  

 

  

 

  

 

  

Goldman Sachs Financial Square Government Institutional Fund

  

 

  

$

43,428

$

43,428

Other cash accounts

 

  

 

 

  

 

  

 

3,314

 

3,314

Cash, Cash Equivalents, and Restricted Cash (4.7%)*

 

  

 

 

  

 

  

 

46,742

 

46,742

 

  

 

 

  

 

  

 

  

 

  

Total Portfolio Investments and Cash and Cash Equivalents (97.8% of net assets)

 

  

 

 

  

 

  

$

844,598

$

920,212

(1)All portfolio companies are located in North America. As of December 31, 2021, the Company had three foreign domiciled portfolio companies, which are based in Canada and, in total, represent 13.5% of total net asset value based on fair value. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale and may be deemed to be “restricted securities” under the Securities Act.
(2)All debt investments are income producing unless otherwise noted. All equity and warrant investments are non-income producing unless otherwise noted. Equipment financed under our equipment financing investments relates to operational equipment essential to revenue production for the portfolio company in the industry noted.
(3)Investment date represents the date of initial investment date, either purchases or funding, not adjusted for modifications. For assets purchased from the Legacy Funds (as defined below) as part of the Formation Transactions (as defined below), investment date is January 16, 2020, the date of the Formation Transactions.
(4)Interest rate is the fixed or variable rate of the debt investments and does not include any original issue discount, end-of-term (“EOT”) payment, or additional fees related to such investments, such as deferred interest, commitment fees, prepayment fees or exit fees. EOT payments are contractual payments due in cash at the maturity date of the loan, including upon prepayment, and are a fixed rate determined at the inception of the loan. At the end of the term of certain equipment financings, the borrower has the option to purchase the underlying assets at fair market value, generally subject to a cap, or return the equipment and pay a restocking fee. The fair values of the financed assets have been estimated as a percentage of original cost for purpose of the EOT payment value. The EOT payment is amortized and recognized as non-cash income over the loan or equipment financing prior to its payment and is included as a component of the cost basis of the Company’s current debt securities.
(5)Principal is net of repayments, if any, as per the terms of the debt instrument’s contract.

43

Table of Contents

(6)Except as noted, all investments were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s board of directors.
(7)The Company uses the North American Industry Classification System (“NAICS”) code for classifying the industry grouping of its portfolio companies.
(8)The interest rate on variable interest rate investments represents a benchmark rate plus spread. The benchmark interest rate is subject to an interest rate floor. The benchmark rate Prime was 3.25% and 1-month U.S. Dollar London Interbank Offered Rate (“LIBOR”) was 0.10% as of December 31, 2021.
(9)Asset is valued using Level 2 inputs.
(10)Indicates a “non-qualifying asset” under section 55(a) by the Investment Company Act of 1940, as amended (the “1940 Act”). The Company’s percentage of non-qualifying assets at fair value represents 6.4% of the Company’s total assets as of December 31, 2021. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets. Asset is not a U.S. entity. Hut 8 Holdings, Inc., Invenia, Inc. and Nexii, Inc. are Canadian corporations.
(11)Investment has zero cost basis as it was purchased at a fair market value of zero as part of the Formation Transactions. 
(12)Investment is a secured loan warehouse facility collateralized by interest in specific assets that meet the eligibility requirements under the facility during the warehouse period. Repayment of the facility will occur over the amortizing period unless otherwise prepaid.
(13)All of the Company’s debt, warrant and equity securities are pledged as collateral supporting the amounts outstanding under the credit facility with Credit Suisse AG (see “Note 5 – Borrowings”), except as noted.
(14)Investment is not pledged as collateral supporting amounts outstanding under the credit facility with Credit Suisse AG.
(15)Investment is considered non-income producing.
(16)Convertible notes represent investments through which the Company will participate in future equity rounds at preferential rates. There are no principal or interest payments made against the note unless conversion does not occur.
(17)Preferred stock represents investments through which the Company will have preference in liquidation rights and do not contain any cumulative preferred dividends.
(18)Investment is on non-accrual status as of December 31, 2021, and is therefore considered non-income producing.
(19)Investment is pledged as collateral supporting amounts outstanding under the credit facility with KeyBank.
(20)Interest on this loan includes a payment-in-kind (“PIK”) provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected.
(21)Company has been issued warrants with pricing and number of shares dependent upon a future round of equity issuance by the portfolio company.
(22)This investment is deemed to be a “Control Investment” or an “Affiliate Investment.” The Company classifies its investment portfolio in accordance with the requirements of the 1940 Act. Control Investments are defined by the 1940 Act as investments in companies in which the Company owns more than 25% of the voting securities or

44

Table of Contents

maintains greater than 50% of board representation. Affiliate Investments are defined by the 1940 Act as investments in companies in which the Company owns between 5% and 25% (inclusive) of the voting securities and does not have rights to maintain greater than 50% of the board representation. As defined in the 1940 Act, the Company is deemed to be an “Affiliated Person” of this portfolio company. Fair value as of December 31, 2021, along with transactions during the year ended December 31, 2021, in these control or affiliated investments are as follows:

Net change in

 Unrealized 

Fair Value at

Gross

Gross

Realized

(Depreciation)/

Fair Value at

Interest

December 31, 2020

  

Additions (1)

  

Reductions (2)

  

Gain/(Loss)

  

 Appreciation

 

December 31, 2021

 

 Income

For the Year Ended December 31, 2021

Control Investments

 

  

    

  

    

  

  

    

Birchbox, Inc.

$

19,369

$

5,569

$

(23,548)

$

(2,725)

$

1,335

$

$

576

Edeniq, Inc.

1,507

914

(2,301)

5,402

5,522

1,675

Project Frog, Inc.

4,516

1,318

(20)

(1,605)

4,209

549

Vertical Communications, Inc.

16,953

1,597

(325)

(843)

17,382

2,082

WorkWell Prevention and Care Inc.

6,385

1,435

(2,719)

5,101

360

Total Control Investments

$

48,730

 

$

10,833

 

$

(26,194)

$

(2,725)

$

1,570

$

32,214

$

5,242

Affiliate Investments

 

  

 

 

  

 

 

  

 

  

 

  

 

  

 

  

FemTec Health, Inc.

$

$

29,499

$

(531)

$

$

(1,220)

$

27,748

$

725

Ology Bioservices, Inc.

15,072

(9,972)

2,159

(7,259)

Store Intelligence, Inc.

12,578

162

(360)

(7,936)

4,444

882

Total Affiliate Investments

$

27,650

 

$

29,661

 

$

(10,863)

$

2,159

$

(16,415)

$

32,192

$

1,607

Total Control and Affiliate Investments

$

76,380

 

$

40,494

 

$

(37,057)

$

(566)

$

(14,845)

$

64,406

$

6,849

(1)Gross additions may include increases in the cost basis of investments resulting from new portfolio investments, PIK interest, the accretion of discounts, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category.
(2)Gross reductions may include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.

45

Table of Contents

TRINITY CAPITAL INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

Note 1. Organization and Basis of Presentation

Trinity Capital Inc., (“Trinity Capital” and, together with its subsidiaries, the “Company”) is a specialty lending company focused on providing debt, including loans and equipment financings, to growth stage companies, including venture-backed companies and companies with institutional equity investors. Trinity Capital was formed on August 12, 2019 as a Maryland corporation and commenced operations on January 16, 2020. Prior to January 16, 2020, Trinity Capital had no operations, except for matters relating to its formation and organization as a business development company (“BDC”).

Trinity Capital is an internally managed, closed-end, non-diversified management investment company that has elected to be regulated as a BDC under the Investment Company Act of 1940, as amended (the “1940 Act”). Trinity Capital has elected to be treated, and intends to continue to qualify annually, as a regulated investment company (a “RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”), for U.S. federal income tax purposes.

On September 27, 2019, Trinity Capital was initially capitalized with the issuance of 10 shares of its common stock for $150 to its sole stockholder. On January 16, 2020, Trinity Capital completed a series of transactions, including a private equity offering, a private debt offering, and the acquisition of Trinity Capital Investment, LLC, Trinity Capital Fund II, L.P. (“Fund II”), Trinity Capital Fund III, L.P., Trinity Capital Fund IV, L.P., and Trinity Sidecar Income Fund, L.P. (collectively the “Legacy Funds”) through mergers of the Legacy Funds with and into Trinity Capital as well as Trinity Capital’s acquisition of Trinity Capital Holdings, LLC (“Trinity Capital Holdings”) (collectively, the “Formation Transactions”).

Trinity Capital’s common stock began trading on the Nasdaq Global Select Market on January 29, 2021, under the symbol “TRIN” in connection with its initial public offering of shares of its common stock (“IPO”).

Basis of Presentation

The Company’s interim consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Articles 6, 10 and 12 of Regulation S-X. Accordingly, certain disclosures accompanying annual financial statements prepared in accordance with GAAP are omitted. In the opinion of management, the unaudited financial results included herein contain all adjustments, consisting solely of normal accruals, considered necessary for the fair statement of the results for the interim period included herein. The current period’s consolidated results of operations are not necessarily indicative of results that may be achieved for the year. The interim consolidated financial statements and notes thereto should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the Securities and Exchange Commission (“SEC”) on March 3, 2022. As an investment company, the Company follows accounting and reporting guidance determined by the Financial Accounting Standards Board (“FASB”), in Accounting Standards Codification, as amended (“ASC”) 946 - Financial Services – Investment Companies (“ASC 946”).

Principles of Consolidation

Under ASC 946, the Company is precluded from consolidating portfolio company investments, including those in which it has a controlling interest, unless the portfolio company is another investment company. An exception to this general principle occurs if the Company holds a controlling interest in an operating company that provides all or substantially all of its services directly to the Company or to its portfolio companies. None of the portfolio investments made by the Company qualify for this exception. Therefore, the Company’s investment portfolio is carried on the Consolidated Statements of Assets and Liabilities at fair value, as discussed further in “Note 3 - Investments,” with any

46

Table of Contents

adjustments to fair value recognized as "Net unrealized appreciation/(depreciation) from investments" on the Consolidated Statements of Operations.

The Company’s consolidated operations include the activities of its wholly owned subsidiaries, Trinity Funding 1, LLC (“TF1”), and TrinCap Funding, LLC (“TCF”). TF1 was formed on August 14, 2019, as a Delaware limited liability company with Fund II as its sole equity member. On January 16, 2020, in connection with the Formation Transactions, Trinity Capital acquired TF1 through Fund II and became a party to, and assumed, a $300 million credit agreement with Credit Suisse AG (the “Credit Suisse Credit Facility”) through TF1 which matured on January 8, 2022 in accordance with its terms. TCF was formed on August 5, 2021, as a Delaware limited liability company with Trinity Capital as its sole equity member for purposes of securing lending in conjunction with a $300 million credit agreement, as amended, with KeyBank National Association (“KeyBank”) (such credit facility, the “KeyBank Credit Facility”). TF1 and TCF are special purpose bankruptcy-remote entities and are separate legal entities from Trinity Capital. Any assets conveyed to TF1 or TCF are not available to creditors of the Company or any other entity other than TF1 or TCF’s respective lenders. TF1 and TCF are consolidated for financial reporting purposes and in accordance with GAAP, and the portfolio investments held by these subsidiaries, if any, are included in the Company’s consolidated financial statements and recorded at fair value. All intercompany balances and transactions have been eliminated. As part of the Formation Transactions, Trinity Capital acquired 100% of the equity interests of Trinity Capital Holdings. There has been no activity in Trinity Capital Holdings since acquisition.

In accordance with Rule 10-01(b)(1) of Regulation S-X, as amended, the Company must determine which of its unconsolidated controlled portfolio companies, if any, are considered “significant subsidiaries.” In evaluating these unconsolidated controlled portfolio companies, there are two significance tests utilized per Rule 1-02(w) of Regulation S-X to determine if any of the Company’s Control Investments (as defined in “Note 2 - Summary of Significant Accounting Policies”) are considered significant subsidiaries: the investment test, and the income test. As of June 30, 2022 and December 31, 2021, the Company had no single investment that met either of these two tests.

Note 2. Summary of Significant Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ materially from those estimates.

Investment Transactions

Loan originations are recorded on the date of the legally binding commitment. Realized gains or losses are recorded using the specific identification method as the difference between the net proceeds received, excluding prepayment fees, if any, and the amortized cost basis of the investment without regard to unrealized gains or losses previously recognized, and include investments written off during the period, net of recoveries. The net change in unrealized gains or losses primarily reflects the change in investment fair values as of the last business day of the reporting period and also includes the reversal of previously recorded unrealized gains or losses with respect to investments realized during the period.

Valuation of Investments

The most significant estimate inherent in the preparation of the Company’s consolidated financial statements is the valuation of investments and the related amounts of unrealized appreciation and depreciation of investments recorded.

The Company’s investments are carried at fair value in accordance with the 1940 Act and ASC 946 and measured in accordance with ASC 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs

47

Table of Contents

used to measure fair value, and provides disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that each of the portfolio investments is sold in a hypothetical transaction in the principal or, as applicable, most advantageous market using market participant assumptions as of the measurement date. Market participants are defined as buyers and sellers in the principal market that are independent, knowledgeable and willing and able to transact. The Company values its investments at fair value as determined in good faith pursuant to a consistent valuation policy by the Company’s Board of Directors (the “Board”) in accordance with the provisions of ASC 820 and the 1940 Act.

While the Board is ultimately and solely responsible for determining the fair value of the Company’s investments, the Company has engaged independent valuation firms to provide the Company with valuation assistance with respect to its investments. The Company engages independent valuation firms on a discretionary basis. Specifically, on a quarterly basis, the Company will identify portfolio investments with respect to which an independent valuation firm will assist in valuing such investments. The Company selects these portfolio investments based on a number of factors, including, but not limited to, the potential for material fluctuations in valuation results, size, credit quality and the time lapse since the last valuation of the portfolio investment by an independent valuation firm.

Investments recorded on the Company’s Consolidated Statements of Assets and Liabilities are categorized based on the inputs to the valuation techniques as follows:

Level 1 — Investments whose values are based on unadjusted quoted prices for identical assets in an active market that the Company has the ability to access (examples include investments in active exchange-traded equity securities and investments in most U.S. government and agency securities).

Level 2 — Investments whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the investment.

Level 3 — Investments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (for example, investments in illiquid securities issued by privately held companies). These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the investment.

Given the nature of lending to venture capital-backed growth stage companies, 99.7%, based on fair value, of the Company’s investments in these portfolio companies are considered Level 3 assets under ASC 820 because there is no known or accessible market or market indexes for these investment securities to be traded or exchanged. Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. The Company uses an internally developed portfolio investment rating system in connection with its investment oversight, portfolio management and analysis and investment valuation procedures. This system takes into account both quantitative and qualitative factors of the portfolio companies. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.

Debt Securities

The debt securities identified on the Consolidated Schedule of Investments are secured loans and equipment financings made to growth stage companies. For portfolio investments in debt securities for which the Company has determined that third-party quotes or other independent pricing are not available, the Company generally estimates the fair value based on the assumptions that hypothetical market participants would use to value the investment in a current hypothetical sale using an income approach.

48

Table of Contents

In its application of the income approach to determine the fair value of debt securities, the Company bases its assessment of fair value on projections of the discounted future free cash flows that the security will likely generate, including analyzing the discounted cash flows of interest and principal amounts for the security, as set forth in the associated loan and equipment financing agreements, as well as market yields and the financial position and credit risk of the portfolio company (the “Hypothetical Market Yield Method”). The discount rate applied to the future cash flows of the security is based on the calibrated yield implied by the terms of the Company’s investment adjusted for changes in market yields and performance of the subject company. The Company’s estimate of the expected repayment date of its loans and equipment financings securities is either the maturity date of the instrument or the anticipated pre-payment date, depending on the facts and circumstances. The Hypothetical Market Yield Method analysis also considers changes in leverage levels, credit quality, portfolio company performance, market yield movements, and other factors. If there is deterioration in credit quality or if a security is in workout status, the Company may consider other factors in determining the fair value of the security, including, but not limited to, the value attributable to the security from the enterprise value of the portfolio company or the proceeds that would most likely be received in a liquidation analysis.

Equity Securities and Warrants

Often the Company is issued warrants by issuers as yield enhancements. These warrants are recorded as assets at estimated fair value on the grant date. The Company determines the cost basis of the warrants or other equity securities received based upon their respective fair values on the date of receipt in proportion to the total fair value of the debt and warrants or other equity securities received. Depending on the facts and circumstances, the Company generally utilizes a combination of one or several forms of the market approach as well as contingent claim analyses (a form of option analysis) to estimate the fair value of the securities as of the measurement date and determines the cost basis using a relative fair value methodology. As part of its application of the market approach, the Company estimates the enterprise value of a portfolio company utilizing customary pricing multiples, based on the development stage of the underlying issuers, or other appropriate valuation methods, such as considering recent transactions in the equity securities of the portfolio company or third-party valuations that are assessed to be indicative of fair value of the respective portfolio company. If appropriate, based on the facts and circumstances, the Company performs an allocation of the enterprise value to the equity securities utilizing a contingent claim analysis and/or other waterfall calculation by which it allocates the enterprise value across the portfolio company’s securities in order of their preference relative to one another.

Fair value estimates are made at discrete points in time based on relevant information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amounts of the Company’s financial instruments, consisting of cash, investments, receivables, payables and other liabilities approximate the fair values of such items due to the short-term nature of these instruments. Refer to “Note 4 – Fair Value of Financial Instruments” for further discussion.

Cash, Cash Equivalents and Restricted Cash

Cash, cash equivalents and restricted cash consist of funds deposited with financial institutions and short-term (original maturity of three months or less) liquid investments in money market deposit accounts. Cash equivalents are classified as Level 1 assets and are valued using the net asset value (“NAV”) per share of the money market fund. As of June 30, 2022 and December 31, 2021, cash, cash equivalents and restricted cash consisted of $13.2 million and $46.7 million, respectively, of which $12.5 million and $43.4 million, respectively, is held in the Goldman Sachs Financial Square Government Institutional Fund. Cash held in demand deposit accounts may exceed the Federal Deposit Insurance Corporation (“FDIC”) insured limit and therefore is subject to credit risk. All of the Company’s cash deposits are held at large, established, high credit quality financial institutions, and management believes that the risk of loss associated with any uninsured balances is remote. As of June 30, 2022, we did not have any restricted cash. As of December 31, 2021, restricted cash consisted of approximately $15.1 million related to the Credit Suisse Credit Facility covenants (See “Note 5 – Borrowings”). In conjunction with the maturity of the Credit Suisse Credit Facility on January 8, 2022, the restrictions on our cash thereunder expired.

49

Table of Contents

Escrow Receivables

Escrow receivables are collected in accordance with the terms and conditions of the escrow agreement. Escrow balances are typically distributed over a period of one year and may accrue interest during the escrow period. Escrow balances are measured for collectability on at least a quarterly basis and fair value is determined based on the amount of the estimated recoverable balances and the contractual maturity date. As of June 30, 2022 and December 31, 2021, there were no material past due escrow receivables. The escrow receivable balance as of June 30, 2022 and December 31, 2021 was measured at fair value and held in accordance with ASC 820.

Other Assets

Other assets generally consist of fixed assets net of accumulated depreciation, right of use assets, prepaid expenses, escrow receivables, security deposits and other assets.

Equity Offering Costs

Equity offering costs consist of fees and costs incurred in connection with the sale of the Company’s common stock, including legal, accounting and printing fees. These costs are deferred at the time of incurrence and are subsequently charged as a reduction to capital when the offering takes place or as shares are issued. Equity offering costs are periodically reviewed and expensed if the related registration is no longer active.

Security Deposits

Security deposits are collected upon funding equipment financings and are applied in lieu of regular payments at the end of the term.

Debt Financing Costs

The Company records costs related to the issuance of debt obligations as deferred debt financing costs. These costs are deferred and amortized using the straight-line method over the stated maturity life of the obligations. Debt financing costs related to secured or unsecured notes are netted with the outstanding principal balance on the Company’s Consolidated Statements of Assets and Liabilities. Debt financing costs related to the KeyBank Credit Facility are recorded as a separate asset on the Company’s Consolidated Statements of Assets and Liabilities.

Income Recognition

Interest Income

The Company recognizes interest income on an accrual basis and recognizes it as earned in accordance with the contractual terms of the loan agreement to the extent that such amounts are expected to be collected. Original issue discount (“OID”) initially includes the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities and is accreted into interest income over the term of the loan as a yield enhancement based on the effective yield method. In addition, the Company may also be entitled to an end-of-term (“EOT”) fee. EOT fees to be paid at the termination of the debt agreements are accreted into interest income over the contractual life of the debt based on the effective yield method. As of June 30, 2022 and December 31, 2021, the EOT payments receivable of approximately $53.2 million and $46.7 million, respectively, is included as a component of the cost basis of the Company’s current debt securities. When a portfolio company pre-pays their indebtedness prior to the scheduled maturity date, the acceleration of the unaccreted OID and EOT is recognized as interest income.

The Company has a limited number of debt investments in its portfolio that contain a payment-in-kind (“PIK”) provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. The Company will generally cease accruing PIK interest if there is insufficient value to support

50

Table of Contents

the accrual or management does not expect the portfolio company to be able to pay all principal and interest due. No PIK interest income was recorded during the three and six months ended June 30, 2022 and 2021.

Income related to application or origination payments, including facility commitment fees, net of related expenses and generally collected in advance, are amortized into interest income over the contractual life of the loan. The Company recognizes nonrecurring fees and additional OID and EOT received in consideration for contract modifications commencing in the quarter relating to the specific modification.

Fee Income

The Company recognizes one-time fee income, including, but not limited to, structuring fees, prepayment penalties, and exit fees related to a change in ownership of the portfolio company, as other income when earned. These fees are generally earned when the portfolio company enters into an equipment financing arrangement or pays off their outstanding indebtedness prior to the scheduled maturity.

Non-Accrual Policy

When a debt security becomes 90 days or more past due, or if management otherwise does not expect that principal, interest, and other obligations due will be collected in full, the Company will generally place the debt security on non-accrual status and cease recognizing interest income on that debt security until all principal and interest due has been paid or the Company believes the borrower has demonstrated the ability to repay its current and future contractual obligations. Any uncollected interest is reversed from income in the period that collection of the interest receivable is determined to be doubtful. However, the Company may make exceptions to this policy if the investment has sufficient collateral value and is in the process of collection.

As of June 30, 2022, loans to three portfolio companies and an equipment financing to one portfolio company were on non-accrual status with a total cost of approximately $20.5 million, and a total fair value of approximately $5.9 million, or 0.6% of the fair value of the Company’s debt investment portfolio. As of December 31, 2021, loans to two portfolio companies were on non-accrual status with a total cost of approximately $12.9 million, and a total fair value of approximately $5.1 million, or 0.7%, of the fair value of the Company’s debt investment portfolio.

Net Realized Gains / (Losses)

Realized gains / (losses) are measured by the difference between the net proceeds from the sale or redemption of an investment or a financial instrument and the cost basis of the investment or financial instrument, without regard to unrealized appreciation or depreciation previously recognized, and includes investments written-off during the period net of recoveries and realized gains or losses from in-kind redemptions. Net proceeds exclude any prepayment penalties, exit fees, and OID and EOT acceleration. Prepayment penalties and exit fees received at the time of sale or redemption are included in fee income on the Consolidated Statements of Operations. OID and EOT acceleration is included in interest income on the Consolidated Statement of Operations.

Net Unrealized Appreciation / (Depreciation)

Net change in unrealized appreciation / (depreciation) reflects the net change in the fair value of the investment portfolio and financial instruments and the reclassification of any prior period unrealized appreciation or depreciation on exited investments and financial instruments to realized gains or losses.

Stock Based Compensation

The Company has issued and may, from time to time, issue restricted stock to its officers and employees under the 2019 Trinity Capital Inc. Long Term Incentive Plan and to its non-employee directors under the Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan. The Company accounts for its share-based compensation plans using the fair value method, as prescribed by ASC 718, Compensation – Stock Compensation. Accordingly, for restricted stock awards, the Company measures the grant date fair value based upon the market price of its common stock on the

51

Table of Contents

date of the grant and amortizes the fair value of the awards as share-based compensation expense over the requisite service period, which is generally the vesting term.

The Company has also adopted Accounting Standards Update (“ASU”) 2016-09, Compensation—Stock Compensation: Improvements to Employee Share-Based Payment Accounting, which requires that all excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards) be recognized as income tax expense or benefit in the income statement and not delay recognition of a tax benefit until the tax benefit is realized through a reduction to taxes payable. Accordingly, the tax effects of exercised or vested awards are treated as discrete items in the reporting period in which they occur. Additionally, the Company has elected to account for forfeitures as they occur.

Earnings Per Share

The Company's earnings per share ("EPS") amounts have been computed based on the weighted-average number of shares of common stock outstanding for the period. Basic earnings per share is computed by dividing net increase (decrease) in net assets resulting from operations by the weighted-average number of common shares outstanding for the period. In accordance with ASC 260, Earnings Per Share, the unvested shares of restricted stock awarded pursuant to Trinity Capital’s equity compensation plans are participating securities and, therefore, are included in the basic earnings per share calculation. Diluted EPS is computed by dividing net increase (decrease) in net assets resulting from operations by the weighted average number of shares of common stock assuming all potential shares had been issued and the additional shares of common stock were dilutive. Diluted EPS, if any, reflects the potential dilution from the assumed conversion of the Company’s 6.00% Convertible Notes due 2025 (the “Convertible Notes”).

Income Taxes

The Company has elected to be treated, and to intends to continue to qualify annually, as a RIC under Subchapter M of the Code for U.S. federal tax purposes. In order to maintain its treatment as a RIC, the Company is generally required to distribute at least annually to its stockholders at least 90% of the sum of its investment company taxable income (which generally includes its net ordinary taxable income and realized net short-term capital gains in excess of realized net long-term capital losses) and its net tax-exempt income (if any). The Company generally will not pay corporate-level income tax on these distributed amounts but will pay corporate-level income tax on any retained amounts.

The Company evaluates tax positions taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority in accordance with ASC 740, Income Taxes (“ASC 740”), as modified by ASC 946. Tax benefits of positions not deemed to meet the more-likely-than-not threshold, or uncertain tax positions, would be recorded as tax expense in the current year. It is the Company’s policy to recognize accrued interest and penalties related to uncertain tax benefits in income tax expense. The Company has no material uncertain tax positions as of June 30, 2022 and December 31, 2021. All the Company’s tax returns remain subject to examination by U.S. federal and state tax authorities.

Based on federal excise distribution requirements applicable to RICs, the Company will be subject to a 4% nondeductible federal excise tax on undistributed taxable income and gains unless the Company distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ending October 31 in that calendar year and (3) any income or gain realized, but not distributed, in the preceding years. For this purpose, however, any ordinary income or capital gain net income retained by the Company and on which the Company paid corporate income tax is considered to have been distributed. The Company, at its discretion, may determine to carry forward taxable income or gain and pay a 4% excise tax on the amount by which it falls short of this calendar-year distribution requirement. If the Company chooses to do so, this generally will increase expenses and reduce the amount available to be distributed to stockholders. The Company will accrue excise tax on estimated undistributed taxable income and gain as required on an annual basis.

52

Table of Contents

Distributions

Distributions to common stockholders are recorded on the record date. The amount of taxable income to be paid out as a distribution is determined by the Board each quarter and is generally based upon the earnings estimated by management. Capital gains, if any, are distributed at least annually, although the Company may decide to retain all or some of those capital gains for investment and pay corporate-level income taxes on those retained amounts. If the Company chooses to do so, this generally will increase expenses and reduce the amount available to be distributed to stockholders.

Note 3. Investments

The Company provides debt, including loans and equipment financings, to growth stage companies, including venture capital-backed companies and companies with institutional equity investors, primarily in the United States. The Company’s investment strategy includes making investments consisting primarily of term loans and equipment financings, and, to a lesser extent, working capital loans, equity and equity-related investments. In addition, the Company may obtain warrants or contingent exit fees at funding from many of its portfolio companies.

Debt Securities

The Company’s debt securities primarily consist of direct investments in interest-bearing secured loans and equipment financings to privately held companies based in the United States. Secured loans are generally secured by a blanket first lien or a blanket second lien on the assets of the portfolio company. Equipment financings typically include a specific asset lien on mission critical assets as well as a second lien on the assets of the portfolio company. These debt securities typically have a term of between three and five years from the original investment date. Certain of the debt securities are “covenant-lite” loans, which generally are loans that do not have a complete set of financial maintenance covenants and have covenants that are incurrence-based, meaning they are only tested and can only be breached following an affirmative action of the borrower rather than by a deterioration in the borrower’s financial condition. The equipment financings in the investment portfolio generally have fixed interest rates. The loans in the investment portfolio generally have fixed interest rates or floating interest rates subject to interest rate floors. Both equipment financings and loans generally include an EOT payment.

The specific terms of each debt security vary depending on the creditworthiness of the portfolio company and the projected value of the financed assets. Companies with stronger creditworthiness may receive an initial period of lower financing factor, which is analogous to an interest-only period on a traditional term loan. Equipment financings may include upfront interim payments and security deposits. Equipment financing arrangements have various structural protections, including customary default penalties, information and reporting rights, material adverse change or investor abandonment provisions, consent rights for any additions or changes to senior debt, and, as needed, intercreditor agreements with cross-default provisions to protect the Company’s second lien positions.

Warrant Investments

In connection with the Company’s debt investments, the Company may receive warrants in the portfolio company. Warrants received in connection with a debt investment typically include a potentially discounted contract price to exercise, and thus, as a portfolio company appreciates in value, the Company may achieve additional investment return from this equity interest. The warrants typically contain provisions that protect the Company as a minority-interest holder, as well as secured or unsecured put rights, or rights to sell such securities back to the portfolio company, upon the occurrence of specified events. In certain cases, the Company may also obtain follow-up rights in connection with these equity interests, which allow the Company to participate in future financing rounds.

Equity Investments

In specific circumstances, the Company may seek to make direct equity investments in situations where it is appropriate to align the interests of the Company with key management and stockholders of the portfolio company, and to allow for participation in the appreciation in the equity values of the portfolio company. These equity investments are generally made in connection with debt investments. The Company seeks to maintain fully diluted equity positions in the portfolio companies of 5% to 50% and may have controlling equity interests in some instances.

53

Table of Contents

Portfolio Composition

The Company’s portfolio investments are in companies conducting business in a variety of industries. The following table summarizes the composition of the Company’s portfolio investments by industry at cost and fair value and as a percentage of the total portfolio as of June 30, 2022 and December 31, 2021 (dollars in thousands):

June 30, 2022

December 31, 2021

Cost

Fair Value

Cost

Fair Value

Industry

    

Amount

    

%

    

Amount

    

%

    

Amount

    

%

    

Amount

    

%

Manufacturing

$

268,030

25.1%

$

268,338

25.4%

$

169,381

 

21.1%

$

222,011

25.4%

Professional, Scientific, and Technical Services

 

244,771

22.9%

255,633

24.3%

 

140,847

 

17.6%

161,217

18.5%

Information

 

81,235

7.6%

83,737

8.0%

 

101,031

 

12.7%

107,696

12.3%

Finance and Insurance

 

68,184

6.4%

70,121

6.7%

 

62,000

 

7.8%

65,109

7.5%

Management of Companies and Enterprises

69,723

6.5%

69,033

6.6%

22,333

2.8%

22,332

2.6%

Rental and Leasing Services

 

49,135

4.6%

50,559

4.8%

 

32,749

 

4.1%

33,513

3.8%

Real Estate

 

45,977

4.3%

39,597

3.8%

 

40,776

 

5.1%

41,351

4.7%

Health Care and Social Assistance

50,688

4.8%

36,097

3.4%

50,458

 

6.3%

44,518

5.1%

Administrative and Support and Waste Management and Remediation Services

 

34,818

3.3%

34,812

3.3%

 

29,353

 

3.7%

29,337

3.4%

Retail Trade

 

34,905

3.3%

33,695

3.2%

 

39,542

 

5.0%

39,162

4.5%

Space Research and Technology

30,635

2.9%

31,327

3.0%

30,479

 

3.8%

30,698

3.5%

Educational Services

 

18,429

1.7%

17,070

1.6%

 

18,246

 

2.3%

18,813

2.2%

Utilities

15,795

1.5%

15,725

1.5%

20,445

 

2.6%

20,436

2.3%

Agriculture, Forestry, Fishing and Hunting

 

12,000

1.1%

13,061

1.2%

 

12,025

 

1.5%

13,396

1.5%

Construction

13,538

1.3%

9,198

0.9%

13,445

 

1.7%

8,903

1.0%

Wholesale Trade

 

6,887

0.6%

7,180

0.7%

 

9,417

 

1.2%

9,848

1.1%

Other Services (except Public Administration)

5,013

0.5%

5,015

0.5%

Accommodation and Food Services

3,915

0.4%

3,915

0.4%

Transportation and Warehousing

9,765

0.9%

3,838

0.4%

Arts, Entertainment, and Recreation

3,086

0.3%

3,123

0.3%

Pharmaceutical

 

69

0.0%

0.0%

 

5,329

 

0.7%

5,130

0.6%

Total

$

1,066,598

 

100.0%

$

1,051,074

 

100.0%

$

797,856

 

100.0%

$

873,470

 

100.0%

54

Table of Contents

The geographic composition is determined by the location of the corporate headquarters of the portfolio company. The following table summarizes the composition of the Company’s portfolio investments by geographic region of the United States and other countries at cost and fair value and as a percentage of the total portfolio as of June 30, 2022 and December 31, 2021 (dollars in thousands):

June 30, 2022

December 31, 2021

 

Cost

    

Fair Value

Cost

    

Fair Value

Geographic Region

    

Amount

    

%  

    

Amount

    

%

    

Amount

    

%  

    

Amount

    

%

United States:

West

$

470,496

44.1%

$

474,055

45.1%

$

370,791

 

46.5%

$

442,659

 

50.7%

Northeast

 

233,518

21.9%

232,688

22.1%

 

210,302

 

26.4%

 

213,823

 

24.5%

South

 

103,050

9.7%

103,885

9.9%

 

60,455

 

7.6%

 

61,166

 

7.0%

Mountain

 

105,724

9.9%

102,428

9.7%

 

65,223

 

8.2%

 

70,886

 

8.1%

Midwest

 

62,784

5.9%

52,854

5.0%

 

29,825

 

3.7%

 

23,958

 

2.7%

Southeast

 

6,262

0.6%

6,066

0.6%

 

1,125

 

0.1%

 

768

 

0.1%

International:

 

 

Canada

66,600

6.2%

60,637

5.8%

60,135

 

7.5%

 

60,210

 

6.9%

Western Europe

18,164

1.7%

18,461

1.8%

Total

$

1,066,598

 

100.0%

$

1,051,074

 

100.0%

$

797,856

 

100.0%

$

873,470

 

100.0%

The following table summarizes the composition of the Company’s portfolio investments by investment type at cost and fair value and as a percentage of the total portfolio as of June 30, 2022 and December 31, 2021 (dollars in thousands):

June 30, 2022

December 31, 2021

 

Cost

Fair Value

Cost

Fair Value

Investment

    

Amount

    

%

    

Amount

    

%

    

Amount

    

%

    

Amount

    

%

 

Secured Loan

$

776,524

72.9%

$

769,659

73.2%

$

557,627

69.8%

$

551,894

 

63.2%

Equipment Financing

 

231,475

21.7%

224,934

21.4%

 

183,298

23.0%

184,074

 

21.1%

Warrants

 

20,741

1.9%

33,192

3.2%

 

14,885

1.9%

36,770

 

4.2%

Equity

 

37,858

3.5%

23,289

2.2%

 

42,046

5.3%

100,732

 

11.5%

Total

$

1,066,598

100.0%

$

1,051,074

 

100.0%

$

797,856

100.0%

$

873,470

 

100.0%

55

Table of Contents

Certain Risk Factors

In the ordinary course of business, the Company manages a variety of risks including market risk, credit risk and liquidity risk. The Company identifies, measures and monitors risk through various control mechanisms, including trading limits and diversifying exposures and activities across a variety of instruments, markets and counterparties.

Market risk is the risk of potential adverse changes to the value of financial instruments because of changes in market conditions, including as a result of changes in the credit quality of a particular issuer, credit spreads, interest rates, and other movements and volatility in security prices or commodities. In particular, the Company may invest in issuers that are experiencing or have experienced financial or business difficulties (including difficulties resulting from the initiation or prospect of significant litigation or bankruptcy proceedings), which involves significant risks. The Company manages its exposure to market risk through the use of risk management strategies and various analytical monitoring techniques.

The Company’s investments may, at any time, include securities and other financial instruments or obligations that are illiquid or thinly traded, making purchase or sale of such securities and financial instruments at desired prices or in desired quantities difficult. Furthermore, the sale of any such investments may be possible only at substantial discounts, and it may be extremely difficult to value any such investments accurately.

The Company’s investments consist of growth stage companies, many of which have relatively limited operating histories and also may experience variation in operating results. Many of these companies conduct business in regulated industries and could be affected by changes in government regulations. Most of the Company’s borrowers will need additional capital to satisfy their continuing working capital needs and other requirements, and in many instances, to service the interest and principal payments on the debt.

56

Table of Contents

Note 4. Fair Value of Financial Instruments

ASC 820 defines fair value, establishes a framework for measuring fair value, and establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. The Company accounts for its investments at fair value in accordance with ASC 820. As of June 30, 2022 and December 31, 2021, the Company’s portfolio investments consisted primarily of investments in secured loans and equipment financings. The fair value amounts have been measured as of the reporting date and have not been reevaluated or updated for purposes of these financial statements subsequent to that date. As such, the fair values of these financial instruments subsequent to the reporting date may be different than amounts reported.

In accordance with ASC 820, the Company has categorized its investments based on the priority of the inputs to the valuation technique into a three-level fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical investments (Level 1) and the lowest priority to unobservable inputs (Level 3). See “Note 2 - Summary of Significant Accounting Policies.”

As required by ASC 820, when the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). Therefore, unrealized appreciation and depreciation related to such investments categorized within the Level 3 tables below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).

The fair value determination of each portfolio investment categorized as Level 3 required one or more of the following unobservable inputs:

Financial information obtained from each portfolio company, including unaudited statements of operations and balance sheets for the most recent period available as compared to budgeted numbers;
Current and projected financial condition of the portfolio company;
Current and projected ability of the portfolio company to service its debt obligations;
Type and amount of collateral, if any, underlying the investment;
Current financial ratios (e.g., fixed charge coverage ratio, interest coverage ratio and net debt/EBITDA ratio) applicable to the investment;
Current liquidity of the investment and related financial ratios (e.g., current ratio and quick ratio);
Pending debt or capital restructuring of the portfolio company;
Projected operating results of the portfolio company;
Current information regarding any offers to purchase the investment;
Current ability of the portfolio company to raise any additional financing as needed;
Changes in the economic environment, which may have a material impact on the operating results of the portfolio company;
Internal occurrences that may have an impact (both positive and negative) on the operating performance of the portfolio company;
Qualitative assessment of key management;

57

Table of Contents

Contractual rights, obligations or restrictions associated with the investment; and
Time to exit.

The use of significant unobservable inputs creates uncertainty in the measurement of fair value as of the reporting date. The significant unobservable inputs used in the fair value measurement of the Company’s investments, are (i) earnings before interest, tax, depreciation, and amortization (“EBITDA”) and revenue multiples (both projected and historic), and (ii) volatility assumptions. Significant increases (decreases) in EBITDA and revenue multiple inputs in isolation would result in a significantly higher (lower) fair value measurement. Similarly, significant increases (decreases) in volatility inputs in isolation would result in a significantly higher (lower) fair value assessment. Conversely, significant increases (decreases) in weighted average cost of capital inputs in isolation would result in a significantly lower (higher) fair value measurement. However, due to the nature of certain investments, fair value measurements may be based on other criteria, such as third-party appraisals of collateral and fair values as determined by independent third parties, which are not presented in the tables below.

The Company’s assets measured at fair value by investment type on a recurring basis as of June 30, 2022 were as follows:

Fair Value Measurements at Reporting Date Using

Quoted Prices

Significant

in Active

Other

Significant

Markets for

Observable

Unobservable

Identical Assets

Inputs

Inputs

Assets

(Level 1)

(Level 2)

(Level 3)

Total

Secured Loans

$

$

$

769,659

$

769,659

Equipment Financings

224,934

224,934

Warrants

33,192

33,192

Equity

184

2,670

20,435

23,289

Total Investments at fair value

184

2,670

1,048,220

1,051,074

Escrow Receivable (1)

2,441

2,441

Cash, cash equivalents and restricted cash

13,226

13,226

Total

$

13,410

$

2,670

$

1,050,661

$

1,066,741

(1)Escrow receivable is included in other assets on the Consolidated Statement of Assets and Liabilities.

The Company’s assets measured at fair value by investment type on a recurring basis as of December 31, 2021 were as follows:

Fair Value Measurements at Reporting Date Using

Quoted Prices

Significant

in Active

Other

Significant

Markets for

Observable

Unobservable

Identical Assets

Inputs

Inputs

Assets

(Level 1)

(Level 2)

(Level 3)

Total

Secured Loans

$

$

$

551,894

$

551,894

Equipment Financings

184,074

184,074

Equity

78,944

21,788

100,732

Warrants

17

36,753

36,770

Total Investments at fair value

78,961

794,509

873,470

Escrow Receivable (1)

4,152

4,152

Cash, cash equivalents and restricted cash

46,742

46,742

Total

$

46,742

$

78,961

$

798,661

$

924,364

(1)Escrow receivable is included in other assets on the Consolidated Statement of Assets and Liabilities.

58

Table of Contents

The methodology for determining the fair value of the Company’s investments is discussed in “Note 2 – Summary of Significant Accounting Policies”. The significant unobservable input used in the fair value measurement of the Company’s escrow receivables is the amount recoverable at the contractual maturity date of the escrow receivable. The following table provides a summary of the significant unobservable inputs used to fair value the Level 3 portfolio investments as of June 30, 2022.

  

Fair Value as of

  

  

  

  

 

June 30, 2022

Valuation Techniques/ 

 Unobservable

Weighted

Investment Type

  

(in thousands)

  

Methodologies

  

Inputs (1)

  

Range

  

Average (2)

 

 

Debt investments

$

814,887

 

Discounted Cash Flows

 

Hypothetical Market Yield

 

11.4% - 32.3%

15.0

%

 

 

  

 

  

 

  

 

  

 

154,689

 

Originated within the past three months

 

Origination Market Yield

 

11.0% - 21.3%

13.5

%

 

19,890

Transactions Precedent(6)

 

Transaction Price

 

n/a

n/a

 

5,127

 

Liquidation Scenario

 

Probability Weighting of Alternative Outcomes

 

10.0% - 80.0%

n/a

 

 

  

 

  

 

 

  

Equity investments

 

17,435

Market Approach

 

Revenue Multiple Only (3)

n/a

0.8

x

 

Revenue Multiple (3)

0.9x - 2.3x

1.8

x

 

Volatility (5)

45.1% - 76.7%

61.3

%

 

Risk-Free Interest Rate

 

2.9% - 3.0%

3.0

%

  

 

  

 

Estimated Time to Exit (in years)

 

2.3 - 4.5

 

3.0

 

  

 

Discount for Lack of Marketability (8)

26.1% - 27.6%

4.6

%

 

3,000

Transactions Precedent(6)

 

Transaction Price

 

n/a

n/a

Warrants

 

26,786

 

Market Approach

 

Revenue Multiple (3)

0.2x - 11.9x

1.2

x

Company Specific Adjustment (4)

6.1% - 34.4%

15.1

%

Volatility (5)

 

23.7% - 107.6%

51.7

%

 

 

  

 

Risk-Free Interest Rate

 

1.2% - 3.2%

2.8

%

 

 

  

 

Estimated Time to Exit (in years)

 

0.1 - 4.5

 

2.0

679

Black Scholes Option Pricing Model

Volatility (5)

42.6% - 65.4%

62.4

%

Discount for Lack of Marketability

19.6% - 27.2%

26.2

%

Risk-Free Interest Rate

1.8% - 3.4%

3.1

%

Estimated Time to Exit (in years)

4.2 - 9.8

4.9

5,727

Other

 

Probability Weighting of Alternative Outcomes

 

10.0% - 90.0%

n/a

Total Level 3 Investments

$

1,048,220

 

  

 

  

 

  

 

  

(1)The significant unobservable inputs used in the fair value measurement of the Company’s debt securities are hypothetical market yields and premiums/(discounts). The hypothetical market yield is defined as the exit price of an investment in a hypothetical market to hypothetical market participants where buyers and sellers are willing participants. The significant unobservable inputs used in the fair value measurement of the Company’s equity and warrant securities are revenue multiples and portfolio company specific adjustment factors. Additional inputs used in the option pricing model (“OPM”) include industry volatility, risk free interest rate and estimated time to exit. Significant increases (decreases) in the inputs in isolation would result in a significantly higher (lower) fair value measurement, depending on the materiality of the investment. For some investments, additional consideration may be given to data from the last round of financing or merger/acquisition events near the measurement date.
(2)Weighted averages are calculated based on the fair value of each investment.
(3)Represents amounts used when the Company has determined that market participants would use such multiples when pricing the investments.
(4)Represents amounts used when the Company has determined market participants would take into account these discounts when pricing the investments.
(5)Represents the range of industry volatility used by market participants when pricing the investment.

59

Table of Contents

(6)Represents investments where there is an observable transaction or pending event for the investment.
(7)The fair value of these investments is derived based on recent private market and merger and acquisition transaction prices.
(8)Represents amounts used when the Company has determined market participants would take into account these discounts when pricing the investments.

The following table provides a summary of the significant unobservable inputs used to fair value the Level 3 portfolio investments as of December 31, 2021.

  

Fair Value as of

  

  

  

  

 

December 31, 2021

Valuation Techniques/ 

 Unobservable

Weighted

Investment Type

  

(in thousands)

  

Methodologies

  

Inputs (1)

  

Range

  

Average (2)

 

 

Debt investments

$

508,756

 

Discounted Cash Flows

 

Hypothetical Market Yield

 

10.8% - 33.2%

14.6

%

 

  

 

  

 

  

 

  

 

  

 

188,226

 

Originated within the past three months

 

Origination Market Yield

 

11.3% - 16.2%

13.0

%

 

34,542

 

Transactions Precedent(6)

 

Transaction Price

 

n/a

n/a

 

4,444

 

Liquidation Scenario

 

Probability Weighting of Alternative Outcomes

 

20.0% - 80.0%

n/a

 

  

 

  

 

  

 

 

  

Equity investments

 

20,788

Market Approach

 

Revenue Multiple Only (3)

0.8x - 2.3x

1.9

x

 

Revenue Multiple (3)

0.2x - 6.8x

3.5

x

 

Volatility (5)

47.0% - 85.0%

65.1

%

 

Risk-Free Interest Rate

 

0.1% - 1.1%

0.9

%

  

 

  

 

Estimated Time to Exit (in years)

 

0.2 - 3.8

 

2.9

 

  

 

Discount for Lack of Marketability (8)

9.0% - 32.3%

24.5

%

 

1,000

Transactions Precedent(6)

 

Transaction Price

 

n/a

n/a

Warrants

 

23,573

 

Market Approach

 

Revenue Multiple (3)

0.2x - 30.0x

1.5

x

Company Specific Adjustment (4)

7.9% - 34.5%

9.9

%

Volatility (5)

 

35.1% - 111.3%

63.7

%

 

  

 

  

 

Risk-Free Interest Rate

 

0.1% - 1.3%

0.8

%

 

  

 

  

 

Estimated Time to Exit (in years)

 

0.2 - 5.0

 

2.3

2,312

Black Scholes Option Pricing Model

Volatility (5)

42.1% - 83.5%

56.8

%

Discount for Lack of Marketability

27.2% - 30.3%

27.7

%

Risk-Free Interest Rate

0.4% - 1.3%

0.7

%

Estimated Time to Exit (in years)

1.0 - 5.0

2.3

 

984

Transactions Precedent(6)

 

Transaction Price

 

n/a

n/a

9,884

Other⁽⁷⁾

 

Probability Weighting of Alternative Outcomes

 

10.0% - 90.0%

n/a

Total Level 3 Investments

$

794,509

 

  

 

  

 

  

 

  

(1)The significant unobservable inputs used in the fair value measurement of the Company’s debt securities are hypothetical market yields and premiums/(discounts). The hypothetical market yield is defined as the exit price of an investment in a hypothetical market to hypothetical market participants where buyers and sellers are willing participants. The significant unobservable inputs used in the fair value measurement of the Company’s equity and warrant securities are revenue multiples and portfolio company specific adjustment factors. Additional inputs used in the option pricing model (“OPM”) include industry volatility, risk free interest rate and estimated time to exit. Significant increases (decreases) in the inputs in isolation would result in a significantly higher (lower) fair value measurement, depending on the materiality of the investment. For some investments, additional consideration may be given to data from the last round of financing or merger/acquisition events near the measurement date.
(2)Weighted averages are calculated based on the fair value of each investment.

60

Table of Contents

(3)Represents amounts used when the Company has determined that market participants would use such multiples when pricing the investments.
(4)Represents amounts used when the Company has determined market participants would take into account these discounts when pricing the investments.
(5)Represents the range of industry volatility used by market participants when pricing the investment.
(6)Represents investments where there is an observable transaction or pending event for the investment.

The following table provides a summary of changes in the debt, including loans and equipment financings (collectively “Debt”), equity, and warrants fair value of the Company’s Level 3 portfolio investments for the six months ended June 30, 2022 (in thousands):

    

Debt

    

Equity

    

Warrants

    

Escrow Receivable

    

Total

Fair Value as of December 31, 2021

$

735,968

$

21,788

$

36,753

$

4,152

$

798,661

Purchases, net of deferred fees

 

401,886

3,800

6,929

 

412,615

Transfers out of Level 3 (1)

(6,687)

(6,687)

Proceeds from sales and paydowns

 

(140,898)

(664)

(731)

(1,711)

 

(144,004)

Accretion of OID and EOT payments

 

15,516

 

15,516

Net realized gain/(loss)

 

(9,429)

(68)

303

 

(9,194)

Change in unrealized appreciation/(depreciation)

 

(8,450)

(4,421)

(3,375)

 

(16,246)

Fair Value as of June 30, 2022

$

994,593

$

20,435

$

33,192

$

2,441

$

1,050,661

Net change in unrealized appreciation/depreciation on Level 3 investments still held as of June 30, 2022

$

(16,005)

$

(5,152)

$

(3,380)

$

$

(24,537)

(1)Transfers out of Level 3 during the six months ended June 30, 2022 primarily relates to the exercise of warrants held in two portfolio companies and the corresponding companies’ public offering transactions during the period. During the six months ended June 30, 2022, there were no transfers into Level 3.

61

Table of Contents

The following table provides a summary of changes in the debt, including loans and equipment financings (collectively “Debt”), equity, and warrants fair value of the Company’s Level 3 portfolio investments for the year ended December 31, 2021 (in thousands):

Type of Investment

    

Debt

    

Equity

    

Warrants

    

Escrow Receivable

    

Total

Fair Value as of December 31, 2020

$

443,219

$

32,654

$

17,778

$

$

493,651

Purchases, net of deferred fees (1)

 

533,146

12,153

5,573

 

4,152

 

555,024

Non-cash conversion (2)

916

916

Transfers out of Level 3 (3)

(2,611)

(2,611)

Proceeds from sales and paydowns

 

(264,386)

(14,098)

(9,100)

 

 

(287,584)

Accretion of OID and EOT payments

 

21,238

 

 

21,238

Net realized gain/(loss)

 

2,501

2,038

6,061

 

 

10,600

Third party participation (4)

(283)

(283)

Change in unrealized appreciation/(depreciation)

 

(666)

(10,676)

19,052

 

 

7,710

Fair Value as of December 31, 2021

$

735,968

$

21,788

$

36,753

$

4,152

$

798,661

Net change in unrealized appreciation/depreciation on Level 3 investments still held as of December 31, 2021

$

(1,473)

$

(4,641)

$

19,458

$

$

13,344

(1)Escrow receivable purchases may include additions due to proceeds held in escrow from the liquidation of level 3 investments.
(2)The non-cash conversion includes non-cash restructuring resulting in an increase in cost basis or the recognition of PIK interest income.
(3)Transfers out of Level 3 during the year ended December 31, 2021 primarily relates to the exercise of warrants held in four portfolio companies to equity investments during the period, and the corresponding company’s public offering transaction. During the year ended December 31, 2021, there were no transfers into Level 3.
(4)Certain third parties had rights to 17,485 shares of Ology Bioservices common stock at a fair value of approximately $0.6 million as of December 31, 2020. The activity related to these shares and the related liability is recorded against unrealized appreciation/(depreciation).

Fair Value of Financial Instruments Carried at Cost

As of June 30, 2022 and December 31, 2021, the carrying value of the KeyBank Credit Facility was approximately $220.0 million and $81.0 million. The carrying value of the KeyBank Credit Facility as of June 30, 2022 and December 31, 2021 approximates the fair value, which was estimated using a market yield approach with Level 3 inputs.

As of June 30, 2022 and December 31, 2021, the carrying value of the 7.00% Notes due 2025 (the “2025 Notes”) was approximately $122.0 million and $121.4 million, respectively, net of unamortized deferred financing costs of $3.0 million and $3.6 million, respectively. The 2025 Notes have a fixed interest rate as discussed in “Note 5 – Borrowings.” The fair value of the 2025 Notes as of June 30, 2022 and December 31, 2021 was approximately $130.6 million and $139.0 million, respectively, which was estimated using a relative market yield approach with Level 3 inputs.

As of June 30, 2022 and December 31, 2021, the carrying value of the Convertible Notes was approximately $47.8 million and $47.5 million, respectively, net of unamortized deferred financing costs and discount of $2.2 million and $2.5 million, respectively. The Convertible Notes have a fixed interest rate as discussed in “Note 5 – Borrowings.” The fair value of the Company’s Convertible Notes as of June 30, 2022 and December 31, 2021 was approximately $49.2 million and $55.8 million, respectively, which was estimated using a relative market yield approach with Level 3 inputs.

As of June 30, 2022 and December 31, 2021, the carrying value of the Company’s 4.375% Notes due 2026 (the “August 2026 Notes”) was approximately $122.6 million and $122.3 million, respectively, net of unamortized deferred financing costs and discount of $2.4 million and $2.7 million, respectively. The August 2026 Notes have a fixed interest rate as discussed in “Note 5 – Borrowings.” The fair value of the Company’s August 2026 Notes as of June 30, 2022 and

62

Table of Contents

December 31, 2021, was approximately $110.7 million and $138.4 million, respectively, which was estimated using a relative market yield approach with Level 3 inputs.

As of June 30, 2022, and December 31, 2021, the carrying value of the Company’s 4.25% Notes due 2026 (the “December 2026 Notes”) was approximately $73.3 million, and $73.2 million, respectively, net of unamortized deferred financing fees of $1.7 million and $1.8 million, respectively. The fair value of the Company’s December 2026 Notes as of June 30, 2022 was approximately $65.8 million, which was estimated using a relative market yield approach with Level 3 inputs. The fair value of the Company’s December 2026 Notes as of December 31, 2021 was approximately $73.2 million, which was based on the recent funding.

Note 5. Borrowings

Credit Suisse Credit Facility

On January 9, 2020, TF1 and its affiliates borrowed $190.0 million under the Credit Suisse Credit Facility. On January 16, 2020, in connection with the Formation Transactions, through its wholly owned subsidiary, TF1, the Company became a party to, and assumed, the credit facility with Credit Suisse.

Borrowings under the Credit Suisse Credit Facility bore interest at a rate of the three-month London Interbank Offered Rate (“LIBOR”) plus 3.25%. The Credit Suisse Credit Facility was collateralized by all investments held by TF1 and permitted an advance rate of up to 65% of eligible investments. The Company had the ability to borrow up to an aggregate of $300.0 million, and the Credit Suisse Credit Facility borrowing base contained certain criteria for eligible investments and includes concentration limits as defined in the Credit Suisse Credit Facility.

On January 8, 2022, the Credit Suisse Credit Facility matured in accordance with its terms, and all outstanding indebtedness thereunder was repaid. Additionally, in conjunction with the maturity of the Credit Suisse Credit Facility on January 8, 2022, the restrictions on our cash thereunder expired.

The summary information regarding the Credit Suisse Credit Facility is as follows (dollars in thousands):

Three Months Ended

Three Months Ended

Six Months Ended

Six Months Ended

    

June 30, 2022

 

June 30, 2021

 

    

June 30, 2022

 

June 30, 2021

 

Stated interest expense

$

n/a

 

$

482

 

$

9

 

$

1,159

 

Amortization of deferred financing costs

 

n/a

527

 

1,054

Total interest and amortization of deferred financing costs

$

n/a

$

1,009

$

9

$

2,213

Weighted average effective interest rate

 

n/a

 

7.2

%

 

3.9

%

 

6.6

%

Weighted average outstanding balance

$

n/a

$

55,769

$

442

$

66,823

KeyBank Credit Facility

On October 27, 2021, TCF, a wholly owned subsidiary of the Company, as borrower, and the Company, as servicer, entered into a credit agreement (as amended, the “KeyBank Credit Agreement”) with the lenders from time-to-time party thereto, KeyBank, as administrative agent and syndication agent, and Wells Fargo, National Association, as collateral custodian and paying agent.

The KeyBank Credit Facility includes a commitment of $300.0 million from KeyBank and other banks and allows the Company, through TCF, to borrow up to $400 million. Borrowings under the KeyBank Credit Agreement bear interest at a rate equal to Adjusted Term Secured Overnight Financing Rate (“SOFR”) plus 2.85%, subject to the number of eligible loans in the collateral pool. The KeyBank Credit Facility provides for a variable advance rate of up to 60% on eligible term loans and up to 64% on eligible equipment finance loans.

63

Table of Contents

The KeyBank Credit Facility includes a three-year revolving period and a two-year amortization period and matures on October 27, 2026, unless extended. Such credit facility is collateralized by all investment assets held by TCF. The KeyBank Credit Agreement contains representations and warranties and affirmative and negative covenants customary for secured financings of this type, including certain financial covenants such as a consolidated tangible net worth requirement and a required asset coverage ratio.

The KeyBank Credit Agreement also contains customary events of defaults (subject to certain grace periods, as applicable), including but not limited to the nonpayment of principal, interest or fees; breach of covenants; inaccuracy of representations or warranties in any material respect; voluntary or involuntary bankruptcy proceedings; and change of control of the borrower without the prior written consent of KeyBank.

During the three months ended June 30, 2022, the Company borrowed $116.0 million and made repayments of $30.0 million under the KeyBank Credit Facility. During the six months ended June 30, 2022, the Company borrowed $184 million and made repayments of $45 million under the KeyBank Credit Facility. The Company incurred approximately $3.2 million of financing costs in connection with the KeyBank Credit Facility that were capitalized and deferred using the straight-line method over the life of the facility. As of June 30, 2022, and December 31, 2021, unamortized deferred financing costs related to the KeyBank Credit Facility were $2.8 million and $2.3 million, respectively. As of June 30, 2022 and December 31, 2021, the Company had a borrowing availability of approximately $80.0 million and $38.1 million. See “Note 14 – Subsequent Events.”

The summary information regarding the KeyBank Credit Facility is as follows (dollars in thousands):

Three Months Ended

Three Months Ended

Six Months Ended

Six Months Ended

    

June 30, 2022

 

June 30, 2021

 

    

June 30, 2022

 

June 30, 2021

 

Stated interest expense

$

1,791

 

$

n/a

 

$

2,643

 

$

n/a

 

Amortization of deferred financing costs

 

173

n/a

 

331

n/a

Total interest and amortization of deferred financing costs

$

1,964

$

n/a

$

2,974

$

n/a

Weighted average effective interest rate

 

4.4

%

 

n/a

 

4.5

%

 

n/a

Weighted average outstanding balance

$

180,271

$

n/a

$

131,357

$

n/a

2025 Notes

Concurrent with the completion of a private common stock offering (the “Private Common Stock Offering”), on January 16, 2020, the Company completed its offering of $105.0 million in aggregate principal amount of the unsecured 2025 Notes in reliance upon the available exemptions from the registration requirements of the Securities Act (the “144A Note Offering”). Keefe, Bruyette & Woods, Inc. (“KBW”), as the initial purchaser, exercised in full its option to purchase or place additional Notes and on January 29, 2020, the Company issued and sold an additional $20.0 million in aggregate principal amount of the 2025 Notes. As a result, the Company issued and sold a total of $125.0 million in aggregate principal amount of the 2025 Notes pursuant to the 144A Note Offering.

The 2025 Notes were issued pursuant to an Indenture dated as of January 16, 2020 (the “Base Indenture”), between the Company and U.S. Bank National Association, as trustee (together with its successor in interest, U.S. Bank Trust Company, National Association, the “Trustee”), and a First Supplemental Indenture, dated as of January 16, 2020 (the “First Supplemental Indenture” and together with the Base Indenture, the “2025 Notes Indenture”), between the Company and the Trustee. The 2025 Notes mature on January 16, 2025 (the “Maturity Date”), unless repurchased or redeemed in accordance with their terms prior to such date. The 2025 Notes are redeemable, in whole or in part, at any time, or from time to time, at the Company’s option, on or after January 16, 2023 at a redemption price equal to 100% of the outstanding principal amount thereof, plus accrued and unpaid interest to, but excluding, the date of redemption. The holders of the 2025 Notes do not have the option to have the notes repaid or repurchased by the Company prior to the Maturity Date.

64

Table of Contents

The 2025 Notes bear interest at a fixed rate of 7.00% per year payable quarterly on March 15, June 15, September 15, and December 15 of each year, commencing on March 15, 2020. The 2025 Notes are direct, general unsecured obligations of the Company and rank pari passu, or equal in right of payment with all of the Company’s existing and future unsecured indebtedness or other obligations that are not so subordinated.

Concurrent with the closing of the 144A Note Offering, on January 16, 2020, the Company entered into a registration rights agreement for the benefit of the purchasers of the 2025 Notes in the 144A Note Offering. Pursuant to the terms of this registration rights agreement, the Company filed with the SEC a registration statement, which was initially declared effective on October 20, 2020, registering the public resale of the 2025 Notes by the holders thereof that elected to include their 2025 Notes in such registration statement.

Aggregate offering costs in connection with the 2025 Notes issuance, including the underwriter’s discount and commissions, were approximately $5.9 million, which were capitalized and deferred. As of June 30, 2022 and December 31, 2021, unamortized deferred financing costs related to the 2025 Notes were $3.0 million and $3.6 million, respectively.

The components of interest expense and related fees for the 2025 Notes are as follows (in thousands):

Three Months Ended

Three Months Ended

Six Months Ended

Six Months Ended

   

June 30, 2022

   

June 30, 2021

   

June 30, 2022

   

June 30, 2021

Stated interest expense

$

2,188

$

2,188

$

4,375

$

4,375

Amortization of deferred financing costs

 

298

292

 

595

583

Total interest and amortization of deferred financing costs

$

2,486

$

2,480

$

4,970

$

4,958

Weighted average effective interest rate

8.0

%

7.9

%

8.0

%

7.9

%

August 2026 Notes

On August 24, 2021, the Company issued and sold $125.0 million in aggregate principal amount of its unsecured August 2026 Notes under its shelf Registration Statement on Form N-2. The August 2026 Notes were issued pursuant to the Base Indenture and a Third Supplemental Indenture, dated as of August 24, 2021 (together with the Base Indenture, the “August 2026 Notes Indenture”), between the Company and the Trustee. The August 2026 Notes mature on August 24, 2026, unless repurchased or redeemed in accordance with their terms prior to such date. The August 2026 Notes are redeemable, in whole or in part, at any time, or from time to time, at the Company’s option, at a redemption price equal to the greater of (1) 100% of the principal amount of the August 2026 Notes to be redeemed or (2) the sum of the present values of the remaining scheduled payments of principal and interest (exclusive of accrued and unpaid interest to the date of redemption) on the August 2026 Notes to be redeemed, discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) using the applicable treasury rate plus 50 basis points, plus, in each case, accrued and unpaid interest to the redemption date; provided, however, that if the Company redeems any August 2026 Notes on or after July 24, 2026, the redemption price for the August 2026 Notes will be equal to 100% of the principal amount of the August 2026 Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption. In addition, if a change of control repurchase event (as defined in the August 2026 Notes Indenture) occurs prior to the maturity date of the August 2026 Notes or the Company’s redemption of all outstanding August 2026 Notes, the Company will be required, subject to certain conditions, to make an offer to the holders thereof to repurchase for cash some or all of the August 2026 Notes at a repurchase price equal to 100% of the principal amount of the August 2026 Notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the date of repurchase.

The August 2026 Notes bear interest at a fixed rate of 4.375% per year payable semiannually on February 15 and August 15 of each year, commencing on February 15, 2022. The August 2026 Notes are direct, general unsecured

65

Table of Contents

obligations of the Company and rank pari passu, or equal in right of payment, with all of the Company’s existing and future unsecured indebtedness or other obligations that are not so subordinated.

Aggregate offering costs in connection with the August 2026 Notes issuance, including the underwriter’s discount and commissions, were approximately $2.9 million, which were capitalized and deferred. As of June 30, 2022 and December 31, 2021, unamortized deferred financing costs related to the August 2026 Notes were $2.4 million and $2.7 million, respectively.

The components of interest expense and related fees for the 2026 Notes are as follows (in thousands):

Three Months Ended

Three Months Ended

Six Months Ended

Six Months Ended

   

June 30, 2022

   

June 30, 2021

   

June 30, 2022

   

June 30, 2021

Stated interest expense

$

1,367

$

n/a

$

2,719

$

n/a

Amortization of deferred financing costs

 

144

n/a

 

288

n/a

Total interest and amortization of deferred financing costs

$

1,511

$

n/a

$

3,007

$

n/a

Weighted average effective interest rate

4.8

%

n/a

4.8

%

n/a

December 2026 Notes

On December 15, 2021, the Company issued and sold $75.0 million in aggregate principal amount of its unsecured December 2026 Notes under its shelf Registration Statement on Form N-2. The December 2026 Notes were issued pursuant to the Base Indenture and a Fourth Supplemental Indenture, dated as of December 15, 2021 (together with the Base Indenture, the “December 2026 Notes Indenture”), between the Company and the Trustee. The December 2026 Notes mature on December 15, 2026, unless repurchased or redeemed in accordance with their terms prior to such date. The December 2026 Notes are redeemable, in whole or in part, at any time, or from time to time, at the Company’s option, at a redemption price equal to the greater of (1) 100% of the principal amount of the December 2026 Notes to be redeemed or (2) the sum of the present values of the remaining scheduled payments of principal and interest (exclusive of accrued and unpaid interest to the date of redemption) on the December 2026 Notes to be redeemed, discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) using the applicable treasury rate plus 50 basis points, plus, in each case, accrued and unpaid interest to the redemption date; provided, however, that if the Company redeems any December 2026 Notes on or after November 15, 2026, the redemption price for the December 2026 Notes will be equal to 100% of the principal amount of the December 2026 Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption. In addition, if a change of control repurchase event (as defined in the December 2026 Notes Indenture) occurs prior to the maturity date of the December 2026 Notes or the Company’s redemption of all outstanding December 2026 Notes, the Company will be required, subject to certain conditions, to make an offer to the holders thereof to repurchase for cash some or all of the December 2026 Notes at a repurchase price equal to 100% of the principal amount of the December 2026 Notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the date of repurchase.

The December 2026 Notes bear interest at a fixed rate of 4.25% per year payable semiannually on June 15 and December 15 of each year, commencing on June 15, 2022. The December 2026 Notes are direct, general unsecured obligations of the Company and rank pari passu, or equal in right of payment, with all of the Company’s existing and future unsecured indebtedness or other obligations that are not so subordinated.

Aggregate offering costs in connection with the December 2026 Notes issuance, including the underwriter’s discount and commissions, were approximately $1.9 million, which were capitalized and deferred. As of June 30, 2022 and December 31, 2021, unamortized deferred financing costs related to the December 2026 Notes were $1.7 million and $1.8 million, respectively.

66

Table of Contents

The components of interest expense and related fees for the December 2026 Notes are as follows (in thousands):

Three Months Ended

Three Months Ended

Six Months Ended

Six Months Ended

   

June 30, 2022

   

June 30, 2021

   

June 30, 2022

   

June 30, 2021

Stated interest expense

$

797

$

n/a

$

1,594

$

n/a

Amortization of deferred financing costs

 

93

n/a

 

186

n/a

Total interest and amortization of deferred financing costs

$

890

$

n/a

$

1,780

$

n/a

Weighted average effective interest rate

4.7

%

n/a

4.7

%

n/a

6.00% Convertible Notes due 2025

On December 11, 2020, the Company completed a private offering (the “Private Convertible Note Offering”) of $50.0 million in aggregate principal amount of its unsecured Convertible Notes in reliance upon the available exemptions from the registration requirements of the Securities Act. KBW acted as the initial purchaser and placement agent in connection with the Private Convertible Note Offering pursuant to a purchase/placement agreement dated December 4, 2020, by and between the Company and KBW.

The Convertible Notes were issued pursuant to the Base Indenture and a Second Supplemental Indenture, dated as of December 11, 2020 (the “Second Supplemental Indenture” and together with the Base Indenture, the “Convertible Notes Indenture”), between the Company and the Trustee. Concurrent with the closing of the Convertible Note Offering, on December 11, 2020, the Company entered into a registration rights agreement for the benefit of the holders of the Convertible Notes and the shares of common stock issuable upon conversion thereof. Aggregate offering costs in connection with the Convertible Note Offering, including the initial purchaser and placement agent discount and commissions, were approximately $1.9 million which were capitalized and deferred.

The Convertible Notes bear interest at a fixed rate of 6.00% per year, subject to additional interest upon certain events, payable semiannually in arrears on May 1 and November 1 of each year, beginning on May 1, 2021. If an investment grade rating is not maintained with respect to the Convertible Notes, additional interest of 0.75% per annum will accrue on the Convertible Notes until such time as the Convertible Notes have received an investment grade rating of “BBB-” (or its equivalent) or better. The rating remained at investment grade as of June 30, 2022. The Convertible Notes mature on December 11, 2025 (the “Convertible Notes Maturity Date”), unless earlier converted or repurchased in accordance with their terms.

Holders may convert their Convertible Notes, at their option, at any time on or prior to the close of business on the business day immediately preceding the Convertible Notes Maturity Date. The conversion rate was initially 66.6667 shares of the Company’s common stock, per $1,000 principal amount of the Convertible Notes (equivalent to an initial conversion price of approximately $15.00 per share of common stock). Effective immediately after the close of business on June 30, 2022, the conversion rate changed to 68.7855 shares of the Company’s common stock, per $1,000 principal amount of the Convertible Notes (equivalent to a conversion price of approximately $14.54 per share of common stock) as a result of a certain cash dividend of the Company. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events, further described in the Convertible Note Indenture, that occur prior to the Convertible Notes Maturity Date, the Company will increase the conversion rate for a holder who elects to convert its Convertible Notes in connection with such a corporate event in certain circumstances. Upon conversion of the Convertible Notes, the Company will pay or deliver, as the case may be, cash, shares of common stock, or a combination of cash and shares of common stock, at the Company’s election, per $1,000 principal amount of the Convertible Notes, equal to the then existing conversion rate.

At the Company’s option, it may cause holders to convert all or a portion of the then outstanding principal amount of the Convertible Notes plus accrued but unpaid interest, at any time on or prior to the close of business on the business day immediately preceding the Convertible Notes Maturity Date, if the closing sale price of the Company’s common stock for any 30 consecutive trading days exceeds 120% of the conversion price, as may be adjusted. Upon such conversion, the Company will pay or deliver, as the case may be, cash, shares of common stock, or a combination of

67

Table of Contents

cash and shares of common stock, at the Company’s election, per $1,000 principal amount of the Convertible Notes, equal to the then existing conversion rate, and a forced conversion make-whole payment (as defined in the Second Supplemental Indenture), if any, in cash.

The Company may not redeem the Convertible Notes at its option prior to maturity. In addition, if the Company undergoes a fundamental change (as defined in the Second Supplemental Indenture), holders may require the Company to repurchase for cash all or part of such holders’ Convertible Notes at a repurchase price equal to 100% of the principal amount of the Convertible Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.

The Convertible Notes are direct unsecured obligations of the Company and rank pari passu, or equal, in right of payment with all of the Company’s existing and future unsecured indebtedness or other obligations that are not so subordinated, including, without limitation, the 2025 Notes, and senior in right of payment to all of the Company’s future indebtedness or other obligations that are expressly subordinated, or junior, in right of payment to the Convertible Notes.

The Convertible Notes are accounted for in accordance with ASC 470-20, Debt Instruments with Conversion and Other Options. In accounting for the Convertible Notes, the Company estimated at the time of issuance that the values of the debt and the embedded conversion feature of the Convertible Notes were approximately 99.1% and 0.9%, respectively. The original issue discount of 0.9%, or approximately $0.5 million, attributable to the conversion feature of the Convertible Notes was recorded in “capital in excess of par value” in the Consolidated Statements of Assets and Liabilities as of December 31, 2020.

In January 2021, the Company early adopted Accounting Standard Update (“ASU”) No. 2020-06, Debt – Debt with Conversion and Other Options (“ASU 2020-06”), under which the accounting for convertible instruments was simplified by removing the separate accounting for embedded conversion features. As such, approximately $0.5 million was reversed out of net assets and reduced the original issue discount for the Convertible Notes.

The components of the carrying value of the Convertible Notes were as follows (in thousands):

   

June 30, 2022

   

December 31, 2021

Principal amount of debt

$

50,000

$

50,000

Unamortized debt financing cost

(1,297)

(1,480)

Original issue discount, net of accretion

(904)

(1,035)

Carrying value of Convertible Notes

$

47,799

$

47,485

The components of interest expense and related fees for the Convertible Notes were as follows (in thousands):

Three Months Ended

Three Months Ended

Six Months Ended

Six Months Ended

   

June 30, 2022

   

June 30, 2021

   

June 30, 2022

   

June 30, 2021

Stated interest expense

$

750

$

750

$

1,500

$

1,492

Amortization of deferred financing costs and original issue discount

 

160

155

 

319

311

Total interest and amortization of deferred financing costs and original issue discount

$

910

$

905

$

1,819

$

1,803

Weighted average effective interest rate

7.3

%

7.2

%

7.3

%

7.2

%

As of June 30, 2022 and December 31, 2021, the Company was in compliance with the terms of the KeyBank Credit Facility, the 2025 Notes Indenture, the August 2026 Notes Indenture, the December 2026 Notes Indenture and the Convertible Notes Indenture.

68

Table of Contents

Note 6. Commitments and Contingencies

Unfunded Commitments

The Company’s commitments and contingencies consist primarily of unused commitments to extend credit in the form of loans or equipment financings to the Company’s portfolio companies. A portion of these unfunded contractual commitments as of June 30, 2022 and December 31, 2021 are generally dependent upon the portfolio company reaching certain milestones before the debt commitment becomes available. Furthermore, the Company’s credit agreements contain customary lending provisions that allow the Company relief from funding obligations for previously made commitments in instances where the underlying portfolio company experiences materially adverse events that affect the financial condition or business outlook for the Company. Since a portion of these commitments may expire without being withdrawn, unfunded contractual commitments do not necessarily represent future cash requirements. As such, the Company’s disclosure of unfunded contractual commitments as of June 30, 2022 and December 31, 2021 includes only those commitments that are available at the request of the portfolio company and are unencumbered by milestones or additional lending provisions.

As of June 30, 2022 and December 31, 2021 the Company had no outstanding unfunded commitments. The Company will fund its unfunded commitments, if any, from the same sources it uses to fund its investment commitments that are funded at the time they are made (which are typically through existing cash and cash equivalents and borrowings under its credit facilities) and maintains adequate liquidity to fund its unfunded commitments through these sources.

In the normal course of business, the Company enters into contracts that provide a variety of representations and warranties, and general indemnifications. Such contracts include those with certain service providers, brokers and trading counterparties. Any exposure to the Company under these arrangements is unknown as it would involve future claims that may be made against the Company; however, based on the Company’s experience, the risk of loss is remote and no such claims are expected to occur. As such, the Company has not accrued any liability in connection with such indemnifications.

Leases

FASB ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”) requires that a lessee evaluate its leases to determine whether they should be classified as operating or financing leases. The Company identified two significant operating leases for its office space in Chandler, AZ and its headquarters in Phoenix, AZ. The lease for the Chandler office commenced February 21, 2017, and expires July 31, 2022. The Chandler lease contains a five-year extension option for a final expiration date of July 31, 2027, which the company will not exercise. The Company has also entered into a lease for office space in downtown Phoenix, Arizona (“PHX”), which commenced on July 10, 2021, and expires on December 31, 2028. The PHX lease contains two five-year extension options for a final expiration date of December 31, 2038.

The total lease expense incurred for the three months ended June 30, 2022 and 2021 was approximately $0.1 million for each period. The total lease expense incurred for the six months ended June 30, 2022 and 2021 was approximately $0.2 million and $30,000, respectively. As of June 30, 2022 and December 31, 2021, the right of use asset related to the office operating leases was $2.3 million and $2.5 million, respectively, and the lease liability was $2.5 million and $2.7 million, respectively. As of June 30, 2022, the remaining lease term for the Chandler office was 0.1 years. As of June 30, 2022, the remaining lease term for the Phoenix office was 6.5 years. The discount rate is determined at the commencement of the lease, and is 3.25% for the Chandler lease and is 3.75% for the Phoenix lease.

69

Table of Contents

The following table shows future minimum payments under the Company’s operating leases as of June 30, 2022 (in thousands):

For the Years Ended December 31, 

    

Total

2022

$

208

2023

 

383

2024

 

382

2025

386

2026

396

Thereafter

821

Total

$

2,576

Legal Proceedings

The Company may, from time to time, be involved in litigation arising out of its operations in the normal course of business or otherwise. Furthermore, third parties may try to seek to impose liability on the Company in connection with the activities of its portfolio companies. As of June 30, 2022, there are no material legal matters or material litigation pending of which the Company is aware.

Note 7. Stockholder’s Equity

The Company authorized 200,000,000 shares of its common stock with a par value of $0.001 per share. On September 27, 2019, the Company was initially capitalized with the issuance of 10 shares of its common stock for an aggregate purchase price of $150 to its sole shareholder.

Private Common Stock Offerings

On January 16, 2020, the Company completed the Private Common Stock Offering in reliance upon the available exemptions from the registration requirements of the Securities Act. As a result, the Company issued and sold a total of 7,000,000 shares of its common stock for aggregate net proceeds of approximately $105.0 million. The related overallotment option was exercised in full on January 29, 2020, pursuant to which the Company issued and sold an additional 1,333,333 shares of its common stock for gross proceeds of approximately $20.0 million. As a result, the Company issued and sold a total of 8,333,333 shares of its common stock pursuant to the Private Common Stock Offering for aggregate net proceeds of approximately $114.4 million, net of offering costs of approximately $10.6 million.

Concurrent with the closing of the Private Common Stock Offering, on January 16, 2020, the Company entered into a registration rights agreement for the benefit of the purchasers of shares of its common stock in such offering and the Legacy Investors that received shares of its common stock in connection with the Formation Transactions that were not the Company’s directors, officers and affiliates. Pursuant to the terms of this registration rights agreement, the Company no longer has any registration obligations with respect to such shares because (i) such shares may be sold by any such stockholder in a single transaction without registration pursuant to Rule 144 under the Securities Act, (ii) the Company has been subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, for a period of at least 90 days and is current in the filing of all such required reports and (iii) such shares have been listed for trading on the Nasdaq Global Select Market.

Formation Transactions

On January 16, 2020, immediately following the initial closings of the Private Common Stock Offering and the Private Convertible Note Offering (together, the “Private Offerings”), the Company used the proceeds from the Private Offerings to complete the Formation Transactions, pursuant to which the Company acquired the Legacy Funds and Trinity Capital Holdings. In consideration for the Legacy Funds, the Company issued 9,183,185 shares of common stock at $15.00 per share for a total value of approximately $137.7 million and paid approximately $108.7 million in cash to certain of the Legacy Investors. As consideration for all of the equity interests in Trinity Capital Holdings, the Company

70

Table of Contents

issued 533,332 shares of its common stock at $15.00 per share for a total value of approximately $8.0 million and paid approximately $2.0 million in cash.

Initial Public Offering

On February 2, 2021, the Company completed its initial public offering of 8,006,291 shares of common stock at a price of $14.00 per share, inclusive of the underwriters’ option to purchase additional shares, which was exercised in full. The Company’s common stock began trading on the Nasdaq Global Select Market on January 29, 2021, under the symbol “TRIN.” Proceeds from this offering were primarily used to pay down a portion of our existing indebtedness outstanding under the Credit Suisse Credit Facility.

ATM Program

On November 9, 2021, the Company entered into an open market sale agreement (the “2021 Sales Agreement”) with Jefferies LLC, as sales agent and/or principal thereunder, pursuant to which the Company can issue and sell, from time to time, up to $50 million in aggregate offering price of shares of its common stock by any method permitted by law and deemed to be part of an “at-the-market” offering (as defined in Rule 415 under the Securities Act) (the “ATM Program”). During the six months ended June 30, 2022, the Company issued and sold 176,148 shares of its common stock at a weighted-average price of $16.56 per share and raised $2.9 million of net proceeds after deducting commissions to the sales agent on shares sold under the ATM Program. During the year ended December 31, 2021, the Company issued and sold 35,714 shares of its common stock at a weighted-average price of $16.55 per share and raised $0.6 million of net proceeds after deducting commissions to the sales agent on shares sold under the ATM Program. The Company did not have the ATM Program prior to November 9, 2021. The Company generally uses net proceeds from the ATM Program to make investments in accordance with its investment objective and investment strategy and for general corporate purposes.

Equity Offering

On April 7, 2022, the Company issued 2,754,840 shares of the Company’s common stock, par value $0.001 per share, at a public offering price of $18.15 per share, resulting in net proceeds to the Company of approximately $47.9 million, after deducting discounts and commissions and offering expenses. In addition, the underwriters exercised their option to purchase an additional 413,226 shares of common stock, resulting in additional net proceeds to the Company of $7.2 million, after deduction discounts and commissions and offering expenses.

Distribution Reinvestment Plan

The Company’s amended and restated distribution reinvestment plan (“DRIP”) provides for the reinvestment of distributions in the form of common stock on behalf of its stockholders, unless a stockholder has elected to receive distributions in cash. As a result, if the Company declares a cash distribution, its stockholders who have not “opted out” of the DRIP by the opt out date will have their cash distribution automatically reinvested into additional shares of the Company’s common stock. The share requirements of the DRIP may be satisfied through the issuance of common shares or through open market purchases of common shares by the DRIP plan administrator. Newly issued shares will be valued based upon the final closing price of the Company’s common stock on the valuation date determined for each distribution by the Board.

The Company’s DRIP is administered by its transfer agent on behalf of the Company’s record holders and participating brokerage firms. Brokerage firms and other financial intermediaries may decide not to participate in the Company’s DRIP but may provide a similar distribution reinvestment plan for their clients. During the three months ended June 30, 2022, the Company issued 30,800 shares of common stock for a total of approximately $0.6 million under the DRIP. During the six months ended June 30, 2022, the Company issued 90,334 shares of common stock for a total of approximately $1.6 million under the DRIP. During the year ended December 31, 2021, the Company issued 281,149 shares of common stock for a total of approximately $4.1 million under the DRIP.

71

Table of Contents

Distributions

The following table summarizes distributions declared and/or paid by the Company since inception:

Declaration Date

Type

Record Date

Payment Date

Per Share Amount

May 7, 2020

Quarterly

May 29, 2020

June 5, 2020

$

0.22

August 10, 2020

Quarterly

August 21, 2020

September 4, 2020

0.27

November 9, 2020

Quarterly

November 20, 2020

December 4, 2020

0.27

December 22, 2020

Quarterly

December 30, 2020

January 15, 2021

0.27

March 23, 2021

Quarterly

March 31, 2021

April 16, 2021

0.28

June 15, 2021

Quarterly

June 30, 2021

July 15, 2021

0.29

September 13, 2021

Quarterly

September 30, 2021

October 15, 2021

0.33

December 16, 2021

Quarterly

December 31, 2021

January 14, 2022

0.36

March 15, 2022

Quarterly

March 31, 2022

April 15, 2022

0.40

March 15, 2022

Supplemental

March 31, 2022

April 15, 2022

0.15

June 15, 2022

Quarterly

June 30, 2022

July 15, 2022

0.42

June 15, 2022

Supplemental

June 30, 2022

July 15, 2022

0.15

Total

$

3.41

Note 8. Equity Incentive Plans

2019 Long Term Incentive Plan

The Company’s Board adopted and approved the 2019 Trinity Capital Inc. Long Term Incentive Plan (the “2019 Long Term Incentive Plan”) on October 17, 2019 and the Company’s stockholders approved the 2019 Long Term Incentive Plan on June 17, 2021 at the Company’s 2021 Annual Meeting of Stockholders, with the 2019 Long Term Incentive Plan becoming effective on June 17, 2021. Under the 2019 Long Term Incentive Plan, awards of restricted stock, incentive stock options and non-statutory stock options (together with incentive stock options, “Options”) may be granted to certain of the Company’s executive officers, employee directors and other employees (collectively, the “Employee Participants”) in accordance with the SEC exemptive order the Company received on May 27, 2021 (the “SEC Exemptive Order”). While the 2019 Long Term Incentive Plan contemplates grants of restricted stock, restricted stock units, Options, dividend equivalent rights, performance awards and other stock-based awards to the Employee Participants, the Company only sought and received exemptive relief from the SEC pursuant to the SEC Exemptive Order to grant awards of restricted stock and Options. As a result, the Company will only grant awards of such securities under the 2019 Long Term Incentive Plan. The Employee Participants will have the right to receive dividends on such awarded restricted stock, unless and until the restricted stock is forfeited.

Subject to certain adjustments under the 2019 Long Term Incentive Plan, the maximum aggregate number of shares of the Company’s common stock authorized for issuance under the 2019 Long Term Incentive Plan is 3,600,000 shares. The 2019 Long Term Incentive Plan is to be administered by the Compensation Committee of the Board (the “Compensation Committee”) in accordance with the terms of the 2019 Long Term Incentive Plan. The 2019 Long Term Incentive Plan will terminate on the day prior to the tenth anniversary of the date it was initially adopted by the Board, unless terminated sooner by action of the Board or the Compensation Committee, as applicable.

For additional information regarding the 2019 Long Term Incentive Plan, please refer to the Company’s Current Report on Form 8-K filed with the SEC on June 23, 2021, and the Company’s definitive proxy statement filed with the SEC on April 27, 2022. The following table summarizes issuances, vesting, and retirement of shares under the plan as well as the fair value of granted stock for the three and six months ended June 30, 2022 and 2021 and the twelve months ended December 31, 2021 (dollars in thousands).

72

Table of Contents

Six Months Ended

Weighted Average

Six Months Ended

Weighted Average

June 30, 2022

   

Grant Date Fair Value

   

June 30, 2021

   

Grant Date Fair Value

Unvested as of December 31, 2021

536,552

16.48

-

-

Shares Granted

698,943

17.30

-

-

Shares Vested

(96,727)

16.54

-

-

Shares Forfeited

(3,218)

16.85

-

-

Unvested as of June 30, 2022

1,135,550

16.98

-

-

Fair Value of Granted Stock

$

12,092

$

-

Compensation cost recognized

$

2,464

$

-

As of June 30, 2022, there was approximately $18.2 million of total unrecognized compensation costs related to the non-vested restricted stock awards. These costs are expected to be recognized over a weighted average period of 3.8 years. As of June 30, 2021, there was no stock based compensation costs or unrecognized compensation costs as no restricted stock has been issued under the plan. As of December 31, 2021, there was approximately $8.7 million of total unrecognized compensation costs related to non-vested restricted stock awards. These costs are expected to be recognized over a weighted average period of 2.8 years.

2019 Restricted Stock Plan

The Company’s Board adopted and approved the Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan (the “2019 Restricted Stock Plan”) on October 17, 2019 and the Company’s stockholders approved the 2019 Restricted Stock Plan on June 17, 2021 at the Company’s 2021 Annual Meeting of Stockholders. The 2019 Restricted Stock Plan became effective on June 17, 2021 and provides for grants of restricted stock awards (“Non-Employee Director Awards”) to the Company’s non-employee directors (the “Non-Employee Director Participants”), which are directors who are not “interested persons” of the Company (as such term is defined in Section 2(a)(19) of the 1940 Act) in accordance with the SEC Exemptive Order. The Non-Employee Director Participants will have the right to receive dividends on such awarded restricted stock, unless and until the restricted stock is forfeited.

Subject to certain adjustments under the 2019 Restricted Stock Plan, the total number of shares of the Company’s common stock that may be subject to Non-Employee Director Awards is 60,000 shares. The 2019 Restricted Stock Plan is to be administered by the Compensation Committee, subject to the discretion of the Board. The 2019 Restricted Stock Plan will terminate on the day prior to the tenth anniversary of the date it was approved by the Company’s stockholders, unless terminated sooner by action of the Board.

For additional information regarding the 2019 Restricted Stock Plan, please refer to the Company’s Current Report on Form 8-K, filed with the SEC on June 23, 2021, and the Company’s definitive proxy statement filed with the SEC on April 27, 2022. The following table summarizes issuances, vesting, and retirement of shares under the plan as well as the fair value of granted stock for the three and six months ended June 30, 2022 and 2021 and the twelve months ended December 31, 2021 (dollars in thousands).

Six Months Ended

Weighted Average

Six Months Ended

Weighted Average

June 30, 2022

   

Grant Date Fair Value

   

June 30, 2021

   

Grant Date Fair Value

Unvested as of December 31, 2021

6,066

16.48

-

-

Shares Granted

19,320

15.53

-

-

Shares Vested

(11,846)

16.88

-

-

Shares Forfeited

-

-

-

-

Unvested as of June 30, 2022

13,540

14.77

-

-

Fair Value of Granted Stock

$

300

$

-

Compensation cost recognized

$

169

$

-

73

Table of Contents

As of June 30, 2022, there was approximately $0.2 million of total unrecognized compensation costs related to non-vested restricted stock awards. These costs are expected to be recognized over a twelve-month period. As of June 30, 2021, there were no unrecognized compensation costs as no restricted stock had been issued under the plan. As of December 31, 2021, there was approximately $0.1 million of total unrecognized compensation costs related to non-vested restricted stock awards. These costs are expected to be recognized over a six-month period.

Note 9. Earnings Per Share

The following table sets forth the computation of the basic and diluted earnings per common share for the three and six months ended June 30, 2022 and 2021 (in thousands except shares and per share information):

Three Months Ended

Three Months Ended

Six Months Ended

Six Months Ended

    

June 30, 2022

    

June 30, 2021

June 30, 2022

    

June 30, 2021

Earnings per common share - basic

Numerator for basic earnings per share

$

(7,723)

$

24,705

$

(16,787)

$

50,030

Denominator for basic weighted average shares

30,955,022

26,478,747

29,188,790

25,024,925

Earnings/(Loss) per common share - basic

$

(0.25)

$

0.93

$

(0.58)

$

2.00

Earnings per common share - diluted

Numerator for increase in net assets per share

$

(7,723)

$

24,705

$

(16,787)

$

50,030

Adjustment for interest expense and deferred financing costs on Convertible Notes(1)

Numerator for diluted earnings per share

(7,723)

24,705

(16,787)

50,030

Denominator for basic weighted average shares

30,955,022

26,478,747

29,188,790

25,024,925

Adjustment for dilutive effect of Convertible Notes(1)

Denominator for diluted weighted average shares

30,955,022

26,478,747

29,188,790

25,024,925

Earnings/(Loss) per common share - diluted

$

(0.25)

$

0.93

$

(0.58)

$

2.00

(1)No adjustments for interest or incremental shares were included for the three and six months ended June 30, 2022 and 2021, because the effect would be antidilutive.

In certain circumstances, the Convertible Notes will be convertible into cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock, at the Company’s election which can be dilutive to common stockholders. Diluted earnings (loss) available to each share of common stock outstanding during the reporting period included any additional shares of common stock that would be issued if all potentially dilutive securities were exercised. In accordance with ASU 2020-06, the Company is required to disclose diluted EPS using the if-converted method that assumes conversion of convertible securities at the beginning of the reporting period and is intended to show the maximum dilution effect to common stockholders regardless of how the conversion can occur.

Note 10. Income Taxes

The amount of taxable income to be paid out as a distribution is determined by the Board each quarter and is generally based upon the annual earnings estimated by management of the Company. Net capital gains, if any, are

74

Table of Contents

distributed at least annually, although the Company may decide to retain all or some of those capital gains for investment and pay corporate-level income taxes on those retained amounts. If the Company chooses to do so, this generally will increase expenses and reduce the amount available to be distributed to stockholders. In the event the Company’s taxable income (including any net capital gains) for a fiscal year fall below the amount of distributions declared and paid with respect to that year, however, a portion of the total amount of those distributions may be deemed a return of capital for tax purposes to the Company’s stockholders.

Because federal income tax regulations differ from accounting principles generally accepted in the United States, distributions in accordance with tax regulations may differ from net investment income and realized gains recognized for financial reporting purposes. Differences may be permanent or temporary in nature. Permanent differences are reclassified among capital accounts in the financial statements to reflect their appropriate tax character. Temporary differences arise when certain items of income, expense, gain or loss are recognized at some time in the future.

For the three and six months ended June 30, 2022, $0.7 million and $1.3 million, respectively, was recorded for U.S. federal excise tax. There was no U.S. federal excise tax recorded for the three months ended June 30, 2021, and there was $0.1 million recorded for U.S. federal excise tax in the six months ended June 30, 2021.

The following table sets forth the tax cost basis and the estimated aggregate gross unrealized appreciation and depreciation from investments for federal income tax purposes as of and for the six months ended June 30, 2022 and December 31, 2021 (in thousands):

June 30, 2022

December 31, 2021

Tax Cost of Investments (1)

$

1,083,460

$

849,402

June 30, 2022

December 31, 2021

Unrealized appreciation

 

$

29,775

$

97,569

Unrealized depreciation

(48,935)

(26,759)

Net unrealized appreciation/(depreciation) from investments

$

(19,160)

$

70,810

(1)Includes cost of short-term investments, including cash and cash equivalents.

75

Table of Contents

Note 11. Financial Highlights

The following presents financial highlights (in thousands except share and per share information):

Six Months Ended

Six Months Ended

June 30, 2022

June 30, 2021

Per Share Data: (1)

  

  

Net asset value, beginning of period

$

16.40

$

13.03

Net investment income

 

1.07

 

0.69

Net realized and unrealized gains/(losses) on investments (2)

 

(1.65)

 

1.31

Net increase/(decrease) in net assets resulting from operations

 

(0.58)

 

2.00

Offering costs

 

(0.08)

 

(0.30)

Effect of shares issued (3)

0.19

Equity component of convertible notes

(0.02)

Distributions (4)

(1.12)

(0.57)

Total increase/(decrease) in net assets

(1.78)

1.30

Net asset value, end of period

$

14.62

$

14.33

Shares outstanding, end of period

 

31,355,832

 

26,491,274

Weighted average shares outstanding

 

29,188,790

 

25,024,925

Total return based on net asset value (5)(6)

 

(4.0)

%

 

14.4

%

(9)

Total return based on market value (7)(6)

(13.6)

%

7.5

%

Ratio/Supplemental Data:

 

  

 

  

Per share market value at end of period

$

14.47

$

14.48

Net assets, end of period

$

458,343

$

379,720

Ratio of total expenses to average net assets(8)

 

15.6

%

 

11.7

%

Ratio of net investment income to average net assets(8)

 

14.4

%

 

10.4

%

Ratio of interest and credit facility expenses to average net assets(8)

 

6.7

%

 

5.4

%

Portfolio turnover rate(6)(9)

 

21.7

%

 

27.9

%

Asset coverage ratio (10)

 

177.0

%

 

255.0

%

(1)Based on actual number of shares outstanding at the end of the corresponding period or the weighted average shares outstanding for the period, unless otherwise noted, as appropriate.
(2)Net realized and unrealized gains/(losses) on investments include rounding adjustments to reconcile the change in net asset value per share.
(3)Includes the impact of the different share amounts as a result of calculating certain per share data based on the weighted-average basic shares outstanding during the period and certain per share data based on the shares outstanding as of a period end or transaction date. Also includes the impact of the issuance of shares related to the equity incentive plans. Refer to “Note 8 – Equity Incentive Plans” for further details.
(4)The per share data reflects the actual amount of distributions declared per share for the applicable period.
(5)Total return based on net asset value is calculated as the change in net asset value per share during the period plus declared distributions per share during the period, divided by the beginning net asset value per share.
(6)Not annualized.
(7)Total return based on market value is calculated as the change in market value per share during the period, taking into account dividends. For the six months ended June 30, 2021, the beginning market value per share is

76

Table of Contents

based on the market price of $14.00 per share on January 29, 2021, the date of the Company’s listing on the Nasdaq Global Select Market, and not annualized.
(8)Annualized.
(9)Portfolio turnover rate is calculated using the lesser of year-to-date cash sales/repayments or year-to-date cash purchases over the average of the total investments at fair value.
(10)Based on outstanding debt of $595.0 million and $245.0 million as of June 30, 2022 and 2021, respectively.

Senior Securities

Information about the Company’s senior securities (including debt securities and other indebtedness) is shown in the following table as of June 30, 2022, December 31, 2021, 2020, and 2019. No senior securities were outstanding as of December 31, 2019.

Class and Period

Total
Amount
Outstanding
Exclusive of
Treasury
Securities (1)

Asset
Coverage
per Unit (2)

Involuntary
Liquidating
Preference
per Unit (3)

Average
Market Value
per Unit (4)

Credit Suisse Credit Facility

June 30, 2022(5)

$

-

-

-

-

December 31, 2021

10,000

1,958

-

-

December 31, 2020

135,000

1,770

-

-

December 31, 2019

-

-

-

-

KeyBank Credit Facility

June 30, 2022

$

220,000

1,770

-

-

December 31, 2021

81,000

1,958

-

-

December 31, 2020

-

-

-

-

December 31, 2019

-

-

-

-

2025 Notes

June 30, 2022

$

125,000

1,770

-

-

December 31, 2021

125,000

1,958

-

-

December 31, 2020

125,000

1,770

-

-

December 31, 2019

-

-

-

-

Convertible Notes

June 30, 2022

$

50,000

1,770

-

-

December 31, 2021

50,000

1,958

-

-

December 31, 2020

50,000

1,770

-

-

December 31, 2019

-

-

-

-

August 2026 Notes

June 30, 2022

$

125,000

1,770

-

-

December 31, 2021

125,000

1,958

-

-

December 31, 2020

-

-

-

-

December 31, 2019

-

-

-

-

December 2026 Notes

June 30, 2022

$

75,000

1,770

-

-

December 31, 2021

75,000

1,958

-

-

December 31, 2020

-

-

-

-

December 31, 2019

-

-

-

-

Total

June 30, 2022

$

595,000

1,770

-

-

December 31, 2021

466,000

1,958

-

-

December 31, 2020

310,000

1,770

-

-

December 31, 2019

-

-

-

-

(1)Total amount of each class of senior securities outstanding at the end of the period presented.

77

Table of Contents

(2)Asset coverage per unit is the ratio of the carrying value of total assets, less all liabilities excluding indebtedness represented by senior securities in this table to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness and is calculated on a consolidated basis.
(3)The amount to which such class of senior security would be entitled upon the Company’s involuntary liquidation in preference to any security junior to it. The “—” in this column indicates information that the SEC expressly does not require to be disclosed for certain types of senior securities.
(4)Not applicable because the senior securities are not registered for public trading on a securities exchange.
(5)Credit Suisse Credit Facility matured on January 8, 2022, in accordance with its terms, and all outstanding indebtedness thereunder was repaid.

Note 12. Related Party Transactions

During the three and six months ended June 30, 2022 and the year ended December 31, 2021, certain related parties received distributions from the Company relating to their shares held. Refer to “Note 7 – Stockholder’s Equity” for further details on the Company’s DRIP and the distributions declared. Additionally, in connection with the Company’s IPO, certain related parties purchased additional shares of the Company’s common stock. These acquisitions were made at the IPO price of $14.00 per share. During the three and six months ended June 30, 2022 and the year ended December 31, 2021, the Company’s directors and executive officers and certain employees received restricted stock awards under the 2019 Long Term Incentive Plan and the 2019 Restricted Stock Plan. Refer to “Note 8 – Equity Incentive Plans” for further details on the Company’s share-based compensation plans.

The Company has entered into indemnification agreements with its directors and executive officers. The indemnification agreements are intended to provide the Company’s directors and executive officers the maximum indemnification permitted under Maryland law and the 1940 Act. Each indemnification agreement provides that the Company shall indemnify the director or executive officer who is a party to the agreement, or an “Indemnitee,” including the advancement of legal expenses, if, by reason of his or her corporate status, the Indemnitee is, or is threatened to be, made a party to or a witness in any threatened, pending, or completed proceeding, to the maximum extent permitted by Maryland law and the 1940 Act.

The Company and its executives and directors are covered by directors and officers insurance. In addition, each of our directors and officers have entered into an indemnification agreement with us pursuant to which our directors and officers are indemnified by us to the maximum extent permitted by Maryland law subject to the restrictions of the 1940 Act.

Note 13. Recent Accounting Pronouncements

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” and in January 2021, the FASB issued ASU 2021-01, “Reference Rate Reform (Topic 848).” The amendments in these updates provide optional expedients and exceptions for applying U.S. GAAP to certain contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform and became effective upon issuance for all entities. ASU 2020-04 and ASU 2021-01 are elective and are effective on March 12, 2020 through December 31, 2022. The Company does not intend to adopt this guidance, as it expects such adoption would not have a material impact on its consolidated financial statements.

In June 2022, the FASB issued Accounting Standards Update (ASU) No. 2022-03 “Fair Value Measurements (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.” This change prohibits entities from taking into account contractual restrictions on the sale of equity securities when estimating fair value and introduces required disclosures for such transactions. The standard is effective for annual periods beginning

78

Table of Contents

after December 15, 2023, and should be applied prospectively. Early adoption is permitted. The adoption of ASU 2022-03 is not expected to have a material impact on the Company’s future financial statements.

Rule 2a-5 under the 1940 Act was recently adopted by the SEC and establishes a framework for determining fair value in good faith for purposes of the 1940 Act. The Company is evaluating the impact of Rule 2a-5 and intends to comply with the new rule’s requirements on or before the compliance date in September 2022.

Note 14. Subsequent Events

The Company’s management evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. Except as noted below, there have been no subsequent events that occurred during such period that would require recognition or disclosure.

On July 22, 2022, the Company issued $50.0 million in aggregate principal amount of the 2025 Notes in an additional issuance of such 2025 Notes. On July 27, 2022, the underwriters exercised, in full, their option to purchase from the Company an additional $7.5 million in aggregate principal amount of the 2025 Notes solely to cover over-allotments in accordance with the Underwriting Agreement. The 2025 Notes issued pursuant to this offering are treated as a single series with the existing 2025 Notes under the 2025 Notes Indenture (the “Existing 2025 Notes”) and have the same terms as the Existing 2025 Notes (other than issue date and issue price). The 2025 Notes have the same CUSIP number and are fungible and rank equally. Following this additional issuance of the 2025 Notes, the outstanding aggregate principal amount of the 2025 Notes is $182.5 million.

In connection with the additional issuance of the 2025 Notes, the 2025 Notes began trading on the Nasdaq Global Select Market under the symbol “TRINL” on July 29, 2022.

79

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Except where the context suggests otherwise, the terms “we,” “us,” “our,” and “the Company” refer to Trinity Capital Inc. and its consolidated subsidiaries. The information contained in this section should be read in conjunction with our consolidated financial statements and related notes thereto appearing elsewhere in this Quarterly Report on Form 10-Q.

Forward-Looking Statements

This quarterly report contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors and undue reliance should not be placed thereon. Any statements about our expectations, beliefs, plans, predictions, forecasts, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but not always, made through the use of words or phrases such as “anticipate,” “believes,” “can,” “could,” “may,” “predicts,” “potential,” “should,” “will,” “estimate,” “plans,” “projects,” “continuing,” “ongoing,” “expects,” “intends” and similar words or phrases. Accordingly, these statements are only predictions and involve estimates, known and unknown risks, assumptions and uncertainties that could cause actual results to differ materially from those expressed in them. Our actual results could differ materially from those anticipated in such forward-looking statements as a result of several factors discussed under Item 1A. “Risk Factors” of Part II of this quarterly report and Item 1A. “Risk Factors” of Part I of our Annual Report on Form 10-K, filed with the SEC on March 3, 2022, including the following factors, among others:

our limited operating history as a business development company (“BDC”);
our future operating results, including the impact of the SARS-CoV-2 (“COVID-19”) pandemic;
our dependence upon our management team and key investment professionals;
our ability to manage our business and future growth;
risks related to investments in growth stage companies, other venture capital-backed companies and generally U.S. companies;
the ability of our portfolio companies to achieve their objectives, including as a result of the COVID-19 pandemic;
the use of leverage;
risks related to the uncertainty of the value of our portfolio investments;
changes in political, economic or industry conditions, the interest rate and inflation rate environments or conditions affecting the financial and capital markets, including as a result of the COVID-19 pandemic;
uncertainty surrounding the financial and/or political stability of the United States, the United Kingdom, the European Union and China, including as a result of the COVID-19 pandemic, and the military conflict between Russia and Ukraine;
the dependence of our future success on the general economy and its impact on the industries in which we invest;
risks related to changes in interest rates and inflation rates, our expenses, and other general economic conditions and the effect on our net investment income;
the effect of changes in tax laws and regulations and interpretations thereof;

80

Table of Contents

the impact on our business of new or amended legislation or regulations, including the Coronavirus Aid, Relief and Economic Security Act, the stimulus package passed by Congress and signed into law in December 2020 and the American Rescue Plan Act of 2021 signed into law in March 2021;
risks related to market volatility, including general price and volume fluctuations in stock markets;
our ability to make distributions, including as a result of the COVID-19 pandemic; and
our ability to maintain our status as a BDC under the Investment Company Act of 1940, as amended (the “1940 Act”), and qualify annually for tax treatment as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

Additionally, there may be other risks that are otherwise described from time to time in the reports that we file with the Securities and Exchange Commission. Any forward-looking statements in this report should be considered in light of various important factors, including the risks and uncertainties listed above, as well as others. All forward-looking statements are necessarily only estimates of future results, and there can be no assurance that actual results will not differ materially from expectations, and, therefore, you are cautioned not to place undue reliance on such statements. Any forward-looking statements are qualified in their entirety by reference to the risk factors discussed throughout this quarterly report. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. Because we are an investment company, the forward-looking statements and projections contained in this quarterly report are excluded from the safe harbor protections provided by Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (the “safe harbor” provision of the Private Securities Litigation Reform Act of 1995).

Overview

We are a specialty lending company providing debt, including loans and equipment financings, to growth stage companies, including venture-backed companies and companies with institutional equity investors. We are an internally managed, closed-end, non-diversified management investment company that has elected to be regulated as BDC under the 1940 Act. We have elected to be treated, and intend to continue to qualify annually, as a RIC under Subchapter M of the Code for U.S. federal income tax purposes. As a BDC and a RIC, we are required to comply with certain regulatory requirements.

Our investment objective is to generate current income and, to a lesser extent, capital appreciation through our investments. We seek to achieve our investment objective by making investments consisting primarily of term loans and equipment financings and, to a lesser extent, working capital loans, equity and equity-related investments. In addition, we may obtain warrants or contingent exit fees at funding from many of our portfolio companies, providing an additional potential source of investment returns. We generally are required to invest at least 70% of our total assets in qualifying assets in accordance with the 1940 Act but may invest up to 30% of our total assets in non-qualifying assets, as permitted by the 1940 Act.

We target investments in growth stage companies, which are typically private companies, including venture-backed companies and companies with institutional equity investors. We define “growth stage companies” as companies that have significant ownership and active participation by sponsors, such as institutional investors or private equity firms, and expected annual revenues of up to $100.0 million. Subject to the requirements of the 1940 Act, we are not limited to investing in any particular industry or geographic area and seek to invest in under-financed segments of the private credit markets.

Our loans and equipment financings may have initial interest-only periods of up to 24 months and generally fully amortize over a total term of up to 60 months. These investments are typically secured by a blanket first position lien, a specific asset lien on mission critical assets and/or a blanket second position lien. We may also make a limited number of direct equity and equity-related investments in conjunction with our debt investments. We target growth stage companies that have recently issued equity to raise cash to offset potential cash flow needs related to projected growth, have

81

Table of Contents

achieved positive cash flow to cover debt service, or have institutional investors committed to providing additional funding. A loan or equipment financing may be structured to tie the amortization of the loan or equipment financing to the portfolio company’s projected cash balances while cash is still available for operations. As such, the loan or equipment financing may have a reduced risk of default. We believe that the amortizing nature of our investments will mitigate risk and significantly reduce the risk of our investments over a relatively short period. We focus on protecting and recovering principal in each investment and structure our investments to provide downside protection.

Our History

Trinity Capital Inc. was incorporated under the general corporation laws of the State of Maryland on August 12, 2019 and commenced operations on January 16, 2020. Prior to January 16, 2020, we had no operations, except for matters relating to our formation and organization as a BDC.

On January 16, 2020, through a series of transactions (the “Formation Transactions”), we acquired Trinity Capital Investment, LLC, Trinity Capital Fund II, L.P. (“Fund II”), Trinity Capital Fund III, L.P., Trinity Capital Fund IV, L.P. and Trinity Sidecar Income Fund, L.P. (collectively, the “Legacy Funds”) and all of their respective assets (the “Legacy Assets”), including their respective investment portfolios (the “Legacy Portfolio”), as well as Trinity Capital Holdings, LLC (“Trinity Capital Holdings”), a holding company whose subsidiaries managed and/or had the right to receive fees from certain of the Legacy Funds. In order to complete these transactions we used a portion of the proceeds from our private equity offering and private debt offering that occurred on January 16, 2020.

The Legacy Funds were merged with and into the Company, and we issued 9,183,185 shares of our common stock for an aggregate amount of approximately $137.7 million and paid approximately $108.7 million in cash to the Legacy Funds’ investors, which included the general partners, managers or managing members of the Legacy Funds (the “Legacy Investors”), to acquire the Legacy Funds and all of their respective assets, including the Legacy Portfolio. Our senior management team, led by Steven L. Brown, comprises the majority of the senior management team that managed the Legacy Funds and sourced the Legacy Portfolio.

As part of the Formation Transactions, we also acquired 100% of the equity interests of Trinity Capital Holdings for an aggregate purchase price of $10.0 million, which was comprised of 533,332 shares of our common stock, totaling approximately $8.0 million, and approximately $2.0 million in cash. In connection with the acquisition of such equity interests, the Company also assumed a $3.5 million severance related liability with respect to a former member of certain general partners of certain Legacy Funds. In connection with the acquisition of Trinity Capital Holdings, approximately $13.5 million (consisting of the aggregate purchase price and severance related liability assumed) was expensed to Costs related to the acquisition of Trinity Capital Holdings and Legacy Funds in the Consolidated Statements of Operations. As a result of the Formation Transactions, Trinity Capital Holdings became a wholly owned subsidiary of the Company.

On February 2, 2021, we completed our initial public offering of 8,006,291 shares of our common stock at a price of $14.00 per share, inclusive of the underwriters’ option to purchase additional shares, which was exercised in full. Our common stock began trading on the Nasdaq Global Select Market on January 29, 2021 under the symbol “TRIN.” Proceeds from this offering were primarily used to pay down a portion of our existing indebtedness outstanding under the Credit Suisse Credit Facility.

Critical Accounting Policies

The Company’s financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) and pursuant to Regulation S-X under the Securities Act of 1933, as amended (the “Securities Act”). The Company follows accounting and reporting guidance as determined by the Financial Accounting Standards Board (“FASB”), in FASB Accounting Standards Codification (“ASC”) 946, Financial Services — Investment Companies.

82

Table of Contents

The preparation of our financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Changes in the economic environment, financial markets and any other parameters used in determining such estimates could cause actual results to differ materially. Valuation of investments, income recognition, realized / unrealized gains or losses and U.S. federal income taxes are considered to be our critical accounting policies and estimates. –For additional information, please refer to “Note 2 - Summary of Significant Accounting Policies” in the notes to the consolidated financial statements included with this Quarterly Report on Form 10-Q.

Valuation of Investments

The most significant estimate inherent in the preparation of the Company’s consolidated financial statements is the valuation of investments and the related amounts of unrealized appreciation and depreciation of investments recorded. The Company’s investments are carried at fair value in accordance with the 1940 Act and ASC 946 and measured in accordance with ASC 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs used to measure fair value, and provides disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that each of the portfolio investments is sold in a hypothetical transaction in the principal or, as applicable, most advantageous market using market participant assumptions as of the measurement date. Market participants are defined as buyers and sellers in the principal market that are independent, knowledgeable and willing and able to transact. The Company values its investments at fair value as determined in good faith by the Company’s Board of Directors (the “Board”) in accordance with the provisions of ASC 820 and the 1940 Act.

While the Board is ultimately and solely responsible for determining the fair value of the Company’s investments, the Company has engaged independent valuation firms to provide the Company with valuation assistance with respect to its investments. The Company engages independent valuation firms on a discretionary basis. Specifically, on a quarterly basis, the Company will identify portfolio investments with respect to which an independent valuation firm will assist in valuing certain investments. The Company selects these portfolio investments based on a number of factors, including, but not limited to, the potential for material fluctuations in valuation results, size, credit quality and the time lapse since the last valuation of the portfolio investment by an independent valuation firm.

Investments recorded on our Consolidated Statements of Assets and Liabilities are categorized based on the inputs to the valuation techniques as follows:

Level 1 — Investments whose values are based on unadjusted quoted prices for identical assets in an active market that the Company has the ability to access (examples include investments in active exchange-traded equity securities and investments in most U.S. government and agency securities).

Level 2 — Investments whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the investment.

Level 3 — Investments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (for example, investments in illiquid securities issued by privately held companies). These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the investment.

83

Table of Contents

Given the nature of lending to venture capital-backed growth stage companies, substantially all of the Company’s investments in these portfolio companies are considered Level 3 assets under ASC 820 because there is no known or accessible market or market indexes for these investment securities to be traded or exchanged. The Company uses an internally developed portfolio investment rating system in connection with its investment oversight, portfolio management and analysis and investment valuation procedures. This system takes into account both quantitative and qualitative factors of the portfolio companies. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.

Fair value estimates are made at discrete points in time based on relevant information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amounts of the Company’s financial instruments, consisting of cash, investments, receivables, payables and other liabilities approximate the fair values of such items due to the short-term nature of these instruments.

Income Recognition

Interest Income

The Company recognizes interest income on an accrual basis and recognizes it as earned in accordance with the contractual terms of the loan agreement to the extent that such amounts are expected to be collected. Original issue discount (“OID”) initially includes the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities, and is accreted into interest income over the term of the loan as a yield enhancement based on the effective yield method. In addition, the Company may also be entitled to an end-of-term (“EOT”) fee. EOT fees related to debt investments to be paid at the termination of the financing arrangements are accreted into interest income over the contractual life of the debt based on the effective yield method. As of June 30, 2022 and December 31, 2021, the Company had an EOT payments receivable of approximately $53.2 million and $37.9 million, respectively, which is included as a component of the cost basis of the Company’s current debt securities. When a portfolio company pre-pays their indebtedness prior to the scheduled maturity date, then the acceleration of the unaccreted OID and EOT is recognized as interest income.

Income related to application or origination payments, including facility commitment fees, net of related expenses and generally collected in advance, are amortized into interest income over the contractual life of the loan. The Company recognizes nonrecurring fees and additional OID and EOT received in consideration for contract modifications commencing in the quarter relating to the specific modification.

Fee Income

The Company recognizes one-time fee income, including, but not limited to, structuring fees, prepayment penalties, and exit fees related to a change in ownership of the portfolio company, as other income when earned. These fees are generally earned when the portfolio company enters into an equipment financing arrangement or pays off their outstanding indebtedness prior to the scheduled maturity.

Portfolio Composition and Investment Activity

Portfolio Composition

As of June 30, 2022, our investment portfolio had an aggregate fair value of approximately $1,051.1 million and was comprised of approximately $769.7 million in secured loans, $224.9 million in equipment financings, and $56.5 million in equity and warrants, across 108 portfolio companies. As of December 31, 2021, our investment portfolio had an aggregate fair value of approximately $873.5 million and was comprised of approximately $551.9 million in secured loans, $184.1 million in equipment financings, and $137.5 million in equity and warrants, across 94 portfolio companies.

84

Table of Contents

A summary of the composition of our investment portfolio at cost and fair value as a percentage of total investments are shown in following table as of June 30, 2022 and December 31, 2021:

    

June 30, 2022

    

December 31, 2021

 

Fair

Fair

Type

Cost

Value

Cost

Value

 

Secured Loans

 

72.9%

73.2%

 

69.8%

63.2%

Equipment Financings

 

21.7%

21.4%

 

23.0%

21.1%

Equity

3.5%

2.2%

 

5.3%

11.5%

Warrants

 

1.9%

3.2%

 

1.9%

4.2%

Total

 

100.0%

100.0%

 

100.0%

100.0%

The following table shows the composition of our investment portfolio by geographic region at cost and fair value as a percentage of total investments as of June 30, 2022 and December 31, 2021. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.

    

June 30, 2022

    

December 31, 2021

Fair

Fair

Geographic Region

Cost

Value

Cost

Value

United States

West

 

44.1%

45.1%

 

46.5%

50.7%

Northeast

 

21.9%

22.1%

 

26.4%

24.5%

Mountain

 

9.9%

9.7%

 

8.2%

8.1%

South

 

9.7%

9.9%

 

7.6%

7.0%

Midwest

 

5.9%

5.0%

 

3.7%

2.7%

Southeast

 

0.6%

0.6%

 

0.1%

0.1%

International:

 

Canada

 

6.2%

5.8%

 

7.5%

6.9%

Western Europe

 

1.7%

1.8%

 

0.0%

0.0%

Total

 

100.0%

100.0%

 

100.0%

100.0%

85

Table of Contents

Set forth below is a table showing the industry composition of our investment portfolio at cost and fair value as a percentage of total investments as of June 30, 2022 and December 31, 2021:

    

June 30, 2022

    

December 31, 2021

 

Fair

Fair

Industry

Cost

Value

Cost

Value

 

Manufacturing

 

25.1%

25.4%

 

21.1%

25.4%

Professional, Scientific, and Technical Services

 

22.9%

24.3%

 

17.6%

18.5%

Information

 

7.6%

8.0%

 

12.7%

12.3%

Finance and Insurance

 

6.4%

6.7%

 

7.8%

7.5%

Management of Companies and Enterprises

6.5%

6.6%

2.8%

2.6%

Rental and Leasing Services

 

4.6%

4.8%

 

4.1%

3.8%

Real Estate

 

4.3%

3.8%

 

5.1%

4.7%

Health Care and Social Assistance

 

4.8%

3.4%

 

6.3%

5.1%

Administrative and Support and Waste Management and Remediation Services

 

3.3%

3.3%

 

3.7%

3.4%

Retail Trade

3.3%

3.2%

5.0%

4.5%

Space Research and Technology

 

2.9%

3.0%

 

3.8%

3.5%

Educational Services

 

1.7%

1.6%

 

2.3%

2.2%

Utilities

1.5%

1.5%

2.6%

2.3%

Agriculture, Forestry, Fishing and Hunting

 

1.1%

1.2%

 

1.5%

1.5%

Construction

 

1.3%

0.9%

 

1.7%

1.0%

Wholesale Trade

 

0.6%

0.7%

 

1.2%

1.1%

Other Services (except Public Administration)

0.5%

0.5%

 

0.0%

0.0%

Accommodation and Food Services

0.4%

0.4%

 

0.0%

0.0%

Transportation and Warehousing

 

0.9%

0.4%

 

0.0%

0.0%

Arts, Entertainment, and Recreation

 

0.3%

0.3%

 

0.0%

0.0%

Pharmaceutical

 

0.0%

0.0%

0.7%

0.6%

Total

100.0%

100.0%

 

100.0%

100.0%

As of June 30, 2022 and December 31, 2021, the debt, including loans and equipment financings, in our portfolio had a weighted average time to maturity of approximately 3.4 years. Additional information regarding our portfolio is set forth in the schedule of investments and the related notes thereto included with this Quarterly Report on Form 10-Q.

Concentrations of Credit Risk

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount. Industry and sector concentrations will vary from period to period based on portfolio activity.

As of June 30, 2022 and December 31, 2021, the Company’s ten largest portfolio companies represented approximately 31.3% and 36.1%, respectively, of the total fair value of the Company’s investments in portfolio companies. As of June 30, 2022 and December 31, 2021, the Company had 14 and nine portfolio companies that represented 5% or more of the Company’s net assets, respectively.

Investment Activity

During the six months ended June 30, 2022, we made an aggregate of approximately $229.6 million of investments in 21 new portfolio companies and approximately $186.7 million of investments in 26 existing portfolio companies, excluding fees. During the six months ended June 30, 2022, we received an aggregate of $203.4 million in proceeds from repayments and sales of our investments, including proceeds of approximately $86.5 million from early repayments on our debt investments.

During the year ended December 31, 2021, we invested approximately $395.3 million in 33 new portfolio companies and approximately $163.0 million in 24 existing portfolio companies, excluding deferred fees. During the

86

Table of Contents

year ended December 31, 2021, we received an aggregate of approximately $290.2 million in proceeds from repayments of our debt investments, including proceeds of approximately $190.1 million from early debt repayments.

The following table provides a summary of the changes in the investment portfolio for the six months ended June 30, 2022 and the year ended December 31, 2021 (in thousands):

Six Months Ended

Year Ended

June 30, 2022

December 31, 2021

Beginning Portfolio, at fair value

$

873,470

$

493,651

Purchases, net of deferred fees

413,615

554,832

Non-cash conversion

916

Principal payments received on investments

(54,364)

(74,278)

Proceeds from early debt repayments

(86,534)

(190,107)

Sale of investments

(62,518)

(25,787)

Accretion of OID and EOT payments

15,516

21,238

Net realized gain/(loss)

43,027

12,708

Third party participation (1)

(283)

Change in unrealized appreciation/(depreciation)

(91,138)

80,580

Ending Portfolio, at fair value

$

1,051,074

$

873,470

(1)Certain third parties had rights to 17,485 shares of Ology Bioservices common stock at a fair value of approximately $0.6 million as of December 31, 2020. During March 2021, these shares were reissued by Ology Bioservices directly to the third parties and the corresponding liability was removed from the Consolidated Statement of Assets and Liabilities. The activity related to these shares and the related liability is recorded against unrealized appreciation/(depreciation).

The level of our investment activity can vary substantially from period to period depending on many factors, including the amount of debt, including loans and equipment financings, and equity capital required by growth stage companies, the general economic environment and market conditions and the competitive environment for the types of investments we make.

Portfolio Asset Quality

Our portfolio management team uses an ongoing investment risk rating system to characterize and monitor our outstanding loans and equipment financings. Our portfolio management team monitors and, when appropriate, recommends changes to the investment risk ratings. Our Investment Committee reviews the recommendations and/or changes to the investment risk ratings, which are submitted on a quarterly basis to the Board and its Audit Committee.

87

Table of Contents

For our investment risk rating system, we review seven different criteria and, based on our review of such criteria, we assign a risk rating on a scale of 1 to 5, as set forth in the following illustration.

Graphic

The following table shows the distribution of our loan and equipment financing investments on the 1 to 5 investment risk rating scale range at fair value as of June 30, 2022 and December 31, 2021 (dollars in thousands):

    

    

June 30, 2022

 

December 31, 2021

 

Investment Risk Rating 

Investments at

    

Percentage of

 

Investments at

    

Percentage of

Scale Range

Designation

Fair Value

Total Portfolio

 

Fair Value

Total Portfolio

 

4.0 - 5.0

Very Strong Performance

$

62,719

6.3%

$

84,785

 

11.5%

3.0 - 3.9

Strong Performance

 

382,593

38.5%

 

236,466

 

32.1%

2.0 - 2.9

Performing

 

529,285

53.2%

 

396,846

 

53.9%

1.6 - 1.9

Watch

 

18,706

1.9%

 

13,427

 

1.9%

1.0 - 1.5

Default/Workout

 

1,290

0.1%

 

4,444

 

0.6%

Total

$

994,593

 

100.0%

$

735,968

 

100.0%

At June 30, 2022 and December 31, 2021, our debt investments had a weighted average risk rating score of 3.0 for each period.

Debt Investments on Non-Accrual Status

When a debt security becomes 90 days or more past due, or if our management otherwise does not expect that principal, interest, and other obligations due will be collected in full, we will generally place the debt security on non-accrual status and cease recognizing interest income on that debt security until all principal and interest due has been paid or we believe the borrower has demonstrated the ability to repay its current and future contractual obligations. Any uncollected interest is reversed from income in the period that collection of the interest receivable is determined to be doubtful. However, we may make exceptions to this policy if the investment has sufficient collateral value and is in the process of collection.

As of June 30, 2022, loans to three portfolio companies and an equipment financing to one portfolio company were on non-accrual status with a total cost of approximately $20.5 million, and a total fair value of approximately $5.9 million, or 0.6%, of the fair value of the Company’s debt investment portfolio. As of December 30, 2021, loans to two portfolio companies were on non-accrual status with a total cost of approximately $12.9 million, and a total fair value of approximately $5.1 million, or 0.7%, of the total fair value of the Company’s debt investment portfolio.

88

Table of Contents

Results of Operations

The following discussion and analysis of our results of operations encompasses our consolidated results for the three and six months ended June 30, 2022 and 2021.

Investment Income

The following table sets forth the components of investment income (in thousands):

Three Months Ended

Three Months Ended

Six Months Ended

Six Months Ended

June 30, 2022

    

June 30, 2021

June 30, 2022

June 30, 2021

Stated interest income

$

25,097

$

12,429

$

45,355

$

24,179

Amortization of original issue discount

 

5,998

 

3,709

 

10,987

 

7,156

Acceleration of amortization of original issue discount

1,416

1,976

4,575

3,123

Prepayment penalty and related fees

125

1,239

2,680

1,946

Other fee income

822

123

1,706

391

Total investment income

$

33,458

$

19,476

$

65,303

$

36,795

We generate revenues primarily in the form of investment income from the investments we hold, generally in the form of interest income from our debt securities. Investment income represents interest income recognized as earned in accordance with the contractual terms of the loan agreement. Interest income from original issue discount (“OID”) represents the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities, including loans and equipment financings and is accreted into interest income over the term of the loan as a yield enhancement. Interest income from payment-in-kind (“PIK”) represents contractually deferred interest added to the loan balance recorded on an accrual basis to the extent such amounts are expected to be collected.

Loan and commitment fees in excess of related expenses are amortized into interest income over the contractual life of the loan. The Company also recognizes certain fees as one-time fee income, including, but not limited to, prepayment penalties, fees related to select covenant default, late-payment fees, structuring fees and exit fees related to a change in ownership of the portfolio company.

For the three months ended June 30, 2022, total investment income was approximately $33.5 million, which represents an approximate effective yield of 13.8% on the average investments during such period. For the three months ended June 30, 2021, total investment income was approximately $19.5 million, which represents an approximate effective yield of 15.9% on the investments during the period. The increase in investment income for the three months ended June 30, 2022 is due to higher stated interest income and amortization of OID and EOT based on an increased principal value of income producing debt investments and increased non-recurring fee income, which fluctuates based on investment activity and early repayment activity.

For the six months ended June 30, 2022, total investment income was approximately $65.3 million, which represents an approximate effective yield of 14.9% on the average investments during such period. For the six months ended June 30, 2021, total investment income was approximately $36.8 million, which represents an approximate effective yield of 15.8% on the investments during the period. The increase in investment income for the six months ended June 30, 2022 is due to higher stated interest income and amortization of OID and EOT based on an increased principal value of income producing debt investments and increased non-recurring fee income, which fluctuates based on investment activity and early repayment activity.

Operating Expenses and Excise Taxes

Our operating expenses are comprised of interest and fees on our borrowings, employee compensation, professional fees and general and administrative expenses. Our operating expenses totaled approximately $17.1 million and $9.4 million for the three months ended June 30, 2022 and 2021, respectively, and $32.6 million and $19.4 million for the six months then ended June 30, 2022 and 2021. For the three months ended June 30, 2022 and 2021, we expensed excise

89

Table of Contents

taxes of $0.7 million and did not expense any excise tax for the three months ended June 30, 2021. For the six months ended June 30, 2022 and 2021, we expensed excise taxes of $1.3 million and $0.1 million, respectively. The increase in excise tax was primarily due to increase in estimated undistributed taxable income in 2022.

Interest Expense and Other Debt Financing Costs

Interest expense and other debt financing costs on our borrowings totaled approximately $7.8 million and $4.4 million for the three months ended June 30, 2022 and 2021, respectively, and totaled approximately $14.6 million and $9.0 million for the six months ended June 30, 2022 and 2021, respectively. These costs are primarily comprised of interest and fees related to the credit facilities, the 2025 Notes, the August 2026 Notes, the December 2026 Notes and the Convertible Notes. Our weighted average effective interest rate, comprised of interest and amortization of fees and discount was approximately 5.6% and 7.6% for the three months ended June 30, 2022 and 2021, respectively, and 5.8% and 7.4% for the six months then ended. The increase in interest expense for both the three and six months ended June 30, 2022 was primarily due to increased borrowings under our KeyBank Credit Facility.

Employee Compensation and Benefits

Employee compensation and benefits totaled approximately $6.9 million and $3.4 million for the three months ended June 30, 2022 and 2021, respectively, and approximately $13.3 million and $7.4 million for the six months then ended. The increase in employee compensation related expenses relates primarily to the accrual of bonuses expected to be paid at the discretion of management or upon approval of the Board, as applicable, as well as an increased headcount. As of June 30, 2022 and 2021, the Company had 52 and 39 employees, respectively.

The Board and the Company’s stockholders have adopted and approved the (i) 2019 Trinity Capital Inc., Long-Term Incentive Plan (the “2019 Long Term Incentive Plan”); and (ii) Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan (the “2019 Restricted Stock Plan”), with each plan becoming effective on June 17, 2021. During the six months ended June 30, 2022, the Company granted 598,988 shares of restricted stock, net of 96,727 vested shares and 3,218 forfeited shares under the plan of the 3.6 million authorized under the 2019 Long Term Incentive Plan. During the six months ended June 30, 2022, the Company granted 19,320 shares of restricted stock of the 60,000 authorized under the 2019 Restricted Stock Plan. See “Note 8 – Equity Incentive Plans” in the Notes to Consolidated Financial Statements. During the three and six months ended June 30, 2021, no shares were granted under either plan.

Professional Fees Expenses

Professional fees expenses, consisting of legal fees, accounting fees, third-party valuation fees, and talent acquisition fees were approximately $0.9 million and $0.6 million for the three months ended June 30, 2022 and 2021, respectively. Professional fees expenses were approximately $1.7 million and $1.2 million for the six months ended June 30, 2022 and 2021, respectively. The increase in professional fees expenses for the three and six months ended June 30, 2022, resulted primarily from outside consulting expenses.

General and Administrative Expenses

General and administrative expenses include insurance premiums, rent, taxes and various other expenses related to our ongoing operations. Our general and administrative expenses totaled approximately $1.6 million and $1.0 million for the three months ended June 30, 2022 and 2021, respectively. General and administrative expenses totaled approximately $3.0 million and $1.8 million for the six months ended June 30, 2022 and 2021, respectively. The increase in general and administrative expenses for the three and six months ended June 30, 2022 is primarily due to increases in directors and officers liability insurance.

Net Investment Income

As a result of approximately $33.5 million in total investment income as compared to approximately $17.8 million in total expenses including excise tax expense, net investment income for the three months ended June 30, 2022 was approximately $15.7 million. As a result of approximately $19.5 million in total investment income as compared to

90

Table of Contents

approximately $9.4 million in total expenses including excise tax expense, net investment income for the three months ended June 30, 2021 was approximately $10.1 million.

As a result of approximately $65.3 million in total investment income as compared to approximately $34.0 million in total expenses including excise tax expense, net investment income for the six months ended June 30, 2022 was approximately $31.3 million. As a result of approximately $36.8 million in total investment income as compared to approximately $19.5 million in total expenses including excise tax expense, net investment income for the six months ended June 30, 2021 was approximately $17.3 million.

Net Realized Gains and Losses

Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption of an investment or a financial instrument and the cost basis of the investment or financial instrument, without regard to unrealized appreciation or depreciation previously recognized, and includes investments written-off during the period.

During the six months ended June 30, 2022, our gross realized gains primarily consisted of the sale of our equity positions in two portfolio companies, and our gross realized losses primarily consisted of the sale of our debt positions in two portfolio companies.

The net realized gains (losses) from the sales, repayments, or exits of investments were comprised of the following (in thousands):

Three Months Ended

Three Months Ended

Six Months Ended

Six Months Ended

    

June 30, 2022

    

June 30, 2021

    

June 30, 2022

    

June 30, 2021

Net realized gain (loss) on investments:

 

  

  

 

  

  

Gross realized gains

$

511

$

2,502

$

53,807

$

5,469

Gross realized losses

 

(10,128)

 

(507)

 

(10,780)

 

(879)

Total net realized gains/(losses) on investments

$

(9,617)

$

1,995

$

43,027

$

4,590

Net Change in Unrealized Appreciation / (Depreciation) from Investments

Net change in unrealized appreciation/(depreciation) from investments primarily reflects the net change in the fair value of the investment portfolio and financial instruments and the reclassification of any prior period unrealized appreciation or depreciation on exited investments and financial instruments to realized gains or losses.

91

Table of Contents

Net unrealized appreciation and depreciation on investments for the three and six months ended June 30, 2022 and 2021 is comprised of the following (in thousands):

Three Months Ended

Three Months Ended

Six Months Ended

Six Months Ended

    

June 30, 2022

    

June 30, 2021

    

June 30, 2022

    

June 30, 2021

Gross unrealized appreciation

$

9,945

$

28,342

$

17,826

$

57,110

Gross unrealized depreciation

 

(33,636)

 

(12,543)

 

(45,856)

 

(21,969)

Third party participation (1)

283

Net unrealized appreciation/depreciation reclassified related to net realized gains or losses

 

9,871

 

(3,169)

(63,108)

 

(7,318)

Total net unrealized gains (losses) on investments

$

(13,820)

$

12,630

$

(91,138)

$

28,106

(1)Certain third parties had rights to 17,485 shares of Ology Bioservices common stock at a fair value of approximately $0.6 million as of December 31, 2020. During March 2021, these shares were reissued by Ology Bioservices directly to the third parties and the corresponding liability was removed from the Consolidated Statement of Assets and Liabilities. The activity related to these shares and the related liability is recorded against unrealized appreciation/(depreciation).

During the three months ended June 30, 2022, we recorded net unrealized depreciation of $13.8 million, which was from net unrealized depreciation of $6.1 million from our warrant investments, $5.3 million from our equity investments and $2.4 million from our debt investments. During the six months ended June 30, 2022, we recorded net unrealized depreciation $91.1 million, which was primarily from gross unrealized depreciation reclassified related to net realized gains of approximately $70.5 million related to the sale of two equity investments.

During the three and six months ended June 30, 2021, we recorded net unrealized appreciation of $12.6 million and $28.1 million, respectively, which was primarily from net unrealized appreciation of approximately $8.2 million and $20.2 million, respectively, from our equity investments and $6.3 million and $10.5 million, respectively, from our warrant investments, offset by the reversal of unrealized appreciation upon pay-off of our portfolio companies during the period.

Net Increase (Decrease) in Net Assets Resulting from Operations

Net decrease in net assets resulting from operations during the three months ended June 30, 2022, was approximately $7.7 million. Net increase in net assets resulting from operations during the three months ended June 30, 2021, was approximately $24.7 million. Net decrease in net assets resulting from operations during the six months ended June 30, 2022, was approximately $16.8 million. Net increase in net assets resulting from operations during the six months ended June 30, 2021, was approximately $50.0 million.

Net Increase (Decrease) in Net Assets Resulting from Operations and Earnings Per Share

For the three months ended June 30, 2022 basic and diluted net decrease in net assets per common share were $0.25. For the three months ended June 30, 2021, basic net increase in net assets per common share was $0.93. The decrease in 2022 is result of gross unrealized depreciation reclassified related to net realized gains. For the six months ended June 30, 2022, basic and fully diluted net decrease in net assets per common share were $0.58. For the six months ended June 30, 2021, basic and diluted net decrease in net assets per common share were $2.00.

92

Table of Contents

Financial Condition, Liquidity and Capital Resources

Our liquidity and capital resources are generated primarily from the net proceeds of offerings of our securities, including our initial public offering, the Private Offerings, the Convertible Notes offering, the August 2026 Notes offering and the December 2026 Notes offering, borrowings under the KeyBank Credit Facility and cash flows from our operations, including investment sales and repayments, as well as income earned on investments and cash equivalents. Our primary use of our funds includes investments in portfolio companies, payments of interest on our outstanding debt, and payments of fees and other operating expenses we incur. We also expect to use our funds to pay distributions to our stockholders. We have used, and expect to continue to use, our borrowings, including under the KeyBank Credit Facility or any future credit facility, and proceeds from the turnover of our portfolio to finance our investment objectives and activities.

We may, from time to time, enter into additional credit facilities, increase the size of our existing Credit Facility, or issue additional securities in private or public offerings. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions, and other factors.

For the six months ended June 30, 2022, we experienced a net decrease in cash and cash equivalents in the amount of $33.5 million, which is the net result of $195.7 million of cash used in operating activities partially offset by a $0.02 million of cash provided by investing activities and $162.2 million of cash provided by financing activities. During the six months ended June 30, 2021, we experienced a net decrease in cash and cash equivalents in the amount of $26.6 million, which is the net result of $54.9 million of cash used in operating activities and $0.8 million of cash used in investing activities partially offset by $29.1 million of cash provided by financing activities.

As of June 30, 2022 and December 31, 2021, we had cash, cash equivalents and restricted cash of $13.2 million and $46.7 million, respectively, of which $12.5 and $43.4 million, respectively, is held in the Goldman Sachs Financial Square Government Institutional Fund. Cash held in demand deposit accounts may exceed the Federal Deposit Insurance Corporation (“FDIC”) insured limit and therefore is subject to credit risk. All of the Company’s cash deposits are held at large established high credit quality financial institutions, and management believes that the risk of loss associated with any uninsured balances is remote. As of June 30, 2022, we did not have any restricted cash. As of December 31, 2021, restricted cash consisted of approximately $15.1 million related to the Credit Suisse Credit Facility covenants. In conjunction with the maturity of the Credit Suisse Credit Facility on January 8, 2022, the restrictions on our cash thereunder expired.

As of June 30, 2022 and December 31, 2021, we had approximately $80.0 million and $38.1 million, respectively, of available borrowings under the KeyBank Credit Facility, subject to its terms and regulatory requirements. Cash and cash equivalents, taken together with available borrowings under the KeyBank Credit Facility, as of June 30, 2022, are expected to be sufficient for our investing activities and to conduct our operations in the near term.

Refer to “Item 1. Consolidated Financial Statements – Note 5 – Borrowings” included in the notes to our consolidated financial statements appearing elsewhere in this report for a discussion of our borrowings.

Reduced Asset Coverage Requirements

In accordance with the 1940 Act, with certain limited exceptions, we are only allowed to incur borrowings, issue debt securities or issue preferred stock, if immediately after the borrowing or issuance, the ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock, is at least 150%. On September 27, 2019, the Board, including a “required majority” (as such term is defined in Section 57(o) of the 1940 Act) and our initial stockholder approved the application to us of the 150% minimum asset coverage ratio set forth in Section 61(a)(2) of the 1940 Act. As a result, we are permitted to potentially borrow $2 for investment purposes of every $1 of investor equity. As of June 30, 2022, our asset coverage ratio was approximately 177.1% and our asset coverage ratio per unit was approximately $1,770. As of December 31, 2021, our asset coverage ratio was approximately 195.8% and our asset coverage ratio per unit was approximately $1,958.

93

Table of Contents

Commitments and Off-Balance Sheet Arrangements

Other than contractual commitments with respect to our portfolio companies and other legal contingencies incurred in the normal course of our business, we do not have any off-balance sheet financings or liabilities as of June 30, 2022 or December 31, 2021.

The Company’s commitments and contingencies consist primarily of unfunded commitments to extend credit in the form of loans to the Company’s portfolio companies. A portion of these unfunded contractual commitments as of June 30, 2022 and December 31, 2021 are dependent upon the portfolio company reaching certain milestones before the debt commitment becomes available. Furthermore, the Company’s credit agreements with its portfolio companies generally contain customary lending provisions that allow the Company relief from funding obligations for previously made commitments in instances where the underlying portfolio company experiences materially adverse events that affect the financial condition or business outlook for the company. Since a portion of these commitments may expire without being withdrawn, unfunded contractual commitments do not necessarily represent future cash requirements. As such, the Company’s disclosure of unfunded contractual commitments includes only those which are available at the request of the portfolio company and unencumbered by milestones. As of June 30, 2022 and December 31, 2021, the Company did not have any outstanding unfunded commitments. The Company will fund future unfunded commitments from the same sources it uses to fund its investment commitments that are funded at the time they are made (which are typically through existing cash and cash equivalents and borrowings under the KeyBank Credit Facility).

In the normal course of business, the Company enters into contracts that provide a variety of representations and warranties, and general indemnifications. Such contracts include those with certain service providers, brokers and trading counterparties. Any exposure to the Company under these arrangements is unknown as it would involve future claims that may be made against the Company; however, based on the Company’s experience, the risk of loss is remote and no such claims are expected to occur. As such, the Company has not accrued any liability in connection with such indemnifications.

Contractual Obligations

A summary of our contractual payment obligations as of June 30, 2022, is as follows:

    

Payments Due by Period

    

  

Less than 1

year

    

1 - 3 years

    

4 - 5 years

    

After 5 years

    

Total

KeyBank Credit Facility

$

220,000

220,000

2025 Notes

 

 

 

125,000

 

 

125,000

Convertible Notes

50,000

50,000

August 2026 Notes

125,000

125,000

December 2026 Notes

75,000

75,000

Operating Leases (1)

 

208

 

765

 

782

821

 

2,576

Total Contractual Obligations

$

208

$

765

$

595,782

$

821

$

597,576

(1)Relates to the lease for our headquarters in downtown Phoenix, Arizona which commenced on June 4, 2021. Also includes the lease for our Chandler office, which expires on July 31, 2022 and is subject to a five-year extension option that will not be exercised.

Distributions

We intend to pay quarterly distributions to our stockholders out of assets legally available for distribution. All distributions will be paid at the discretion of the Board and will depend on our earnings, financial condition, maintenance of our tax treatment as a RIC, compliance with applicable BDC regulations and such other factors as the Board may deem relevant from time to time.

94

Table of Contents

The following table summarizes distributions declared and/or paid by the Company since inception:

Declaration Date

Type

Record Date

Payment Date

Per Share Amount

May 7, 2020

Quarterly

May 29, 2020

June 5, 2020

$

0.22

August 10, 2020

Quarterly

August 21, 2020

September 4, 2020

0.27

November 9, 2020

Quarterly

November 20, 2020

December 4, 2020

0.27

December 22, 2020

Quarterly

December 30, 2020

January 15, 2021

0.27

March 23, 2021

Quarterly

March 31, 2021

April 16, 2021

0.28

June 15, 2021

Quarterly

June 30, 2021

July 15, 2021

0.29

September 13, 2021

Quarterly

September 30, 2021

October 15, 2021

0.33

December 16, 2021

Quarterly

December 31, 2021

January 14, 2022

0.36

March 15, 2022

Quarterly

March 31, 2022

April 15, 2022

0.40

March 15, 2022

Supplemental

March 31, 2022

April 15, 2022

0.15

June 15, 2022

Quarterly

June 30, 2022

July 15, 2022

0.42

June 15, 2022

Supplemental

June 30, 2022

July 15, 2022

0.15

Total

$

3.41

Price Range of Common Stock

Our common stock began trading on the Nasdaq Global Select Market (“Nasdaq”) on January 29, 2021 under the symbol “TRIN” in connection with our initial public offering, which closed on February 2, 2021 (“IPO”). Prior to our IPO, the shares of our common stock were offered and sold in transactions exempt from registration under the Securities Act. As such, there was no public market for shares of our common stock during our fiscal quarters and years preceding December 31, 2020. Since our IPO, our common stock has traded at prices both above and below our net asset value per share. It is not possible to predict whether our common stock will trade at a price per share at, above or below net asset value per share.

The following table sets forth the net asset value per share of our common stock, the range of high and low closing sales prices of our common stock reported on Nasdaq, the closing sales price as a premium (discount) to net asset value and the dividends declared by us in each fiscal quarter since we began trading on Nasdaq. On August 3, 2022, the last reported closing sales price of our common stock on Nasdaq was $14.94 per share, which represented a premium of approximately 2.2% to our net asset value per share of $14.62 as of June 30, 2022. As of August 3, 2022, we had approximately 90 stockholders of record, which does not include stockholders for whom shares are held in nominee or “street” name.

Price Range

 

Class and Period

Net Asset Value(1)

High

Low

High Sales Price Premium (Discount) to Net Asset Value(2)

Low Sales Price Premium (Discount) to Net Asset Value(2)

Cash Dividend Per Share(3)

Year Ending December 31, 2022

Third Quarter (through August 3, 2022)

*

$

15.02

$

14.01

*

*

*

Second Quarter

$

14.62

$

19.44

$

14.27

33.0

%

(2.4)

%

$

0.57

(5)

First Quarter

$

15.15

$

20.11

$

17.00

32.7

%

12.2

%

$

0.55

(5)

Year Ending December 31, 2021

Fourth Quarter

$

16.40

$

17.65

$

15.79

7.6

%

(3.7)

%

$

0.36

 

Third Quarter

$

14.70

$

16.73

$

14.14

13.8

%

(3.8)

%

$

0.33

Second Quarter

$

14.33

$

15.00

$

14.10

4.7

%

(1.6)

%

$

0.29

First Quarter(4)

$

13.69

$

15.65

$

13.75

14.3

%

0.4

%

$

0.28

95

Table of Contents

(1)Net asset value per share is determined as of the last day in the relevant quarter and therefore may not reflect the net asset value per share on the date of the high and low closing sales prices. The net asset values shown are based on outstanding shares at the end of the relevant quarter.
(2)Calculated as the respective high or low closing sales price less net asset value, divided by net asset value (in each case, as of the applicable quarter).
(3)Represents the dividend or distribution declared in the relevant quarter.
(4)Shares of our common stock began trading on Nasdaq on January 29, 2021, under the trading symbol “TRIN”.
(5)Consists of a quarterly dividend and a supplemental dividend.

* Not determined at time of filing.

Related Party Transactions

Certain members of management as well as employees of the Company hold shares of the Company’s stock.

We have entered into indemnification agreements with our directors and executive officers. The indemnification agreements are intended to provide our directors and executive officers with the maximum indemnification permitted under Maryland law and the 1940 Act. Each indemnification agreement provides that we shall indemnify the director or executive officer who is a party to the agreement, or an “Indemnitee,” including the advancement of legal expenses, if, by reason of his or her corporate status, the Indemnitee is, or is threatened to be, made a party to or a witness in any threatened, pending, or completed proceeding, to the maximum extent permitted by Maryland law and the 1940 Act.

Refer to “Item 1. Consolidated Financial Statements – Note 12 – Related Party Transactions” included in the notes to our consolidated financial statements appearing elsewhere in this report for additional information.

Recent Developments

On July 22, 2022, the Company issued $50.0 million in aggregate principal amount of the 2025 Notes in an additional issuance of such 2025 Notes. On July 27, 2022, the underwriters exercised their option, in full, to purchase from the Company an additional $7.5 million in aggregate principal amount of the 2025 Notes solely to cover over-allotments in accordance with the Underwriting Agreement. The 2025 Notes issued pursuant to this offering are treated as a single series with the existing 2025 Notes under the 2025 Notes Indenture (the “Existing 2025 Notes”) and have the same terms as the Existing 2025 Notes (other than issue date and issue price). The 2025 Notes have the same CUSIP number and are fungible and rank equally. Following this additional issuance of the 2025 Notes, the outstanding aggregate principal amount of the 2025 Notes is $182.5 million.

In connection with the additional issuance of the 2025 Notes, the 2025 Notes began trading on the Nasdaq Global Select Market under the symbol “TRINL” on July 29, 2022.

96

Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are subject to financial market risks, including valuation risk and interest rate risk. Uncertainty with respect to the economic effects of the COVID-19 pandemic has introduced significant volatility in the financial markets, and the effect of the volatility could materially impact our market risks, including those listed below.

Valuation Risk

Our investments may not have a readily available market price, and we value these investments at fair value as determined in good faith by the Board of Directors in accordance with our valuation policy. There is no single standard for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of our investments may fluctuate from period to period, including as a result of the impact of the COVID-19 pandemic on the economy and financial and capital markets. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been used had a ready market for the investments existed, and it is possible that the difference could be material.

Interest Rate Risk

Interest rate sensitivity and risk refer to the change in earnings that may result from changes in the level of interest rates. To the extent that we borrow money to make investments, including under the KeyBank Credit Facility or any future financing arrangement, our net investment income will be affected by the difference between the rate at which we borrow funds and the rate at which we invest these funds. In periods of rising interest rates, our cost of borrowing funds would increase, which may reduce our net investment income. As a result, there can be no assurance that a significant change in market interest rates, including as a result of inflation, will not have a material adverse effect on our net investment income.

As of June 30, 2022, approximately 64.4% of our debt investments based on outstanding principal balance represented floating-rate investments based on Prime or LIBOR, and approximately 35.6% of our debt investments based on outstanding principal balance represented fixed rate investments. In addition, borrowings under the KeyBank Credit Facility are subject to floating interest rates based on SOFR, generally bearing interest at a rate of the Term SOFR Reference Rate plus 2.85%. subject to the number of eligible debt investments in the collateral pool

Based on our Consolidated Statements of Operations as of June 30, 2022, the following table shows the annualized impact on net income of hypothetical base rate changes in the Prime rate on our debt investments (considering interest rate floors for floating rate instruments) and the hypothetical base rate changes in the SOFR on our KeyBank Credit Facility, assuming that there are no changes in our investment and borrowing structure (in thousands):

    

Interest

    

Interest

    

Net

Income

Expense

Income/(Loss)

Up 300 basis points

$

18,990

$

6,600

$

12,390

Up 200 basis points

$

12,643

$

4,400

$

8,243

Up 100 basis points

$

6,295

$

2,200

$

4,095

Down 100 basis points

$

(523)

$

(1,100)

$

577

Down 200 basis points

$

(7,260)

$

(1,100)

$

(6,160)

Down 300 basis points

$

(7,260)

$

(1,100)

$

(6,160)

97

Table of Contents

Currency Risk

In addition, any investments we make that are denominated in a foreign currency will be subject to risks associated with changes in currency exchange rates. These risks include the possibility of significant fluctuations in the foreign currency markets, the imposition or modification of foreign exchange controls and potential illiquidity in the secondary market. These risks will vary depending upon the currency or currencies involved. As of June 30, 2022, we had five foreign domiciled portfolio companies. Our exposure to currency risk related to the debt investments is minimal as payments from such portfolio companies are received in U.S. dollars. No other investments at June 30, 2022 were subject to currency risk.

Hedging

We do not currently engage in any hedging activities. However, we may, in the future, hedge against interest rate and currency exchange rate fluctuations by using standard hedging instruments such as futures, options and forward contracts subject to the requirements of the 1940 Act. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in benefits of lower interest rates with respect to our portfolio of investments with fixed interest rates. We may also borrow funds in local currency as a way to hedge our non-U.S. denominated investments.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

In accordance with Rules 13a-15(b) and 15d-15(b) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), we, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q and determined that our disclosure controls and procedures are effective as of the end of the period covered by this Quarterly Report on Form 10-Q.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the three months ended June 30, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

98

Table of Contents

PART II: OTHER INFORMATION

Item 1.  Legal Proceedings

We are not currently subject to any material legal proceedings, nor, to our knowledge, are any material legal proceedings threatened against us. From time to time, we may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. Furthermore, third parties may seek to impose liability on us in connection with the activities of our portfolio companies. Our business is also subject to extensive regulation, which may result in regulatory proceedings against us. While the outcome of these legal or regulatory proceedings cannot be predicted with certainty, we do not expect that these proceedings will have a material effect upon our financial condition or results of operations.

Item 1A. Risk Factors

Investing in our securities involves a number of significant risks. In addition to the other information set forth in this quarterly report on Form 10-Q, including the risk factors set forth below, you should carefully consider the risk factors discussed in “Item 1A. Risk Factors” of Annual Report on Form 10-K filed with the SEC on March 3, 2022, all of which could materially affect our business, financial condition and/or results of operations. Although the risks described below and in our other SEC filings referenced above represent the principal risks associated with an investment in us, they are not the only risks we face. Additional risks and uncertainties not currently known to us, or that we currently deem to be immaterial, might materially and adversely affect our business, financial condition and/or results of operations.

Other than as described below, during the six months ended June 30, 2022, there have been no material changes to the risk factors discussed in our SEC filings referenced above.

Existing stockholders may incur dilution if, in the future, we sell shares of our common stock in one or more offerings at prices below the then current net asset value per share of our common stock.

The 1940 Act prohibits us from selling shares of our common stock at a price below the current net asset value per share of such stock, with certain exceptions. One such exception is prior stockholder approval of issuances below net asset value provided that our Board of Directors makes certain determinations. At our 2022 Annual Meeting of Stockholders held on June 8, 2022, our stockholders voted to allow us to issue common stock at a price below net asset value per share for the period ending on the earlier of the one-year anniversary of the date of our 2022 Annual Meeting of Stockholders and the date of our 2023 Annual Meeting of Stockholders, which is expected to be held in May or June 2023. The proposal approved by our stockholders at our 2022 Annual Meeting of Stockholders did not specify a maximum discount below net asset value at which we are able to issue our common stock, although the number of shares sold in one or more offerings may not exceed 25% of our outstanding common stock as of the date of stockholder approval of this proposal.

If we were to issue or sell shares of our common stock at a price below our net asset value per share, such sales would result in an immediate dilution to our net asset value per share and pose a risk of dilution to our stockholders. In particular, stockholders who do not purchase additional shares at or below such discounted price in proportion to their current ownership will experience an immediate decrease in net asset value per share (as well as in the aggregate net asset value of their shares if they do not participate at all). These stockholders will also experience a disproportionately greater decrease in their participation in our earnings and assets and their voting power than the increase we experience in our assets, potential earning power and voting interests from such issuance or sale. In addition, such issuances or sales may adversely affect the price at which our common stock trades.

Because the number of shares of common stock that could be so issued and the timing of any issuance is not currently known, the actual dilutive effect cannot be predicted.

99

Table of Contents

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On July 15, 2022, pursuant to its amended and restated distribution reinvestment plan, the Company issued 49,840 shares of its common stock, at a price of $14.28 per share, to stockholders of record as of June 30, 2022 that did not opt out of the Company’s amended and restated distribution reinvestment plan in order to satisfy the reinvestment portion of the Company’s distribution. This issuance was not subject to the registration requirements of the Securities Act.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other Information

None.

100

Table of Contents

Item 6. Exhibits

The following exhibits are filed as part of this Quarterly Report on Form 10-Q or hereby incorporated by reference to exhibits previously filed with the SEC:

Exhibit
Number

    

Description of Exhibits

3.1

 

Articles of Amendment and Restatement (incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form 10 filed on January 16, 2020).

3.2

 

Bylaws (incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form 10 filed on January 16, 2020).

10.1

Underwriting Agreement, dated April 5, 2022, by among Trinity Capital Inc., on the one hand, and Keefe, Bruyette & Woods, Inc., Wells Fargo Securities, LLC and UBS Investment Bank, on the other hand, as representatives of the several underwriters named on Schedule A thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 7, 2022).

10.2

Second Amendment to Credit Agreement, dated as of April 13, 2022, relating to the KeyBank Credit Facility, by and among Trinity Capital Inc., as servicer, TrinCap Funding, LLC, as borrower, KeyBank National Association, as administrative agent and syndication agent, Wells Fargo, National Association, as collateral custodian and paying agent, and the lenders party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 19, 2022).

31.1*

 

Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*

 

Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*

 

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2*

 

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

*  Filed herewith

101

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

TRINITY CAPITAL INC.

Dated: August 4, 2022

By:

/s/ Steven L. Brown

Steven L. Brown

Chairman and Chief Executive Officer

(Principal Executive Officer)

Dated: August 4, 2022

By:

/s/ David Lund

David Lund

Chief Financial Officer and Treasurer

(Principal Financial and Accounting Officer)

102